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ABSTRACT 
The impact of comorbidity on patient outcomes following an intervention has been largely 
ignored. No studies have been reported in the UK or Japan. The aim of this thesis was to 
assess the impact of comorbidity on the outcome of a common major surgical operation -
total hip replacement. 
Comorbidity was measured using the Index of Co-Existent Disease developed in the 
USA, which reliability was assessed. Two retrospective cohorts, one in Japan and one in 
the UK were studied. Data were collected from patients' case notes extraction and by 
postal questionnaire to patients one year after surgery. 
Mter THR, patient's health status was improved in both countries and satisfaction for 
care was high. Significant differences in in-hospital complications were observed 
between Japan and the UK in terms of complication rate. type and severity, and their 
association with independent variables. Comorbidity was significantly associated with 
serious complications and with change in health status in the UK and with minor 
complications in Japan. 
A logistic regression model using the ICED and independent confounding factors 
suggested a significant relationship between comorbidity and complications. However, 
the model did not fit the data well. A multiple regression model for change in health status 
showed that much of the variance was explained by the preoperative health status but not 
by comorbidity. The low number of seIious complications in Japan and the high 
complication rate in patients in the lowest comorbidity severity level in the UK made the 
predicti ve power weak. 
Finally, through the experience of this study, some recommendations for clinical practice 
and further research are discussed. 
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1 Introduction 
Total hip replacement (THR) surgery is one of the most successful orthopaedic advances 
this century. It was preceded by two aIthroplastic measures, namely cup arthroplasty 
used to resurface the degenerated femoral head and femoral endoprosthesis used in the 
case of fracture of the neck of the femur. In the UK, Charnley's original THR consisted 
of acetabular and femoral components cemented to the bones. Continuous refmements in 
materials and design have established THR as the major solution for hip arthtitis. 
The pathology of hip arthritis includes both primary degenerative osteoarthritis and 
secondary arthritis following rheumatoid arthritis and other connective tissue disorders, 
trauma, and avasculaI' necrosis. The majOlity of patients undergoing THR today suffer 
from primaI'y osteoatthlitis which develops over decades and usually becomes evident 
after 60 years of age. 
Extended longevity has also led to increasing demand on functional status, in order to 
maintain an active life style and to sustain physical independence. Fitness of hip joints 
play an important part in detelmining a person's functional status. Joint degeneration is 
irreversible and patients may become confined to a wheelchair or be bedbound. Their 
quality of life can be reduced and their need for social resources such as health care and 
community welfare services increased. 
As the population ages, the prevalence of co-existent diseases increases. The extent of co-
existent diseases in patients with hip arthritis could have a significant impact on the 
outcome of any treatment, including THR. In many studies of therapeutic efficacy, 
however. restIictive eligibility cliteria have been employed to eliminate patients who have 
selious comorbid disease. As a result. studies that address whether treatments are 
effective among patients without comorbid conditions have limited generalisability. An 
alternative is to classify comorbidity and take it into account in a..l\sessing outcome. 
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Initially, comorbidity was measured using a dichotomous classification -the presence or 
absence of co-existent diseases- with no consideration of its sevelity. Then new indices 
were designed in the USA which considered the number and the severity of co-existent 
diseases. However, such measures have rarely been validated in other countries. 
Recently in the USA Greenfield and colleagues (1) demonstrated the presence and 
amount of co-existent disease to be a significant predictor of postoperative complications. 
Functional outcomes, such as disability, were also strongly related to pre-operative co-
existent disease. Moreover, a measure of co-existent disease was crucial in explaining 
differences between hospitals in recovery from THR. They suggested that information 
routinely available in almost every patient's medical record could be used to adjust for 
important differences between hospitals in the amount of co-existent disease suffered by 
their patients. If its not accounted for, compaIison of outcome between hospitals may be 
misleading. 
Previous studies on the appropriateness of total hip replacement have described wide 
variations among surgeons in their views of the importance of the presence or absence of 
different levels of comorbidity (2). Therefore the impact of comorbidity needs to be 
clarified to enable better agreement on appropriate clinical indications for THR to be 
achieved. 
This chapter first reviews the development of methods for measUling comorbidity, then 
the literature on the indications for and the outcome of THR, before desclibing the aims 
and objectives of this thesis. 
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2 . Comorbidity 
2-1. The need for outcome assessment 
As the population ages, demand grows for a wider range of health services to meet 
elderly specific patho-physiology (3). Advancing science and technology have brought 
about more possibilities to cure diseases, though doubts are being raised about the 
efficacy of some expensive medical procedures (4). Consequently, payers, purchasers. 
providers, and more recently patients have been seeking ways to deliver maximally 
effective care as cheaply as possible (5). 
2-1a. A blief history of outcome research 
One of the first advocates of studies that measure patient outcomes was Codman (6). 
What he called the "end result" of care in the evaluation of clinical practice was not only a 
professional activity, but also an organisationaL administrative, and economic enterprise. 
His work was followed by researchers such as Shapiro at the Health Insurance Plan of 
Greater New York, in the study of prematUlity and perinatal m011ality (7). In the UK, 
Lipworth compared case fatality in teaching and non-teaching hospitals (8). 
Quality is often discussed in terms of the structure, process and outcome of care (9). In 
the history of research on quality of care, most emphasis has been on the measurement of 
the process of care and within that on of the technical quality of care (10-12). Donabedian 
cites the work of Lee and Jones (13) as the landmark study on the process of care as it 
offered a concept of quality. a declaration of socially responsible professional norms as 
the standards of assessment, and an explicit enunciation of such standards (14). 
There have also been explorations of the relationship between process and structure, such 
as studies of implicit / explicit criteria and auditing (15-17). The degree of agreement on 
criteria has been studied among members of groups of physicians. as well as among 
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groups of physicians differentiated by specialty or other attributes (18). Another 
refinement in establishing criteria of process has involved linking criteria formulation 
more directly to decision analysis (15,19). 
Recently the emphasis has returned to patient outcomes. For instance, the loint 
Commission on Accreditation of Healthcare Organizations has embarked on a shift 
toward outcome measurement. Also, the Health Care Financing Administration has 
released Medicare mOitality data in an attempt to monitor the effectiveness of health care 
providers. In addition, a concern with patient outcomes strongly drives the current 
directions of research on equity in health services such as geographic v3.1iations in the use 
of services (20). 
The reason for this shift of research interest from process of care to outcome is partly 
because process criteria have often been difficult to relate to patient outcome (11, 12, 21-
23). In addition, Lohr attributes the change of emphasis partly to "health accounting" (24) 
concepts, which arose from the growing concern about the impact of cost (or 
expenditure) containment on patient well-being. 
2-1b. Methods for evaluating effectiveness 
Broadly speaking, there are two methods for evaluating the effectiveness of health care -
experimental and observational. 
Well-conducted randomised controlled trials (RCTs) remain the ideal method for 
assessing effectiveness. However, an exclusive reliance on RCTs to provide definite 
infOimation about effectiveness is not the answer (5). RCTs are out of the question when 
there is little uncertainty among clinicians. In addition, they may require too many 
resources, take too long to conduct, exclude some subgroups of patienl~ who are too ill 
or too difficult to enroll for randomisation, and meet with ethical objections. 
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In addition to randomised studies. evaluation of effectiveness requires the complementary 
and intelligent use of adm inistrati ve and scientific data sets, a variety of which have been 
established and have become increasingly important resources for research. In health 
services research, the following data sources exist (25.26): i) administrative data; ii) 
medical record information; iii) patient-derived data. Studies have focused primarily on 
the first two. 
Claims-based databases maintained by medical insurance plans have been used (27,28). 
Roos describes the potential benefits of such data as "the availability of population-based 
information in many jutisdictions; large numbers of cases; long-term follow-up; relatively 
low cost compared with primary data collection; and the possibility of record linkage to 
further increase the information available"(28). Although it appeals in such practical 
implications as the costliness and feasibility of using the system, there are serious 
limitations regarding information on severity and comorbidity. In addition. the way a 
system is developed may have implications for its generalisability to other data bases or 
health care settings. Therefore, it is suggested that it should be used with great caution 
because data elements contain only limited clinical information and the accuracy of some 
elements is uncertain (29,30). Moreover, bias in reporting may occur. For example, 
chronic disorders are often underreported for patients with life-threatening disorders 
(31,32). Mendenhall attributes the difficulty of relating billing data to quality assurance as 
follows: perceived lack of clinical content; the organisation of data with no logical 
taxonomic structure; the lack of uniformity in billing definition; and the lack of data 
comparability between hospitals (33). 
An alternative is to use medical records. There has been a fair amount of attention paid to 
the completeness and accuracy of the record. and to the implications of this to quality 
assessment as well as clinical management (34-36). Iezzoni has described difficulties in 
the use of medical records for health services research. These include: the quality of 
clinical information in terms of completeness. accuracy. and validity: concerns about the 
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confidentiality of patient data infl uencing the infonnation kept in the records: and the high 
cost of research based on medical record extraction (26). Particularly for the quality of 
clinical information, Iezzoni summarised possible biases as: those existing in the nature 
of the data elements (e.g. technology dependence); those in the data collection approach 
(e.g. differences in case note documentation); and those in the severity findings by 
manipulation of clinical data (e.g. by increasing testing). Moreover. to collect such data, 
"a good reviewer must remain vigilant, to spot the unexpected but significant findings 
amid all the normal material" and it requires a well-ordered, well-dated. legible, and 
complete medical record which is an unattainable ideal in current system (37). 
2-1 Co Measures of outcome 
As the end results of medical care. the concept of outcome usually direcl~ attention to the 
classic five Ds which measure negative rather than positive outcomes: death, disease. 
disability, discomfort, and dissatisfaction (10). 
(c-l) Mortality 
Using routine official information, death is frequently related to several standard time 
period; in hospital- (38,39), 30 days- (31,40,41), 60 days- (42), 1 year- (43-45), or 
longer (46,47). MOltality has often been compared among hospitals as a surrogate index 
of their quality of care (20,48-51). For example, significantly higher death rates have 
been detected for patients operated in small hospitals (20). On the other hand, risk-
adjusted mortality indices suggest such differences depend on the time period chosen 
(48). 
(c-2) Complications and adverse outcomes 
Death is a relatively unusual consequence for most medical and surgical care. so other 
outcome measures have been used. For example, wound infection rates have been 
compared by surgeons as an indicator of the care delivered by their colleagues (52). and 
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adverse events or complications have been used to compare health care providers (45,53-
55). Brennan et al suggest that adverse events and negligence are not randomly 
distributed and that certain types of hospitals have significantly higher rates of injuries 
due to substandard care (53). 
One methodological problem in this area is the semantic distinction between acute 
comorbidities, complications, iatrogenic illnesses, adverse events, and other similar 
terms. Whether it is important to distinguish acute comorbidities related to a natural 
progression of an underlying disease versus those caused by iatrogenic events depends 
on the research goals. 
(c-3) Symptoms, health status, and quality of life 
Other frequently employed measurements are patients' self-evaluation of any change in 
symptoms, in daily functioning, or in their sense of well-being and the health-related 
quality of life (5). Indeed, the positive aspects of health have recently become preferred, 
including states of physiologic. physical, and emotional health, and satisfaction (10). For 
example, in studies of chronic diseases in which mOltality is rare and the goal of medical 
care is to control the course of the disease and improve quality of life. the use of patient 
reported measures of health status is especially impOltant. Even trials for treatment of life 
threatening disease such as cancer have come to require more regular inclusion of qUality 
of life and outcome measure (56-58). Overall, Nelson has concluded that "the 
measurement of health and function is reaching its matUlity as a technical science" and "to 
move their use outside the laboratory will now require investment in assessing not their 
validity but their clinical utility." (59) 
2-ld. The need for lisk adjustment 
Since the need for risk adjustment was understood in outcome research. the use of crude 
data has been cliticised as of little value and potentially misleading. For example. a study 
of 361 hospitals with outlier m0l1ality rates revealed that only 6% were of substandard 
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quality as judged by a peer review organisation (60). On the other hand. another report 
found that some hospitals with known quality shortfalls were not predicted by mortality 
statistics (61). 
2-2. Risk adjustment 
Study of risk has been in progress on many aspects of life especially about physical 
hazards, because of the immediate and obvious relationship between cause and effect. In 
the UK, the Royal Society defined 'risk' as the probability of an adverse event. (62) 
In health care research, in order to adjust for risks a method" should control for multiple 
dimensions of risk, including the risk associated with given clinical conditions, the risk 
associated with different diagnostic or operative approaches to care, and the risk 
associated with different levels of patient severity of illness"(48). A good categOlisation 
system for risk measurement, Horn suggests. should have medical meaningfulness of the 
groups, homogeneity within the groups, and depend on intrinsic patient characteristics 
(63). Consequently the best choice of variables depends on the ultimate use of the 
system. 
Efforts to adjust risks for severity of illness have led to the emergence of a variety of 
scales. Some are developed with the aim of adjusting for resource utilisation, while 
others for outcome assessment. Some scales are diagnosis- or disease-specific, while 
others are generic. For the source of information, many measures use computerised 
databases such as insurance claims data or discharge abstracts. but some require complete 
medical record review or prospective data collection. Methods included in this review are 
limited to methods applied to hospitalised patients. For primary care or ambulatory 
patients. several methods have also been developed (64-70). 
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2-2a. Adjustment for resource use 
(a-I) DRGs (Diagnosis-Related Groups) 
In the enactment and implementation of the prospective payment system for hospitals in 
the USA, Health Care Financing Administration instituted the DRG classification and 
reimbursement system for payment of inpatient hospital care for Medicare beneficimies 
(71). The system is essentially a case-mix system to reimburse hospitals for treating 
patients based on the average amount of hospital resources used in treating a patient 
within a particular diagnostic category. The major improvement in the revised version 
which classifies patients into 470 categories, were adjustments for surgical procedures, 
comorbidities, complications, and in some cases, age and sex (72,73). 
Iezzoni has criticised medical DRGs because of the possibility of clinical overlap (74). 
Although supposedly a diagnosis-specific scale, some DRGs are symptom-related, 
pathology-related, or severity-related. Clinically, many medical DRGs are not mutually 
exclusive because they are based on the ICD-9-CM coding system which groups diseases 
by anatomical site. Gonnella has also questioned the homogeneity of the diseases, the 
arbitrary classification by age and complication/comorbidity. the partitioning of cases into 
medical and surgical treatment. and the fact that it is based upon actual utilisation patterns 
(75). 
(a-2) PMCs (Patient Management Categories) 
Developed by Young (76). this system seeks to develop physician-identified patient 
categories that are based on information obtained from both patient admission and 
discharge records. Data for analysis are obtained from computerised discharge abstracts 
which review the entire hospitalisation. Patients are categorised by considering both the 
reason for admission and the discharge diagnosis together. Anticipated components of 
care are identified for each PMC and together with estimates of relative costs for each 
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component, an estimate of total expected resource use is developed. Therefore the 
emphasis is placed on identification of necessary and effective treatment modalities rather 
than focusing on actual resource use. The derivation and validation of this scale has been 
reported recently by the developers (77). 
(a-3) RUGs (Resource Utilisation Groups) 
Originally developed by Fries and Cooney (78), this classification system clusters 
patients with similar relative needs for resources, in particular, nursing time. RUG-II 
used in New York, is a new version that has replaced an average cost Medicaid payment 
system with a prospective case-mix adjusted per diem payment. RUG-II classifies 
patients into one of five groups (special care, rehabilitation, clinically complex, severe 
behavioral problems, reduced physical functioning), then divides them into sub-groups 
based on an activity of daily living score. The introduction of RUG-II has brought a 
significant change in the mix of patient admitted to nursing homes, particularly to those 
financially constrained (79,80). 
2-2b. Adjustment for outcome assessment 
(b-l) DS (Disease Staging) 
Developed by Gonnella et al (81.82), this is a method for measuring the severity of 
specific, well-defined diseases. Severity is defined as the likelihood of death or residual 
impairment as a result of the disease. A diagnosis is classified according to: the 
characteristic pathophysiological change in the organ or organ system involved; the 
etiologic factor or set of factors causing the pathophysiological changes; and the severity 
of the problem. In staging. diseases are generally divided into four categories of severity: 
from stage 1, conditions with no complications or problems of minimal severity. to stage 
4, death. Medical staging clitetia have been developed for 420 diagnoses and a computer 
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software system has been developed to employ staging on large-scale data bases (83). 
However, Brewster criticises it in that it is still based on discharge diagnosis and requires 
information on the entire stay (84). Moreover, because it allocates patients over four 
levels, it limits cases to two or three categories. 
(b-2) COMPLEX (Disease Complexity) 
Developed by the Mayo Clinic study group in 1992. this is an adaptation of the 
computerised version of Disease Staging to provide a general measure of disease 
complexity on discharge (42). It counts significantly affected body systems (unrelated 
conditions) - those that have at least one diagnostic category with a sevetity rank of 2 or 
more - for each patient. The severity ranking system used is adapted from the Disease 
Staging system, ranging from stage 1 to 4. By taking advantage of the classification of 
each disease category into 1 of 16 body systems, COMPLEX provides a measure that 
decreases the effect of possible redundancy and relatively minor conditions. When 
examined in a population aged 65 years or older, a significant association was observed 
between the COMPLEX score and hospital readmission after adjustment for age, sex, 
diagnosis, and severity. As COMPLEX is based on hospital discharge abstracts and the 
ICD-9 coding system, it suffers from a lack of precision. 
(b-3) MEDISGRPS (The Medical Illness Sevetity Grouping System) 
MEDISGRPS is a prominent, proprietary sevel;ty-measurement system (84). It produces 
admission scores from 0 through 4, indicating increasing Iisk of short tenn organ failure. 
Independent of diagnosis. however, many key clinical findings are disease specific. The 
first review (the admission review) is derived from testing within two days of admission. 
Review 2 (the midstay review) aims to identify morbidity arising during the 
hospitalization and to assess whether the patient has responded to treatment. Given that 
many key clinical findings are condition-specific. it closely resembles the clinical 
components of nongeneric severity algorithms. such a..o.; the medical criteria version of 
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Disease Staging or the Computerized Severity Index. In reviewing MEDISGRPS, Iezzoni 
has criticised the relatively heavy weight given to findings from specialised diagnostic 
technologies which could affect comparisons across hospitals of different teaching status 
and practices for their diagnostic workups; its generic nature the simplicity of which 
exacts a certain cost, and the equal weight on failures across organ systems; and its 
untested utility for widespread quality measurement. However, when MEDISGRPS was 
applied to general medical patients in an English teaching hospital, a highly significant 
association was observed between increasing severity and both length of stay and 
mortality (85). 
(b-4) ASA-PS (The Physical Status Classification by the AmeIican Society of 
Anesthesiolo gists) 
This is the most widely used risk adjustment method in clinical settings to standardise 
physical status (86,87). When Dlipps and his colleagues examined 33,224 patients given 
anaesthesia, the classification clearly showed that death was related to the physical 
condition of the patient (86). The scale assigns patient's physical status into five classes; 
from class 1, a normally healthy patient, to class 5, a moribund patient who is not 
expected to survive for 24 hours with or without operation. The consistency of the ASA-
PS was tested by a questionnaire sent to 304 anesthesiologists (87). When ten 
hypothetical patients were scored, the mean number of patients rated consistently was 
5.9. The anesthesiologists differed in their judgement of patients who were elderly, 
obese, had a previous myocardial infarction, and or anemic. 
(b-5) APACHE (Acute Physiology and Chronic Health Evaluation) 
First developed in 1981 (88). this is frequently used in critical care medicine. Revised 
twice later (89,90), the APACHE scoling system has been widely studied in intensive 
care (38). Originally developed for estimation of the pretreatment risk of death in severely 
ill patients, a review of 5.020 patient~ in intensive care demonstrated it was a useful tool 
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to predict hospital mortality. APACHE II had subsequently been applied in the UK (91), 
New Zealand and Japan (92,93). 
(b-6) SOIl (Severity of Illness Index) and CSI (Computerised Sevelity Index) 
The Severity of lliness (SOIl) Index, one of the more comprehensive indicators, has been 
extensively studied (94-97). It evolved from the AS-SCORE instrument which included 
data on a patient's age, single- or multiple-organ system involvement. stage of disease, 
complications, and response to therapy (98). Developed plimruily as a statistical tool, the 
index is designed to reflect the relative sevelity of illness across patients, not diagnoses or 
diseases. The index is based on seven criteria: stage of the principal diagnosis: other 
interacting conditions that the patient has and that affect the hospital stay: rate of response 
to therapy or rate of recovery: residual impairment remaining after therapy for the acute 
aspect of the hospitalisation: complications of the principal diagnosis: dependency on 
hospital (primmily nursing) staff: and extent of non-operating-room procedures. Each of 
these variables is scored into one of four levels of increasing severity. 
For the CSt data are gathered at several points dUling the hospital stay to monitor the 
quality of care (95). Reliability and validity has been demonstrated by the developers 
(99,100), though it has not been replicated by other researchers (101). 
2-2c. Limitations of risk adjustment methods 
There is much confusion about the role of lisk adjustment systems in clinical research, 
quality assurance. and clinical decision making. pardy because of a lack of clarity about 
the relationship between the methodological requirements of a SCOling system and the 
purpose for which it is developed and used (102). Four principal aspects need to be 
considered when developing or assessing a method. 
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(c-l) Balance between data simplicity and predictive power 
The desire to treat all cases identically introduces simplicity that is appealing, especially in 
the midst of the vagaries of diagnostic terminology. Particularly for generic scales, it is a 
dilemma to improve predictive power in a simplified measurement. As a result systems 
are sometimes criticised because of the limited number of risk factors incorporated. For 
example, comparing surgical infection rates has been questioned because data were "not 
controlled for the patient's underlying illness before surgery, the duration of preoperative 
hospitalisation, the duration of the operation, and several other factors known to alter the 
risk of postoperative infection"(103). Also in attempting to evaluate the usefulness of 
ASA PS, Cohen found it "appears to predict intraoperative and major postoperative 
complications independently, but alone it is insufficient to predict anesthetic morbidity in 
the immediate postoperative period"(104,105). Similar difficulty was also reported in 
another study (27,28). 
At the other extreme, problems arise from the detailed measurement required by some 
methods, such as the CSI. Measures include the response to therapy, procedures 
performed, impairment remaining, as well as laboratory data. "One of its significant 
drawbacks", Gross remarks, "is that it takes 5 to 30 minutes to score a patient"(l06). 
Some are so complex that they require an expensive computerised program for analysis. 
(c-2) Reliability of the method 
Risk adjustment methods must be able to be reapplied consistently by the same observer 
or rater (intrarater reliability) or by different raters (interrater reliability). Agreement 
among different raters is a more rigorous test of reliability and is the usual focus of 
reliability analyses. There are two possible reasons for poor inter-rater reliability: the 
method is flawed or implementation is poor. Many scores specifically eliminate groups of 
patients to improve their predictive power but as a result are subject to selection bias, 
which preclude their universal use. 
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In testing several methods, Schumacher found both the SOIl and the Adverse Patient 
Occurrence Index (APOl) had low interrater-agreement (107). After failing to achieve 
satisfactory agreement, the lack of rater's training was claimed by the designer (l08). 
Acknowledging the importance of full training, however, the study group suggested the 
reasons for poor performance were: an environment where case notes were unfamiliar to 
raters, with time pressures and no help from colleagues: the lack of a reference group: the 
unequal probability of cases occurring in a given level: and better reliability at the 
extremes of severity. The risk of the use of a single method to summatise data has been 
previously described (109). Schumacher has suggested a disease-specific analysis and 
payment-appeal process as more appropriate than system-wide adjustments with single 
unreliable insttuments (107). 
(c-3) Validity of the method 
Validity is a multidimensional concept. According to Donabedian. "the question of 
validity covers two large domains. The first has to do with the accuracy of the data and 
the precision of the measures that are constructed with these data. The second has to do 
with the justifiability of the inferences that are drawn from the data and the 
measurements" (1 10). Given different notions of risk and outcome, assessing the validity 
of a risk adjustment method requires careful attention to the fundamental 
conceptualisation of lisk, illness, outcome, and the goals of the analysis. 
Among numerous different dimensions of validity, Iezzoni recommended the following 
as the most important: face validity, content validity, criterion or construct validity, 
predictive validity, and atttibutional validity (26). 
Methods may be invalid for several reasons. Vincent suggested the subjectivity of the 
score. advances in therapy. and the influence of a given therapy (lll). Scoring systems 
may also not be supelior to assessment by doctors and nurses. and more sophistication is 
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required (112). Due to their low sensitivity and specificity, methods will probably not 
apply to individual decisions. 
International application of measures also requires special attention. For example, 
APACHE II (91) and MEDISGRPS (85), both developed in the USA. were shown not 
to be valid in the UK and Ireland. In review of 8,796 admissions to intensive care units. 
the APACHE II equation was found not to fit the British and ltish data uniformly and 
straight use of American equation was warned (91). Similarly when MEDISGRPS was 
applied to English patients, diagnostic group alone accounted for about twice the amount 
of variation explained by severity (85). 
(c-4) Lack of comorbidity data 
Another criticism has focused on the failure of lisk adjustment methods to include 
information on comorbidity (20,113). Most of these systems fundamentally ignore the 
concept of complexity of illness, which encompasses comorbidities, their interactions, 
and the resultant effect on a patient's health. Although the Q-scale in the Disease Staging 
system (83) combines information from coexisting diseases, it weights the categories by 
expected utilisation of resources and thereby potentially limits its usefulness for adjusting 
for outcome. Specific comorbidities have been demonstrated as having an association 
with particular outcomes such that they should be included as separate covariates in a risk 
adjustment method (42). Questions have also been raised as to whether large 
intermodality differences in outcome may have resulted from comorbidity differences 
(43,114). 
Even if comorbidity is considered in case-mix adjustment. special attention needs to be 
paid to how it is measured. Only those diseases and health problems that a patient has 
before an intervention should be classified as comorbidities. Any new problems arising 
after the intervention should be classified as complications and included as outcomes. 
Shapiro classified comorbidity into "limited other diagnoses" (secondary diagnoses that 
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were very unlikely to result from care received) and "full other diagnoses" (all secondary 
diagnoses irrespective of whether they might have been due to care received) (115). 
Estimates of mortality differences were substantially affected by which secondary 
diagnoses were used in the case-mix adjustment. The study concluded that "judgments of 
quality should not be based on administrative data unless models can be developed that 
validly capture level of sickness at admission." 
2-3. Measurement of comorbidity 
Although co-existent conditions may effect outcome (5,25), few studies have addressed 
the impact of the extent and intensity of co-existent disease. Outcomes obtained may be 
due more to the differences in prognostic factors than to the medical care received 
(43,114). In studies of the effectiveness of care, the need to measure and adjust for 
comorbidity to predict prognoses such as postoperative hospital complications, long-term 
recovery from surgery or health status has been recognised (31.40). For examples, 
illustrate this. First, in a population-based study of osteoporotic hip fracture, Fisher 
found that at younger ages the presence of comorbidity or residence in a nursing home 
was more strongly related to survival than at older ages (44). Second. in a study of 
patients with end-stage renal disease it was shown that lower mortality rates for transplant 
recipients relative to dialysis patients are due, in part, to a healthier case mix among 
patients receiving transplants (116). Third, Hall suggested measures of the severity of 
illness and the extent of comorbidity were more important in determining the risk of a 
poor outcome than was the identity of the diseased organ (117). And finally, Greenfield 
and colleagues found that comorbidity was a critical factor when assessing the quality of 
patient care and when compating patient outcomes in different hospitals (113). 
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2-3a. Early days 
In reviewing the days before comorbidity was studied, Feinstein described how "the 
inter-relationships and effects of multiple diseases have not received suitable taxonomic 
attention in clinical science. In the statistics assembled for both the occurrence and 
management of human ailments, sick people usually receive strictly one-disease 
classifications that ignore the co-morbidity of other diseases occuning in addition to the 
index disease under consideration"(118). Such problems were not paI1icuiarly important 
when much epidemiological and clinical science was concerned with the relatively 
uniform events that occun'ed during epidemics of acute infectious disease. However. it 
became a major barrier in the modern era of chronic diseases. 
The most primitive step in adjustment is to classify patients by the presence or absence of 
any comorbidity. However, Jencks found that when any comorbid condition was 
included (whether it was an acute, active problem or a chronic and inactive problem), it 
did not always cOlTelate with patient outcome, in pat1icular, with inpatient mortality (31). 
In contrast, Munoz correlated the total number of additional ICD-9-CM codes beyond the 
principal diagnosis with m0l1ality and showed a direct correlation (119). 
2-3b. Classification by Kaplan & Feinstein 
One of the earliest attempts to classify comorbid conditions was developed by Kaplan and 
Feinstein. They classified each comorbid diagnosis from grade 0 to 3 depending on the 
severity of the disease (118,120). 
First, they measured comorbidity at three times; initial, post-zero interval (the time of 
entry to the study), and subsequent co-morbidity (including complication). The initial 
comorbidity was further classified into diagnostic, prognostic, and pathogenic. In their 
classification of diabetes mellinls, pathogenic type was further recorded as either vascular 
or nonvascular. Also prognostic severity was classified as either cogent or non-cogent 
depending on whether it might be expected to impair a patient's long-tenn survival. 
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Hence, the term non-cogent was applied to chronic conditions that could be well 
controlled with or without medication and that had no direct effects on vital organs. 
Similarly, episodic events that had occurred once in the past without involvement of the 
heart or brain, and without permanent effects were termed non-cogent. The severity of 
cogent comorbidity was classified as Grades 1,2, and 3 (The Grade 0 was for those with 
non-cogent or no comorbidity) (120). Pompei et al applied this classification to examine 
one year mortality prediction, and found that increasing severity of comorbidity correlated 
with one year survival (43). In their following study, the predictive ability was shown to 
be limited to one year mortality (45). 
Applying the Kaplan-Feinstein index, Pompei et al showed that the number of comorbid 
conditions was an independent predictor of survival during hospitalisation (43,45). They 
found only severe comorbidity was associated with a decreased survival after taking into 
account functional ability and illness severity, and suggested the use of such predictors of 
prognosis to complement any disease specific staging system which might be available 
(43). 
2-3c. Charlson index and the issue of weighting 
Kaplan and Feinstein's approach was fmther developed and modified by Charlson who 
produced a predictor of in-hospital mortality (121). This index was developed to predict 
risk of death attributable to comorbid diseases, not to primary diseases. Conditions that 
had completely resolved or a history of operation for currently inactive conditions were 
not counted as comorbid diseases. The comorbid conditions were classified according to 
the taxonomy devised by Kaplan and Feinstein (120). Then a weighted index was 
developed based on the in-hospital and one year mortality data according to the relative 
risk, to assign each comorbidity a weight ranging from I to 3. 
In effect, this approach does not take into account the severity of a comorbid disease but 
il'i diagnosis. It adjusts risk by assigning different weights. For example. for metastatic 
solid tumor of the acquired immune deficiency syndrome, the assigned weight was 6 
while most other comorbidities were assigned either 1 or 2. These weighted 
comorbidities were added together to produce a total burden of comorbidity. The index 
was tested on plimary breast cancer patients and proved its reliability and validity. 
The differences between the Kaplan-Feinstein comorbidity grade and Charlson index are 
that the former counts the sevelity of each comorbidity while the latter does not, and the 
former takes the peak intensity of comorbidities whereas the latter sums up each weight to 
derive a total score. Despite such differences, a high correlation was observed between 
these two indices when comorbidity was incorporated in a comparison of mortality 
following transurethral resection of the prostate and open prostatectomy (47). 
The Charlson index has also been used successfully when dichotomised into those with 
and those without comorbidity. Fisher showed case fatality following hip fracture was 
higher for those who had documented comorbidity (44). In attempting to improve risk 
adjustment in claims-based research Roos showed that the dichotomised Charlson index 
was satisfactory for the studied population. However for other popUlations, they 
suggested it might provide valuable additional information if not dichotomised (27). 
When it was applied to the analysis of mortality and reoperation after prostatectomy, no 
change was found in the relative risk before and after including comorbidities in the risk 
adjustment (46,122). 
Originally the Charlson index was designed for use with medical records. However, 
Deyo examined this index on administrative databases applying the International 
Classification of Diseases (lCD-9-CM) diagnosis and found an association with 
postoperative complications, mortality, blood transfusion, discharge to nursing home, 
length of hospital stay. and hospital charges (123.124). 
In contrast. Romano argued that the Charlson index should be applied with great caution 
to administrative data because different investigators working independently assigned 
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different sets of ICD-9-CM codes to the same Charlson-defined comorbidities (125). 
Also, he suggested that comorbid conditions have different clinical significance 
depending on the primary diagnosis or surgical procedure. In addition. summation of 
comorbidities has been disputed. Finally, the Charlson index has been criticised as 
having too few observations to exclude significant interactions among patients with 
multiple comorbidities. Romano recommended investigators should use their own data to 
re-estimate the weights, especially if a dependent variable other than I-year mortality is 
under consideration 025-127). 
2-3d. Composite index 
To avoid relying on a single index which assessed only diagnoses. Greenfield and 
colleagues included two other additional aspects into their original Comorbidity Index: 
(i) the baseline sevel;ty of the comorbid condition when first diagnosed; 
(ii) any acute exacerbation at the time of the hospital admission; and 
(iii) the functional status or the effect of all diseases on a patient at that point in time. 
Using this index, wide variation in case-mix was demonstrated among elderly cancer 
patients (13) which accounted for some of the observed differences in hospital 
mortality. Similarly, the relationship between patient age and the patterns of care in 
prostatectomy and breast cancer patients was demonstrated (54,128). Ellwood found this 
index of particular appeal for widespread use in outcomes management because of its 
reliability, feasibility, and comprehensiveness (4). 
This index was later modified to the Index of Co-Existent Disease (ICED) 0,129), 
eliminating acute exacerbation from the original. Using the ICED in the USA, Greenfield 
et al (1) have determined the extent to which co-existent disease predicted the occurrence 
of in-hospital complications and one-year self-reported health status for patients 
undergoing a total hip replacement. Complication rates ranged from 3% to..+l % between 
the lowest and the highest levels of the ICED. Moreover. health status a year after 
surgery was also strongly related to ICED scores after controlling for gender. age. 
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education, and marital status. Furthermore, inclusion of the ICED for adjustment of 
patient charactetistics diminished differences among hospitals. 
Cleary et al used the ICED for adjustment of length of stay for six medical and surgical 
conditions (129). Statistical adjustment for case-mix differences using the ICED 
accounted for most of the interhospital differences in length of stay for total hip 
replacement, but little for other conditions such as acute myocardial infarction and 
cholecystectom y. 
Subsequently, in an application of their ICED in a retrospective cohort study in Italy, 
Nicolucci and colleagues found that comorbidity was a powerful independent prognostic 
factor in determining mortality of end-stage renal disease patients (130). Another study 
on 69 peritoneal dialysis patients by Athienites et al also supported this finding, and 
suggested the ICED was more informative than simple enumeration of comorbid 
conditions (131). 
ICED has also been used to explore the relationship between case-mix and hospital 
readmission (132). In an attempt to identify patients at increased risk for hospital 
readmission, Waite et al used the Charlson Index, Kaplan-Feinstein Index, and the 
ICED. The result suggested none of these three indices disctiminated among patients who 
did and those who did not have 6-month hospital readmissions, and factors other than 
summary scores derived from these indices should be used to identify patients at high 
risk for admission. 
There are no published studies of the use of any of these three indices in the UK. Their 
validity and reliability in the UK therefore remains untested and unknown. 
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· 3. Total hip replacement (THR) 
3-1. Introduction 
Present artificial hip-joint surgery has developed from implants for patients with femoral 
neck fractures. Because of poor bony union after subcapital femoral neck fracture, 
endoprosthesis surgery was designed to replace bone with metallic implants consisting of 
a large femoral head and long stem (133-135). For degenerated hip arthrosis. however. a 
solution was also required for the damaged acetabulum. Early attempts failed in long term 
use (136-138). The success of today's THR owes much to the pioneering work by John 
Charnley. After his series of experiments (139). Charnley developed a low-friction 
arthroplasty with a polyethylene acetabular component and a femoral prosthesis with a 
small head. He also used polymethylmethacrylate as cement to fix these implants to bones 
(138). Those investigations served as landmark studies in the comprehension of joint 
function (140). However, the problems of wear, granuloma formation. and bone lysis 
nearly ended Chatnley's project. The failure rate was as high as 95%. Moreover, he had 
encountered a sepsis rate of nearly 10% accompanied by clinical disasters and massive 
human morbidity. To combat these disappointments. Charnley developed unique 
operating facilities to eliminate operative infection and found new plastic material for the 
acetabular component (141). 
Charnley's THR was certainly far more stable than earlier versions. In later years 
however increasing numbers of mechanical failures led to a reconsideration of the use of 
cement. So many new designs and techniques were developed in the 1980s, together with 
the development of the cementless THR such as press-fit, porous-coated, and threaded 
implants. Greater survival of prostheses was expected for cementless THR (142). The 
use of cement has also been questioned because of possible cardiac toxicity due to the 
monomers it contains and the longer duration of surgery (143). However, cementless 
THR has been criticised because its sUIface area may be too small to assure rigid bonding 
(144). 
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Recently hybrid THRs, in which a cementless acetabular component is combined with a 
cemented femoral component, have been tried as a solution. Preliminary results reported 
excellent pain relief and radiographic stability (145,146). Moreover, it requires shorter 
operating time, less blood loss, and does not require a trochanter osteotomy. An 
increased range of motion was also reported (147), although the rate of hypertrophic 
ossification varies (145,148). As these reports are of short follow-up studies. further 
investigation should be awaited. This is the introduction of a new concept that each case 
should be dealt individually, cemented or cementless. However, in assessment of these 
new implants, it was warned that "only by evaluating long-term clinical performance can 
the potential success or failure of an operative procedure or device be detennined"(142). 
Use of THR has also been extended to patients with a femoral neck fracture because 
osteoarthritic change can frequently be identified in this age group and eventually they'll 
need a THR (149,150). Close observation is necessary because they are more likely to 
have significant comorbidity and subsequent perioperative complications (149). 
As regards the rating of disease severity, many classification methods have been 
published since the development of Merle d'Aubigne's rating scale for scoring hip 
function (151-156). The proliferation of these scales was criticised for using different 
criteria for roentgenographic loosening (142) which made it impossible to compare the 
results without common descriptors or standard nomenclature (157). There were also 
problems with interobserver vruiability of interpreting hip X-rays (158,159), discrepancy 
"between roentgenographic loosening parameters and clinical findings (142), and 
between findings at surgery and preoperative roentgenographic data (160), such as 
benign subsidence (155.161, 162). Finally in 1990 in the USA, authorized parameters 
were published for the clinical and radiographic evaluation of THR. so that standard 
terminology could be adopted by representative authorities (157.163). 
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In this chapter, evaluation of several different outcome of THR are considered: mortality; 
complications; symptomatic and health status change; and satisfaction. Each will be 
considered in tUtn and the finding summarised in Table 1-1. 
3-2. Mortality 
Recent developments in the control of infection have significantly reduced surgical 
mortality. For example, in a study of 10,545 THRs perlOimed in the UK in 1976-85.90 
day mortality was 0.9% and one year m011ality was 1.9% (164). In a study of 149 
Charnley THRs perlonned at UCLA Medical Center in 1986, it was demonstrated that 5 
(3.4%) patients died during the first 2 years after surgery. and 3 more patients in the next 
2 year interval (165). Mortality in elderly patients, such as octogenalians. is generally 
higher. The mortality of 100 patients whose mean age was 80 years was 4% during an 
average hospital stay of 42 days (166). In another study of patients aged 80 years or 
more, one in 42 patients died during the first 30 days. Moreover, at follow-up 5 years 
after surgery, 19 patients (45%) were known to have died (167). What is noteworthy in 
most long-term studies of THR is that the majOlity of the patients die before the 
assessment time. For example, in Chatnley's follow-up study only 33 of 396 patients 
were alive for a follow-up examination 15 years later (168). 
3-3. Complications 
3-3a. Immediate complications 
(a-I) Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) 
Venous thromboembolic disease remains the most common and potentially fatal 
complication after total hip at·throplasty (169). In a study of 253 patients undergoing total 
hip arthroplasty. calf vein thrombosis was documented in 29 (11.5%) patients by 
venography (170). Another study demonstrated 16 (24%) patients out of 66 had DVT 
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(171). Use of heparin has been the subject of many studies (171-174). DVT has been a 
rare event in Japan (175), though the adaptation of a Western life style and awareness of 
DVT have led to greater use of diagnostic techniques and brought increasing numbers of 
case reports (176). 
(a-2) Urinary Tract Infection (UTI) 
Urinary tract infection induced by an indwelling catheter is the most common nosocomial 
infection following THR, although it has received little attention in 011hopaedic surgery. 
Patients with bacteruria after THR have a higher incidence of deep sepsis than those 
without UTI (3.4% vs 1.5%) (177). In one randomised controlled trial, a reduction in 
mortality was associated with reduction in nosocomial UTI (178). Short-term use of 
catheter is recommended for THR patients to prevent Ulinary retention and following 
infection (179,180), although the results are questioned (181). 
(a-3) Joint infection 
Foreign material implanted within the human body calTies a high risk of infection. 
Moreover, the diagnosis of sepsis in THR tends to be obscured because of the use of 
cement (182). A 'glycocalyx' coating on implants has been suggested as being 
responsible (183). Due to a lack of established diagnostic criteria. varying rates of 
infection have been reported. In addition, the use of antibiotics masks microbiological 
examination and in the early years, anaerobes and tissue biopsies were not cultured 
routinely (184). 
Dental surgery may pose a risk through the threat of hematogenous spread of infection. 
The use of prophylactic antibiotics remains controversial and no universally accepted 
protocol exists (185-188). 
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(a-4) Dislocation 
The reported rate of postoperative dislocation varies from 1.1 % (189) to 3.7% (190). 
Previous hip surgery has been identified as the most impOltant risk factor (191). Laxation 
was classified to aid decisions about its treatment (192) and if not accompanied by 
detachment of the greater trochanter, proper positioning of the acetabular component and 
muscle strengthening exercises are suggested as important measures to prevent this 
complication (189,193). 
(a-5) Intraoperative femoral fracture 
Intraoperative fracture of the femur following THR has been reported to occur in 3% 
(194,195) to 4.1 % (196) of plimary THRs, and 2.2% (197) to 6.3% (198) of revision 
operations. Most of the fractures (70%) occun'ed at the distal end of the femoral stem 
(199) and were internally fixed with or without postoperative casting. One study. 
however, repOlted that only half of intraoperative fractures were identified dming surgery 
(194). Possible risk factors include osteoporosis and aggressive canal filling (196). 
Studies of mechanical design of the femoral component have also shown that fractures 
occur more frequently with implants with straight, smaller femoral stem than with the 
anatomically designed larger prostheses (195.196). 
3-3b. Late complications 
(b-l) Loosening and revision surgery 
The most frequent long-term complication is the loosening of implants and the need for 
revision surgery. Differences in the length of the observation period (165,200), the 
proportion of patients reviewed. the definition of failure. and the type of prosthesis make 
it difficult to compare the results. Also survival analysis has not always been used and the 
distinction between acetabular component or femoral component failure has been 
incompletely reported. In summary, the failure rate of cemented THR has been reported 
as 1% per year in patients older than 50 years, and 2% or higher in younger patients 
(201). Similar rates were observed for cementless THR. While improved cementing and 
hybrid THR have been tried in an attempt to solve implant loosening. the presence of 
particulate debris has become the primary problem for THR by causing osteolysis and 
socket loosening (140,202,203). Improved surface coating by new materials may reduce 
the incidence of osteolysis by debris. 
The results of cemented revision THR have not been as encouraging as those for primary 
arthroplasty. 29% loosening has been found in revision cemented THR after only 2.1 
years (204) and in another study 20% of acetabular components and 44% of femoral 
components were loose after 4.5 years (205). Moreover, the results of rerevision 
cemented THR are even more discouraging (206). 
(b-2) Ossification 
The incidence of ossification ranges from 2-20% (139,148,207-210). Ossification is 
sometimes associated with severe limitation of movement and pain. The incidence is 
significantly greater in patients who developed post-operative hematomas, prolonged 
wound drainage, or superficial infection, as well as those whose surgical exposure was 
difficult. Various suggestions have been made to avoid this complication, such as 
postoperative radiation, excision of bone (211.212) and preventive treatment with 
indomethacin (213), though use of non-steroidal antiinflammatory drugs is still 
controversial. 
(b-3) Postoperative femoral fracture 
The incidence of postoperative fracture varies from 1.6% within a mean time of 3.7 years 
(214) to 5% within 10-years (215). In addition to the risk factors suggested for 
intraoperative fracture. an association has been observed with patient's age. body height 
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and weight, osteoporosis and operative procedure, such as perforation of the femoral 
cortex and duration of surgery (214-216). 
(b-4) Trochanter problems 
Osteotomy of the greater trochanter by the lateral approach and its reattachment with wire 
is an important part of Charnley's THR, because of its excellent exposure allowing 
accurate placement and fixation of implants as well as changing the stress moment by its 
reattachment to a new position. However, trochanter-related problems such as 
trochanteric bursitis, delayed and non-union of the greater trochanter, fracture of the 
wires with separation of the trochanter producing pain, a Trendelenburg gait and hip 
instability, are also well recognised patticularly after revision atthroplasty (217-219). 
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Table 1-1: Summary of previously repOlted outcomes of THR 
Outcome 
MORTALITY 
30 days 
90 days 
1 Yrs 
2 Yrs 
4 Yrs 
5 Yrs 
15 Yrs 
Incidence Note 
2.4% 
1.0% 
2.1% 
3.4% 
5.4% 
45 % 
91.7% 
elderly patients (~80 years) 
elderly patients (~80 years) 
Reference No. 
167 
164 
164 
165 
165 
166 
167 
----------------------------------------------------------------------
COMPLICATIONS 
Immediate: 
DVTIPE 10 - 34.3% DVT 
1.2 - 3.6% PE 
UTI 0-43% depends on the use of catheter 
Joint infection <1% Primary THR 
<3% Revision THR 
Dislocation 1.1 - 3.7% 
Intraoperative fracture 
3 - 4.1% PIimary THR 
2.2 - 6.3% Revision THR 
Late: 
Loosening identified- Loosened 
cQmpQn~nt 
by X-ray 4% Overall 
10 - 15% Acetabular 
30 - 50% Femoral 
3% Femoral (new cementing) 
by revision 10 - 30% Overall 
Ossification 2 - 20% 
Postoperati ve 1.6 - 5% ~10 year 
fracture 
Trochanter-related 12.4% Primary THR 
4.2% Revision THR 
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Observation 
periQd 
2 Yrs 
10 Yrs 
10 Yrs 
11 Yrs 
10 Yrs 
170-173 
173 
165,179, 
220,221 
210 
210 
189,190 
193,201 
194-196 
197,198 
140 
210 
210 
210 
210 
155,209 
210 
214,215 
217 
222 
3-4. Symptomatic and health status change 
3-4a. Symptoms 
Immediate relief from hip pain is the most striking benefit of THR, as well as an 
improved range of motion. In Charnley's initial study of 97 hips. most patients had no 
pain at three weeks after surgery and could undeltake leg raising exercises (138). As 
THR was practiced more, longer term outcome has been considered because bony 
remodelling takes a long time. At a minimum of I5-years follow-up of cemented THR, 
80 - 90% of patients were functioning with little or no pain (142). Such long tenn follow-
up is difficult as it is not always possible to bring in patients for follow-up examination 
several years after surgery, especially those who are doing well (165). In the case of 
cementless THR, the reported prevalence of significant Ii m p (0 - 21 %) and thigh pain (12 
- 26%) has varied widely (142). Improvement in the average range of movement has not 
been found to be related to the use of cement (165.223). 
3-4b. Functional ability 
In study of 149 cemented THR patients, their mean functional status had improved from 
3.5 to 7.1 (on an 8 point scale) 4 years after surgery and this improvement was then 
maintained over a ten-year period (165). Substantial improvements in functional status 
have been observed dming the first three months after operation (224). 
3-4c. Quality of life 
In general due to over-emphasis on physician-defined pain relief and measures of 
technical success, improvements in patients' quality of life and satisfaction are often 
neglected or only marginally considered. 
In one study of 38 patients who underwent hip or knee atthroplasty. a large improvement 
in their quality of life was detected three months after using five instruments induding 
Index of Well Being and Sickness Impact Profile (22'+). The study of 54 THR patients 
using three different scales (Sickness Impact Profile, rating on a visual analogue scale, 
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and a utility measure) all showed increases in their quality of life after surgery (225). In 
O'Boyle's schedule for the evaluation of patient-generated quality of life (SEIQoL). the 
quality of life of THR patients increased postoperatively to a significantly higher level 
than that of controls (226). 
In general, surgery has not been shown to change work status because the mean age of 
patients has been over 65 years (227). In Hertzman's study, 42 of 92 nonretired patients 
in their 50s were on sick leave for more than 6 months before surgery. Patients with blue-
collar work preoperatively had a higher risk than white-collar workers of early retirement 
after THR (228). 
3-5. Satisfaction 
Although the methods of measurement were different. most studies have reported high 
level of satisfaction in THR patients. 100% of the 59 patients who responded were 
satisfied with the procedure (229,230). When patient satisfaction was measured by a 5 
point-scale (1 indicated the highest satisfaction) in a study of 356 THR patients, the 
average level was 1.4 with little interhospital difference (181). Patient satisfaction has 
also been used to compare the outcome of different type of implant. This suggested 
greater satisfaction with a cemented femoral stem than with a cementless stem (231). 
While most studies in Western countries repol1 high levels of patient satisfaction, the 
same is not true for Japanese patients. As the Japanese life style requires more hip flexion 
than the European (232), dissatisfaction with continuing pain and inability to sit on their 
legs has been found (233). 
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3-6. Detenninantl\ of outcome 
3-6a. Patient factors 
(a-I) Age 
Analysis of patients younger than fifty-five years old shows IO-year survivals of the 
implant to be 87.6%, suggesting that a primary cemented THR can be expected to 
function durably in an active middle-aged patient (234). However. the use of cemented 
THR has been questioned in patients younger than thilty years old (235). fOlty-five years 
old (236) and forty years old (237). In general, for young patients in Japan. a variety of 
arthroplasties other than THR are performed. following Charnley's advice to delay 
operation in the young patient with osteoaIthrosis of the hip (232, 238-240). On the other 
hand as many as 72% of THRs in octogenalians had complications (excessive bleeding, 
postoperative confusion, UlinaI), tract infection, and dislocation), although different ones 
from those expelienced by younger patients who mostly suffered mechanical problems 
such as loosening (167). However, another study suggested that age should not be a 
contraindication to hip replacement, with patient selection made on the basis of 
symptomatology and overall health (241). 
(a-2) Anatomy 
There is a special concern about the hip anatomy of Japanese patients. In general, finding 
a prosthesis to fit Japanese patients is difficult because of their much smaller and 
shallower acetabula, slender femoral stems (240,241) and straight femoral neck (242). 
Acetabular deficiency is a particular problem for the Japanese. One survey revealed 
88.3% of THR patients had congenital dislocation and acetabular dysplasia (232). This 
factor is reflected in the even greater preponderance of females needing THR than in the 
West (240.243). Due to a nationwide campaign in Japan (244,245). infant hip screening 
is now performed thoroughly and morbidity has been decreasing for the last two decades 
(246). However. the reduction rate by Pavlic splint has also been decreasing (from 
87.1O/c to 80.3%), implying a relative increase of more difticult cases. 
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A marked deficiency of the bone stock necessary for acetabular reconstruction in THR, 
means that the operation may become a technical hazard and may not be feasible (247). A 
new operative technique, using the excised femoral head to fix to the acetabulum, takes 
advantage of an autograft being contoured to the ilium, and also enough volume and 
strength to fix (247). Moreover, its use may eliminate the necessity of taking an 
autogenous bone graft from another site. As a result, two studies have repOIted that only 
one case out of 300 hips undergoing Charnley THR had to be revised because of 
mechanical loosening (232,248). 
(a-3) Diagnosis 
Early mechanicalloosenings of acrylic-fixed implants were predicted in osteoarthritis 
patients and patients under 30 years of age (237). Other rep0l1s were also discouraging 
about the use of THR in rheumatoid arthritis patients (240,249-251). For uncemented 
THR, however, despite the use of corticosteroid and antiintlammatory medications which 
were suspected to retard bone growth, no failure was found (223). In addition, decreased 
activity levels by these patients might benefit stability. In Japan the proportion of 
rheumatoid arthritis patients receiving THR is smaller than in the West (240,248). 
However, as most studies have been done on secondary osteoarthtitis patients in Japan, 
not enough information is available. For aseptic necrosis of the femoral head, reports 
suggest better survival than for osteoartluitis patients, and better in older patients than in 
younger (240,252). 
(a-4) Other factors (weight. number of affected hips, operation) 
Among other tisk factors for loosening, body weight has been demonstrated as the most 
important (165.200.250) and is a consistently better predictor than sex (253). 
Significantly better results in bilateral THR cases were observed than unilateral cases, 
which suggested that increased daily activity of unilateral patients might be the reason 
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(240,254). In general, revision surgery demonstrated poorer results in comparison with 
primary surgery (142) and even worse in rerevision surgery. 
3-6b. Health care factors 
(b-l) Laboratory investigations 
In retrospective analyses, many of the preoperative laboratory tests have been shown to 
have no value in predicting the postoperative course (255). The only tests found to be 
useful were urinalysis, serum glutamate oxaloacetate transaminase. and lactic 
dehydrogenase. Despite the enormous cost of laboratory testing and radiographic 
examinations in the U.S., physicians are mostly unaware of these findings and 
sometimes order tests to protect themselves against potential malpractice suits (255). 
(b-2) Use of cement 
Cemented THR can get excellent immediate interlock. However. the long-term durability 
has been questioned in younger and more active patients. Poor results have led surgeons 
to reconsider their cementing technique and to improvements in component design 
(253,256-261). As a result. a marked reduction has been observed in the rate of 
loosening of the femoral component. but not in the incidence of acetabular loosening 
(256,262). 
(b-3) Transfusion 
Transfusion of prebanked autologous blood has become popular during the past decade. 
Autologous transfusion has often been reported to reduce the amount of homologous 
transfusion, and increase postoperative hemoglobin level (263). One difficulty is that the 
majority of patients undergoing THR are elderly and often anaemic. and are unable to 
donate sufficient quantities of blood to satisfy their operative requirement (264). The use 
of recombinant erythropoietin has been suggested for rheumatoid aI1hritis patients who 
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are often anaemic (265). One proposed solution in revision THR has been to reduce 
blood loss, undertake preoperative blood donation and attempt intraoperative blood 
salvage (266). While autologous preoperative donation has increased dramatically (267), 
intraoperative autologous transfusion has been reported as not cost-effective in primary 
THR and its use should be restricted to revision surgery (268,269). In addition, some 
patients have been found to prefer to run the risk of homologous transfusion (268). 
(b-4) Postoperative mobilisation 
For cemented THRs, patients are allowed to take full weight as soon as possible after the 
operation, 9.5 postoperative days on average (138,270). However this is controversial 
for patients with a bone graft (242,247). For a cementless prosthesis, previous 
suggestions that it should not be subjected to any load for three months (271) is viewed 
as impractical (144). In general the length of hospital stay in Japan is much longer. A 
long non-weight bearing period is often recommended. especially for cementless THR 
(272). 
(b-5) Other factors (physiotherapy, analgesics, wound drainage) 
A comparative study of seven- and five-day physiotherapy coverage suggested the 
consecutive therapy without increasing the number of treatments would not reduce length 
of stay (273). Also in the study of groups with or without physiotherapy service. no 
major differences were found in length of stay between the groups (274). On the other 
hand, the use of a community physiotherapist (275.276) has led to estimated savings of 
£21,500 a year for a practice of 12,000 patients, which suggested that early access to 
physiotherapy is likely to reduce the costs of drug prescribing (277). Patient controlled 
analgesia has been recommended as potentially superior to control postoperative pain 
(278,279) and no benefit has been found in the use of wound drains (2RO). 
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Table 1-2: SummaI)' of previousl y rep0l1ed detenninantl\ of olltcomes 
Determinant 
PATIENT 
Age 
Anatomy 
Diagnosis 
Others 
Factors associated with poor outcomes 
Younger age (and/or more activity) 
Very elderly 
Shallow acetabulum 
Straight femoral neck 
Slender femoral stem 
Rheumatoi d ruth 1; tis (controversial) 
Obesity 
Unilateral operation 
Revision surgery 
----------------------------------------------------------------------
HEALTH CARE 
Use of cement 
Transfusion 
Mobilisation 
Others 
Cemented acetabulum 
Cementless femur 
Homologous transfusion 
Late mobilisation 
Lack of physiotherapy 
Conventional analgesia 
Wound drainage 
4. Aims and objectives 
4-1. Aims 
The aim of this thesis was to assess the impact that comorbidity has on the outcome of 
health care interventions in Japan and the UK. To do this a USA-derived comorbidity 
index (ICED) was investigated in patients undergoing total hip replacement (THR). 
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4-2. Objectives 
There were seven objectives: 
1) to compare the preoperative health and clinical management of patients in Japan and 
in the UK, and between hospitals within the UK; 
2) to desctibe the outcome of total hip replacement one year after surgery; 
3) to compare the outcome ofTHR in the UK and Japan; 
4) to assess the feasibility and reliability of a comorbidity measure (ICED) developed in 
the USA; 
5) to determine the effect of comorbidity on postoperative complications and health 
status one year after surgery both in Japan and in the UK; 
6) to identify factors confounding the relationship between comorbidity and outcome; 
7) to improve the power of comorbidity to predict selious complications. 
4-3. Outline 
This thesis consists of eight chapters. Chapters 2 and 3 desclibe the methods and the 
practicalities of conducting the study and the recruitment and response rates. The validity 
and reliability both of the ICED and health status measurement are repolted in Chapter 4. 
Then in Chapters 5 and 6 the descriptive results are presented - the preoperative health 
status of patients, their clinical management and their outcome. Based on these findings, 
predictive analyses were carried out and these are presented in Chapter 7. Finally the 
implication of the results for clinical practice and fUlther research are discussed in Chapter 
8. 
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· Chapter 2: Materials and methods 
This chapter describes the matelials and methods employed in the study. First, the study 
design and criteria for inclusion of hospitals and patients are explained. Second the 
development of the questionnaires for a one-year follow up of patients is desclibed. 
followed by the method of abstracting data from the patients' case-notes. Finally the 
methods of statistical analysis are documented. 
********************************************************************** 
1 . Design and sampling population 
1-1. Study design 
The study design was two retrospective cohorts of patients who underwent THR one in 
Japan and one in the UK. Postal questionnaires were used for a one-year follow-up and 
data were abstracted from patients' case notes. Data collection in Japan took place from 
June to December 1993, and in the UK from January to September 1994. 
The study had two data sources; clinical data on the index admission exu'acted from 
patients' case notes; and patients' self-administered questionnaires about one year after 
surgery. After obtaining ethics committees' approval (in the UK), the names and 
addresses of eligible patients were identified retrospectively by participating surgeons, 
and the questionnaires were sent with a letter explaining the study (Appendix 1-4). 
Patients were invited to paIticipate, and their consent was obtained for data to be 
abstracted from their case notes. Non-responders were sent two reminder letters at three 
week intervals after the initial questionnaire. Finally, persistent non-responders were 
reminded by telephone call. In receipt of their consent. their case notes were examined 
and the data were collected. 
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1-2. Participating hospitals 
The sampling frame was originally designed to provide a variety of hospitals in tenns of 
teaching status and location. In Japan, hospitals were first selected by their activities in 
hip surgery known through academic exchange. However, due to the generally small 
volume of surgical practice in Japanese hospitals, hospitals were contacted throughout the 
country and all interested hospitals were included ilTespective of their patients volume or 
teaching status. The lack of ethics committees in Japanese hospitals means that. 
permission was given by the professors of the orthopaedic department in the teaching 
hospitals and by the chief surgeon in non-teaching hospitals. Patticular difficulty was 
experienced with teaching hospitals which were not used to collaborating with unfamiliar 
researchers and had a strong feat' of confidentiality of patient infOimation (Table 2-1). 
Table 2-1: Pmicipating Japanese hospitals 
(from Apr - Dec 92' unless otherwise specified) 
Period 
of 
Hospitals recruitment 
Teaching: 
Teilcyo Univ Hospital, Kawasaki, Kanagawa 
Tohoku Univ Hospital. Sendai. Miyagi Jun - Dec 92' 
Kyoto Pref Univ Hospital. Kyoto 
Osaka City Univ Hospital, Osaka May - Dec 92' 
Kobe Univ Hospital, Kobe, Hyogo 
Tokyo Med Dent Univ Hospital, Tokyo 
Juntendo Univ Hospital, Tokyo 
Nagasaki Univ Hospital. Nagasaki 
Kinki Univ Hospital, Osaka Sayama, Osaka 
Shinshu Univ Hospital, Matsuyama, Nagano 
Kyushu Univ Hospital, Fukuoka 
Showa Univ Hospital, Yokohama, Kanagawa 
Non-teaching: 
Kameda General Hospital. Kamogawa, Chiba 
Kagoshima Municipal Hospital, Kagoshima May - Dec 92' 
Kumamoto Kinoh Hospital. Kumamoto 
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No. of patients 
identified 
(Total=30Q) 
5 
7 
8 
12 
13 
15 
16 
18 
22 
23 
47 
59 
9 
10 
36 
In the UK, hospitals were selected from North Thames health region. within about an 
hour's journey for the author. Hospitals were chosen on the basis of at least one of the 
surgeons having expressed an interest in outcome research (Table 2-2). 
Table 2-2: Participating UK hospitals 
Hospitals 
Teaching: 
St. Mary's Hospital, London 
Royal Free Hospital, London 
Royal National Olthopaedic Hospital, Stanmore 
Non-teaching: 
Bedford General Hospital, Bedford 
West Middlesex Univ Hospital, Middlesex 
Whipps Cross Hospital, London 
1-3. Patient eligibility for the study 
Period 
of 
recruitment 
Jan 93' - Aug 93' 
Dec 92' - Aug 93' 
Feb 93' - Oct 93' 
Apr 93' - Aug 93' 
Sept 92' - Aug 93' 
Nov 92' - Aug 93' 
No. of patients 
identified 
(Total-373) 
44 
49 
114 
23 
67 
76 
In both Japan and the UK, all consecutive patients who underwent THR one year 
(between nine and fifteen months) before the study were eligible for inclusion unless: 
I . the operation was a revision of a previous procedure on the same hip 
2. the operation was bilateral during one theatre episode 
3. a diagnosis of Paget's Disease or femoral fracture 
4. younger than 18 years of age 
5 . they had metastatic cancer 
6. they were undergoing chemotherapy 
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7. they had a diagnoses of acquired immune deficiency syndrome (AIDS), or were 
transplant patients. 
2. Health status questionnaire development 
The health status questionnaire was a self-administered questionnaire sent to patients 
about 12 months after surgery which enquired about their sociodemographic 
characteristics, health-related quality of life before and after total hip replacement, 
perceived improvement in health status, health care utilisation and satisfaction with care 
(281,282). Full versions of those used in Japan and the UK appear in Appendix 3 and 4. 
It was designed to assess disability and to detect clinically meaningful changes in health 
status. In order to be able to compare the results with those previously published in the 
USA, the questionnaires used in Japan and the UK retained as many similarities as 
possible to the USA version (1). 
The reliability and validity of the US questionnaire have been reported in terms of 
construct validity and internal consistency (283). Its sensitivity to change has been 
reported in patients who underwent one of four surgical procedures, including total hip 
replacement (283). 
However, because of the difference in health care system, questions about the number of 
doctor's consultations were changed in the UK so that patients could choose among 
several types of health professionals including nurses and physiotherapists (Questions 5 
and 6 of the UK form). Moreover in the UK, a question was added to ask if patients had 
received help from lay carers (Q.7 of the UK form). For Japan, the USA versions of 
these questions were retained due to the similatity of their health care systems. 
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Questions about a patient's education level (Q.73 in the UK and Q.6l in Japan) and 
employment status (Qs.77 and 78 in the UK, and Qs.65 and 66 in Japan) were also 
changed due to international differences in the education systems and labor patterns. 
For the UK, some wording was changed to increase its comprehensibility for a British 
audience. For example, 'hospitalization' was changed to 'admission' or 'hip operation' 
throughout the questionnaire. Questions such as 'Have you felt downhearted and ~?' 
was changed to ' ... and sad?' and also 'homemaker' to 'housework' (Qs.77.78). 
In Japan, as a result of the reluctance of participating surgeons. most of the questions 
asking about a patient's mental health, feeling of fatigue. and cognitive problems were 
excluded. As a result, the number of questions asked of Japanese patients was 66, and to 
of British patients, 78. 
A patient's health status was based on the mean score of responses to 12 questions about 
how much difficulty the respondent had doing different activities. There were three 
questions on the basic activities of daily living (eating, dressing and bathing), six 
questions on instrumental activity of daily living (such as doing light work around the 
house, walking several blocks. and doing vigorous activities) and three questions on 
social activity (visiting friends. palticipating in community activities. and taking care of 
family members). These three scales made up the core of health status. In addition, 
mental health status was based on five questions such as 'Have you been a very nervous 
person? and 'Were you a happy person? 
The questionnaire sought information on the patient's perception of their health status in 
the month prior to surgery and in the most recent month. Scores for each scale were 
averaged and transformed to the range from 0 to 100, with a score of 100 indicating 
maximum health status. Also, five single item questions asked about other aspects of their 
health such as the number of days patients had reduced their normal activity because of 
their health and how satisfied they were with their sexual relationships. 
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In preparing the questionnaire for Japanese patients, the UK questionnaire was first 
translated into Japanese by the author. Then, in order to secure the accuracy of 
translation, it was back-translated to English by a bi-lingual translator and the result was 
compared with the initial UK version. 
Postal surveys have rarely been carried out in Japan so the questionnaires were sent to a 
small number of patients to find out the feasibility of such a strategy. Also this 
preliminary survey was requested by many of participating surgeons who were 
concerned about the length and content of the questionnaires. Hence the aims of the pilot 
study were to see (1) if Japanese patients would respond to a postal questionnaire. (2) the 
response rate to the questionnaire, and (3) if the length of the questionnaire might affect 
the response rate. 
The original length questionnaire (long) and a shortened version were sent to 10 patients 
each, followed by one postal reminder. All 12 questions necessary to calculate health 
status before and after THR were included in the short version of questionnaire. Of those 
who received the long questionnaires, 66% of them responded within 2 weeks, and after 
a reminder all of them returned the questionnaires. 99.S7c- of the original 66 questions 
were answered, except for one patient who didn't answer any of the health status 
questions. For the short form. the final response was 89% with all the questions 
answered. As no significant difference was found in the response patterns, the long 
questionnaire was chosen for use in the main study. 
3 . Case note review 
Case notes were reviewed to abstract information about the pIimary disease: co-existent 
diseases; in-hospital complications; length of stay; past history of joint surgery (on the 
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either hip or knee); and the surgical procedures employed. The proforma used appear in 
Appendix 5 and 6. 
The definition of comorbidity used in this study was the overall severity of illness due to 
diseases other than hip disease that could effect recovery from surgery during the period 
of observation. To measure the amount of preoperative comorbidity, the ICED (Index of 
Co-Existent Disease) was used. 
3-1. ICED (Index of Co-existent Disease) 
Two dimensions were identified as contributing to a single composite index of co-existent 
disease: the severity of specific diseases and a measure of general functional status. A full 
description of the ICED scoring system appears in Appendix 7. 
3-1 a. Index of disea.."e severity nOS) 
To assess the severity of comorbid conditions, infOimation was collected from all parts of 
the medical notes including the anesthesia notes, medical consultations, laboratory 
reports, and operation repOits. 
Thirteen categories of co-existent medical conditions were included: organic heart 
disease, ischemic herut disease, plimru), arrhythmias & conduction problems, congestive 
heart failure, hypertension, cerebral vascular accident, peripheral vascular disease, 
diabetes mellitus, respiratory problems, malignancies, hepatobiliary disease, renal 
disease, and gastro-intestinal disease. For each condition, each patient was placed into 
one of four mutually exclusive levels using an explicit list of symptoms, signs, and 
laboratory tests indicating the presence and severity of the condition, based on an 
approach delived from the Disease Staging system. An example of this for one disease -
diabetes mellitus - is shown in Table 2-3. 
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· Table 2-3: Example of classification by index of disease severity (lOS): Diabetes mellitus 
IDS 0: Absence of coexistent disease 
IDS 1: Chemical diabetes only, not on medication 
IDS 2: Controlled (BS<300) on medications, insulin, or diet 
IDS 3: Diabetes not controlled (BS>300) or with any of neuropathy. nephropathy. 
(creatinine 3.0-6.0), retinopathy, gangrene, etc. 
After assessment in the 13 categories of co-existent diseases, the peak score among them 
was chosen to represent the subindex of disease severity, irrespective of which disease 
category it applied to. 
3-1 b. Functional severity CFS) 
The second dimension, functional severity, was intended to measure the global impact of 
all conditions, diagnosed or not, on the patient's preoperative health. Ten areas were 
identified: circulation, respiration. neurological, mental. Ulinary, fecal. feeding, vision. 
hearing and speech. The same sources of information as for disease sevelity were used, 
plus the nursing notes. Following explicit scoring rules. each of the ten areas was 
classified into one of three functional severity levels. The classification of neurological 
function is shown as an example in Table 2-4. 
Table 2-4: Example of classification by functional sevelity index: Neurolo~ical severity 
FS 0: No problems; a neurological disease with no symptoms 
FS 1: Dizziness, numbness. seizures by history (controlled), syncope by history 
FS 2: Ataxia. partial paralysis, seizures (uncontrolled), bedridden 
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After assessment of all 10 categories of function, the peak score among them was chosen 
to represent the subindex of functional severity. ilTespective of which functional category 
it was rated for. 
3-1 c. Fonnation of ICED 
The scores for the two dimensions were condensed into a single global measure of co-
existent diseases called the ICED. It was an ordinal variable in which the scores for the 
two dimensions were combined to form four levels that were mutually exclusive and 
clinically meaningful (Table 2-5). 
Table 2-5: Grouping system of two subindices into the composite index (ICED) 
Peak Intensity of 
Disease Sevelity 
(Q, 1 ,2,3) 
o 
o 
1 
2 
1 
2 
3 
any (0 - 3) 
3-2. In-hospital complications 
Peak Intensity of 
Functional Severity 
(0,1.2) 
o 
1 
o 
o 
1 
1 
any (0,1 or 2) 
2 
ICED Levels 
(1.2.3.4) 
1 
1 
2 
2 
3 
3 
4 
4 
A list of postoperative complications was selected of both a serious and minor nature. 
Serious complications included hypotension, coma, neuropathy. pulmonary embolism. 
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septicemia, shock, myocardial infarction, congestive heatt failure. cerebro-vascular 
accident (stroke), and renal failure. 
Minor complications were defined as any new postsurgical events that potentially could 
create discomfort or prolong the stay in the hospital, such as mild pneumonia. fever. 
urinary infection, gastrointestinal problems, and wound infection. 
4. Analysis 
4-1. In-hospital complications 
For the dichotomous dependent variables, such as whether or not the patient expeIienced 
a complication, estimates of association were expressed in terms of Odds Ratios (OR). 
The Chi square test for trend was used for associations of complications with severity of 
illness. 
After conducting bivatiate analyses, multivat'iate analysis to identify the effect of each of 
the potential confounders was undertaken. A logistic model was fitted using maximum 
likelihood estimation techniques. The predictive value of co-existent disease was 
determined. 
4-2. Chan~e in health status fol1owin~ THR 
Because of the distribution of change in health status was not normally distributed, non-
parametric analyses were used. However. mean value and standard deviation/error were 
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shown together the results from non-parametric analyses. in consideration of their 
common use for compruison. 
Mann-Whitney U test or Kruskal-Wallis test was used for continuous dependent variables 
in comparing the mean rank of groups. In compru·ison of health status before and after 
THR, significance was examined by Wilcoxon matched-pair test. In order to estimate the 
relationship between the measure of comorbidity (ICED) and the dependent vatiables. 
least squares multiple lineat· regression was used while controlling for the effects of the 
other covariates. Covariates were identified by means of bivru·iate analysis and then 
selected in stepwise, multivariate procedures. A final model was then fitted to describe the 
association between the measure of co-existent disease and the outcomes, taking into 
account the effect of the covruiates. 
5. Sunlmary 
# Desi~n and sampling population: Two retrospective cohort ... of patients who underwent 
primary THR one year before the study. 300 patients treated in 15 Japanese hospitals 
during 1992 and 373 patients treated in 6 UK hospitals (3 teaching and 3 non-teaching 
status) between September 1992 and October 1993. 
# Health status Questionnaire development: A self-administered postal questionnaire was 
sent about 12 months after THR to enquire about sociodemographic characteristics, 
health status and health related quality of life before and after THR, health care 
utilisation and satisfaction with care. The questionnaires were modifications of one 
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previously used in the USA. A pilot study in Japan found the response rate was 
unaffected by the length of the questionnaire. 
# Case note review: Case notes were reviewed to abstract infOImation about the primary 
disease, comorbidity, in-hospital complications and clinical management. Comorbidity 
was measured using the Index of Co-Existent Disease (ICED). 
# Analysis: The incidence of in-hospital complications was first examined in bivaIiate 
analyses. The relationship between comorbidity and complications was then explored 
using multivariate analysis and a logistic model was fitted. For change in health status, 
non-parametric analyses were used. Covariates were identified by bivaIiate analyses 
and a multivariate model was fitted to desctibed the association between the ICED and 
the change in health status. 
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Chapter 3: Recruitment and response 
This chapter describes the recruitment of patients and response rates. First the number of 
eligible cases are considered. Then the response rate to the mailed questionnaire to the 
patients is considered along with an exploration of possible response bias. Finally case 
note abstraction is described and the difference in available recorded information between 
Japan and the UK is discussed. 
********************************************************************** 
1 . Eligibility 
In both countries, some of the patients initially identified for inclusion in the study (10 in 
Japan; 24 in the UK) had to be excluded as they failed to meet the inclusion criteria. In the 
UK this arose, because the patients' list was prepared by participating surgeons in only 
two out of the six hospitals. In the four other hospitals, operated cases were first 
identified by the author from theatre registers. The hospital computer was then used to 
obtain the patient's address for mailing. Mis-classification arose because either the 
operative procedure or the underlying diagnosis had not been precisely enough classified 
in the theatre register as regards whether the ca..~e was a primary or secondary (revision) 
operation, unilateral or bilateral, and THR for hip arthritis or hemiruthroplasty (artificial 
femoral head) for femoral neck fracture. The increasing application of hemiarthroplasty 
for arthritis of the hip in which the acetabulum is conserved, plus the recent trend of using 
THR in patients with a femoral neck fracture. both contributed to difficulties in the correct 
identification of eligible cases. In the latter case, patients' ineligibility became evident only 
after their notes were studied. This was also the case when a patient was undergoing 
chemotherapy or suffering from metastatic cancer. 
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2. Response rate to postal questionnaire 
Table 3-2 shows the result of data collection in Japan and the UK for eligible patients. 
There were four categories of non-responders to the postal questionnaire: some were 
currently inpatients; a few had died; some refused to participate: and some could not be 
traced despite approaches to their GPs. As a result, their vital status a year after surgery 
remained unknown. Overall the recruitment rates were high (Japan 85.3!!C; UK 80.7%). 
Table 3-2: Number and percent of eligible patients recruited and case notes found 
in Japan and the UK 
JAPAN UK 
N (%) N (%) 
Eligible patients 300 373 
One year follow-up 
Current inpatient 3 ( 1.0) 3 ( 0.8) 
Dead 2 ( 0.7) 6 ( 1.6) 
Refused (alive) 27 ( 9.0) 58 (15.5) 
Not traced (vital status unknown) 12 ( 4.0) 5 ( 1.3) 
Recruited patients 256 (85.3) 301 (80.7) 
Case notes found 249 (83.0) 274 (73.5) 
Medical information complete 249 (83.0) 268 (7l.8) 
During the year after discharge, 2 patients in Japan and 6 in the UK died. It was difficult 
to judge if these deaths were related to the original diagnosis or operation. In addition, 3 
cases in each country were unable to answer the questionnaire because they were 
currently in-patients. The causes of their admission included revision of THR and 
surgery on their other hip or knee replacement 
A commoner problem was inaccuracies in patients' addresses. More patients in Japan 
were out of reach because the hospital's information on their address or telephone 
number was incorrect. Although Japanese patients tended to attend the hospital for a 
variety of conditions more frequently than British patients. their vital status was unknown 
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after they changed their doctors. As British patients were usually looked after by their 
general practitioner, who kept updated information, it was possible to check their vital 
status even if they changed their address. 
In both countries completed questionnaires were returned in almost the same period after 
mailing. Nearly half the patients answered within two weeks of mailing . 
.... 
3. Questionnaire completeness 
In terms of questionnaire completion, a few patients failed to answer all the questions. 
From their notes wtitten in the blank space, it appeared that they could not answer either 
because there were too many questions, or because deterioration of their other joint made 
it difficult for them to identify the source of their problems. Some patients also seemed to 
have difficulty answering the 12 questions about their health status before and after the 
operation because of the similar tabulated appearance of the questions which only ditlered 
by the heading desctibed the period in question. As a result some patients answered only 
half of the questionnaire, either the preoperative or postoperative questions. For the 12 
questions about their health status, 10 (3.9%) patients in Japan did not answer questions 
for their preoperative status. and 9 (3.5%) for postoperative. In the UK, 4 (1.3%) 
patients failed to complete the answer for preoperative status and 9 (3.0%) for 
postoperati ve. 
Another problem arose with the questions asking about their mental health. These looked 
difficult to answer and some patients did not see what relevance they had to their hip 
problems and refused to answer. Although Japanese patients had fewer mental health 
questions to answer than Btitish patienl~ (3 for Japan. 5 for the UK), the completion rates 
were almost the same. For preoperative mental health questions. 8 Japanese and 14 
BIitish patients did not answer. and for postoperative questions, 12 Japanese and 9 
British did not do so. Some patients in the UK (3 patients for preoperative questions and 
70 
6 for postoperative) always ticked the same column regardless of the question asked. 
despite the questions varying between positive and negative fOlms ("Were you a happy 
person?" and "Have you been a very nervous person?"). Their answers were eliminated 
from the analysis. 
Table 3-3a shows the number and percentage of patients who did not answer particular 
questions. The levels of missing data in the earlier USA study are also included for 
companson. 
Tilble 3-3a; Number and Qercent of missing data for ~ingle guestiQns 
JAPAN UK USA 
Item N (%) N (%) N (%) 
Percei ved health 10 ( 3.9) 6 ( 2.0) 3 ( 1.1) 
Comparative health 9 ( 3.5) 5 ( 1.7) 3 ( 1.1) 
Sexual satisfaction 32 02.5) 50 (16.6) 30 00.6) 
Former employment 19 ( 7.4) 14 ( 4.6) 49 07.3) 
Current employment 22 ( 8.6) 12 ( 4.0) 16 ( 5.7) 
Education level 8 ( 3.1) 12 ( 4.0) 10 ( 3.5) 
Marital status 12 ( 4.7) 5 ( 1.7) 3 ( 1.1) 
Living alone 11 ( 4.3) 8 ( 2.7) NA 
Home ownership 10 ( 3.9) 5 ( 1.7) NA 
In general. the level of missing data among Japanese patients was higher than for British 
or American patients, with the exception of education level. Among the missing items, 
questions about sexual satisfaction and employment status yielded the highest 
nonresponse rate in all three countries. Instead of selecting available answers, 
respondents frequently commented that their old age meant they had retired from the 
particular activity in question. 
Table 3-3b shows the percentage of patients with items missing in the indices of health 
status. The percentage of patients with all index items missing is shown by %all. For 
those with missing data. the modal number of items missing is also shown. 
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Tabl~ 3-3b: Per~ent and the modal number of missing data 
for indices consisting of multi{lle Questions 
Indices JAPAN UK USA (N of Questions) %any %all mode %any %all mode %any %all mode 
Basic ADL (3) 
Preoperative 5.1 3.9 3 4.0 1.3 1 6.0 2.8 3 
Postoperati ve 6.3 3.9 3 5.6 3.3 3 4.6 1.1 1 
Pre or postoperative 1.9 1.3 
Instrumental ADL (6) 
Preoperative 11.7 3.9 1 11.0 2.0 1 10.6 2.8 1 
Postoperative 13.3 3.5 1 17.6 5.3 1 16.3 1.1 1 
Pre or postoperative 1.9 1.3 
Social activity (3) 
Preoperative 1l.7 4.7 1 10.3 4.3 3 9.5 4.2 3 
Postoperative 12.1 4.3 1 15.3 5.0 1 11.3 3.9 1 
Pre or postoperative 7.0 6.6 
Mental health (5)* 
Preoperative 4.7 3.1 1-2 4.7 2.3 1 8.5 3.5 5 
Postoperative 5.1 4.7 1 9.3 4.3 5 7.1 1.4 1 
Pre or postoperative 1.6 1.3 
Care satisfaction (3) 2.7 1.6 3 3.0 0.6 1 4.6 2.8 3 
*The number of mental health questions in the Japanese study was three. 
Despite considerable international differences in culture and health care system, a striking 
similarity was observed in the pattern of missing data across the five indices studied. In 
general, questions about basic ADL, mental health, and care satisfaction were more often 
answered than those on instrumental ADL and social activity. However, the modal 
number of missing data was less for the latter, suggesting that patients tried to answer as 
much as possible without ignoring the whole index. 
In the USA study, Guadagnoli and Cleary investigated whether missing data was related 
to a patient's age or their health status (284). They found the total number of missing data 
did not vary with age but that the better the health status of patienl~ the less the amount of 
missing data. Table 3-3c shows similar analyses for British and Japanese patients. Health 
status was measured by the average of basic ADL. instrumental ADL. and social activity. 
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Tabl~ 3-3~: Statisti~al sig.ni~cance Qf th~ as~~iatiQn be.tw~en gatient ag~ Qr fun~tiQnal 
status and mIssmg answ~rs tQ smgl~ QuesuQns 
(~xamin~d b~ Mann-Whitn~~ U test; NS- nOl significant at 5~ l~v~l) 
JAPAN UK 
Age Health Status Age Health StatyS 
It~m/Scal~ Pre-og Post-Qg Pre-og Post-QP 
Perceived health NS NS NS NS NS NS 
Comparative health NS NS NS NS NS NS 
Sexual satisfaction NS NS NS 0.018 NS NS 
Former employment NS NS NS 0.005 NS NS 
Current employment NS NS NS 0.022 NS <0.001 
Education level NS 0.025 NS NS NS NS 
Marital status NS NS NS NS NS NS 
Living alone NS NS NS NS NS NS 
Home ownership NS 0.013 NS NS NS NS 
Missing data in Japan did not con-elate with patient age. In contrast, in the UK older 
patients were less likely to answer the questions asking about their sexual relationships 
and employment status. The influence of health status on missing data showed a different 
pattern between Japan and the UK. Patients in Japan with poorer health status before 
surgery were less likely to answer questions regarding their education and house 
ownership. No such association existed in the UK. Blitish patients were less likely to 
answer questions asking about their cun-ent employment status if they had poorer health 
status following surgery. 
Analysis of any association between missing data in each of the five indices with patient 
age is shown in Table 3-3d. On the whole, in Japan patient age did not correlate with 
missing data on any index except for postoperative mental health. In contrast in the UK, 
significant associations were observed between older patients and missing data for all 
indices except preoperative basic ADL. In both countries, however, patient's age was 
strongly associated with a patient missing some questions from either the preoperative or 
the postoperative index. 
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Table 3-3d: Statistical significance of the association between patient aoe and missin o 
answers for indices consisting of multiple Questions ~ • 
(examined by Mann-Whitney U test: NS- not significant at 5% level) 
Indices JAPAN UK 
Basic ADL 
Preoperative NS NS 
Postoperative NS <0.05 
Pre- or postoperative <0.05 <0.05 
Instrumental ADL 
Preoperative NS <0.0001 
Postoperative NS <0.0001 
Pre- or postoperative <0.01 <0.0001 
Social activity 
Preoperative NS <0.01 
Postoperative NS <0.005 
Pre- or postoperative NS <0.001 
Mental health 
Preoperative NS <0.005 
Postoperative <0.05 <0.05 
Pre- or postoperative <0.05 <0.005 
Care satisfaction NS NS 
4 . Case note review 
The rate of case note retrieval for the patients recruited was high in both countries -97.3% 
of recruited patients in Japan and 91.0% in the UK- as was the level of complete medical 
information available. Collection of data from the case notes was markedly different 
between the two countries. All the Japanese case notes were collected in one visit at each 
hospital, while in the UK several visits were necessary. 
Remarkable differences in case note management was also observed between Japanese 
and British hospitals. In Japan. each admission note was edited and bound in a single 
folder for the same patient. Consequently there was no mix-up of data from different 
admissions. Outpatient notes were edited in continuous chronological order and kept 
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separate from the admission folder. The notes were bound firmly. with all forms and 
laboratory reports pasted in in an orderly way. Because most of the participating Japanese 
hospitals were teaching affiliated. they often had their own methods such as a routine data 
entry form for physical examination and computerised maintenance system, although 
these were often not compatible between different hospitals. A disadvantage of the 
Japanese system was that not all hospitals had introduced a common filing system across 
all the departments so sometimes information was not available from other specialties. 
Moreover, free access for patients to any hospital plus the lack of a GP providing 
continuity of care made it impossible to find out the vital status of patients who did not 
respond to the questionnaire. 
In the UK, all patient information was bound chronologically including outpatient and 
admission data. Therefore, in theory, the whole history of a patient's use of health 
services should have been available. This rule was not always practiced and data were 
often missing. Not all the forms and reports were dated and it was sometimes difficult to 
know which admission a particular document referred to. In most cases outpatient 
consultations were typed, which significantly facilitated correct data identification. 
However, it also seemed to be part of the reason why many notes were not returned to the 
medical records depattment even months after a consultation. A variety of administrative 
forms were often found which had not been completed or carried only minimum or 
repetitive information. Basic patient information such as date of birth and discharge status 
were available from the hospital computer database, though it was not always possible to 
ascertain whether the patient was still alive or not. In theory, such computer systems 
should be able to identify eligible patients for a study such as this one. In practice, such a 
function was impossible without a competent technician whose help was not always 
available. 
Table 3-4 shows some examples of the propOltions of data recorded on admission in 
Japanese and British hospitals. While administrative data were recorded for all cases in 
75 
both countries, clinical data were more often recorded in Japanese hospitals than British. 
For anaesthetic information such as body height, body weight, and ASA PS. few British 
hospitals recorded these on a routine basis. Also the amount of blood lost in the theatre 
was not always counted. The one exception to this general pattern was infOimation on the 
surgical approach adopted. 
Table 3-4: Completeness of data for common valiables in the case notes 
in Japan and the UK 
Data JAPAN (%) UK (%) 
Administrati ve: 
Date of bilth, operation, sex 100 100 
Date of admission/discharge 100 100 
Medical history: 
Drinking 90 72 
Smoking 90 87 
Social status: 
Living alone or not 100 78 
Physical examination : 
Body height 100 14 
Body weight 100 58 
Clinical information: 
Surgical approach 68 93 
ASAPS 100 41 
Blood lost in the theatre 100 63 
Blood lost in the ward 97 75 
Preoperative Hemoglobin 100 93 
It was difficult to know if in the UK the information was not collected, was collected but 
not recorded, or merely lost. Differences in data recording were also observed between 
hospitals within countries. For example in all Japanese hospitals, the amount of blood 
lost in the theatre was routinely recorded while that lost in the ward was often not 
recorded or measurement was less precisely carried. Another problem when comparing 
the two countries was the definition of some factors. For example. duration of surgery 
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and of anaesthesia were separately measured and recorded in Japan, but not in the UK. 
Thus duration of surgery may not have been comparable. 
One possible explanation for better data collection in Japanese hospitals could be that the 
anaesthesiologists were more demanding. Usually, for patients undergoing general 
anaesthesia, not only body height / weight but a full laboratory examination is requested. 
A respiratory function test is almost mandatory, inespective of the patient's general health 
status or past history. A general preference for laboratory tests rather than history taking 
or physical examination could be another reason. Finally, financial incentives for 
insurance payment and more defensive medicine could playa part. As a result, Japanese 
anaesthesia records keep more detailed data, such as ASA PS scoring and operation time. 
In most orthopaedic departments in Japanese hospitals, the severity of primary hip 
arthritis was scored according to guidelines issued by the Japanese Orthopaedic 
Association. Consequently the degree of pain, range of motion, and activities of daily 
living were uniformly recorded. Especially in teaching hospitals, more detailed surgical 
information was recorded such as the angle and size of nailing and tightness of joint. This 
was not always true, even in the UK teaching hospitals. The exception was data on the 
surgical approach which was largely ignored in Japanese hospitals, perhaps because 
surgeons tend to always follow the same technique making the routine recording of such 
information unnecessary. 
On the whole in the UK except for one teaching hospitaL no marked differences were 
found between teaching and non-teaching hospitals in telms of the completeness of data 
recorded. In both countlies attempts were made to get quantitative data about the severity 
of the affected joint, such as the range of motion or leg length difference. However, too 
often the measurement differed considerably among observers and was not thought to be 
reliable. 
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5. Summary 
# Eli~ibility: 10 patients in Japan and 24 in the UK were excluded as they had been mis-
classified in the sampling frame (the theatre registers) in terms of the procedure carried 
out or the primary diagnosis. 
# Recruitment rate: High recluitment rates were obtained both in Japan (85.3%) and the 
UK (80.7%). Some of the non-recruited patients were currently inpatients, could not 
be traced or had died. 
# Questionnaire completeness: Apart from questions on sexual satisfaction. most 
questions were answered by over 95% of respondents. Generally. Japanese patients 
were more likely than British or American patients not to answer a question. However 
for multiple questions making up the health status indices. the pattern of missing data 
was remarkably similar among the three countries. In the UK, older patients were 
significantly less likely than younger patients to answer questions on health status. 
# Case note review: The rate of case note retrieval was over 90% in both countries, 
although it was much easier to find case notes in Japan than in the UK. Differences 
were also observed in the organisation and presentation of case notes between the two 
countries. More clinical data were recorded in Japanese hospitals than British. 
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· Chapter 4: Accuracy of measurements 
This chapter reports on the accuracy of the measurement tools used in this study. The 
reliability, validity, and responsiveness of the self-administered questionnaire which 
measured health status is discussed. Second. the reliability of measuling the severity of 
comorbidity using the ICED is rep0l1ed in terms of inter-observer and intra-observer 
differences. Reasons for any observed differences are then discussed. 
********************************************************************** 
1 . Health status measurement by questionnaire 
1-1. Internal consistency 
In order to measure the reliability of the postal questionnaire to patients, the internal 
consistency of the health status scores before and after THR were exam ined (Table 4-1 a). 
Cronbach's alpha, based on the average con-elation of items within a test, was calculated 
for each dimension of health status. The number of items for each dimension was 3 for 
basic ADL, 6 for instrumental ADL, and 3 for social activity. For mental health it was 5 
in the UK and the USA. but 3 in Japan. For fatigue and cognitive problems, there were 2 
items for each test 
The basic-ADL, instrumental-ADL, and social activity indices all had good internal 
consistency, generally close to or greater than 0.70. In general, internal consistency in the 
UK was almost the same or less than in Japan and the USA, which was reversed 
postoperatively. 
Mental health index had the least reliability in Japan before and after surgery among the 
four indices examined. but not in the UK and in the USA. Although the data for mental 
health scores were not exactly comparable due to the different number of questions asked, 
80 
the shorter index in Japan yielded a lower reliability than in the UK and in the USA. 
Likewise, the indices assessing cognitive problems and fatigue, both consisting of only 
two questions, had relatively lower reliability. When compared before and after surgery, 
these shorter indices were less consistent but other indices were stable. 
Table 4-1 a: Internal consistency (Cronbach's alpha) of health status indices 
before and after THR 
Indices JAPAN UK USA 
Basic ADL 
Preoperative 0.85 0.77 0.82 
Postoperative 0.83 0.85 0.75 
Instrumental AD L 
Preoperative 0.88 0.81 0.88 
Postoperative 0.84 0.84 0.85 
Social activity 
Preoperative 0.80 0.71 0.88 
Postoperative 0.72 0.71 0.88 
Mental health 
Preoperative 0.69 0.74 0.80 
Postoperative 0.49 0.74 0.74 
Cognitive problems 
0.38 0.59 Preoperative 
Postoperative 0.61 0.42 
Fatigue 
0.71 0.81 Preoperative 
Postoperative 0.72 0.66 
1-2. Construct validity 
Construct validity was examined by means of the correlation coefficient between several 
single item measures and indices assessing each postoperative dimension of health (basic 
ADL. instrumental ADL, social activity, and mental health) (Table 4-1 b). 
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The correlations were moderately high in both countries. statistically all significant 
(p<O.Ol) and bigger in the UK than in Japan. The con-elation among the four indices of 
health status with these single item measures was similar, suggesting that partly because 
there was a substantial overlap among the four indices. 
Perceived improvement in health and change in the way patients felt had the least 
correlation with all dimensions of health status both in Japan and in the UK, suggesting 
the relatively weak representation of postoperative health status by such a question asking 
on time series. 
Tabl~ 4-1b: CQnstruct validi~ (~Qn'elation cQefficient.~) of health status indices ~xamineQ 
in Ja12an and the UK (All significant at 12<0.01) 
Basic Instrumental Social Mental 
JAPAN ADL ADL Activity Health 
Postoperative status: 
General assessment of health 0.36 0.40 0.32 0.32 
Expected health 0.27 0.36 0.28 0.28 
Expected activity 0.25 0.29 0.26 0.21 
Change in status: 
0.26 0.40 0.28 0.35 Perceived improvement in health 
Perception of change in feeling 0.23 0.35 0.23 0.32 
Happiness about THR 0.27 0.43 0.28 0.40 
-------------------------------
---------------------------------------
Basic Instrumental Social Mental 
UK ADL ADL Activi~ H~allh 
Postoperative status: 
General assessment of health 0.45 0.51 0.45 0.48 
Expected health 0.40 0.45 0.34 0.38 
Expected activity 0.47 0.53 0.47 0.30 
Change in sta.tus: . 
0.39 0.40 0.37 0.27 Perceived Improvement In health 
Perception of change in feeling 0.44 0.42 0.35 0.31 
Happiness about THR 0.50 0.46 0.43 0.32 
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· 1-3. Responsiveness 
Although the scores in functions were not nonnally distributed in Japan and the UK. the 
responsiveness of the scales were compared with previously reported result from the 
USA using the t scores representing the difference between preoperative and 
postoperative function, divided by the standard en-or of the difference (Table 4-1c). The 
scores for all indices suggest statistically significant improvements (p<O.OOO I) after 
THR. There were some differences both among countries and indices. 
Table 4-lc: Impact of THR on outcomes represented by t-score of difference in functions 
Functioninl: 
Limping 
Need for walking support 
Basic-ADL 
Instrumental-ADL 
Social activity 
Mental health 
JAPAN 
16.0 
10.0 
13.3 
12.3 
10.0 
13.2 
2. Measurement of co morbidity by the ICED 
2-1 t Inter-rater reliability 
UK 
19.5 
7.4 
18.8 
17.8 
12.9 
5.5 
USA 
19.9 
8.0 
17.5 
18.1 
13.4 
9.4 
Inter-rater reliability was examined twice in the UK. It was not possible to carry out such 
analyses in Japan for practical reasons. 
2-1 at First study with two raters 
Two raters each examined 39 case notes to rate patients' comorbidity. Both raters were 
qualified doctors; the author, a Japanese orthopaedic specialist (rater A: in the following 
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tables), and a UK general practitioner (rater B). After one fun-day training session, the 39 
case notes were examined and comorbidity was rated independently. Table 4-2a shows 
the percentage of agreement between the two raters. 
The level of agreement at subindex level was analysed using kappa statistics. After 
correcting for chance agreement, the value of kappa for the IDS subindex was smaller 
than that for the FS subindex. When the extent of marginally permitted agreement was 
included by way of the ratio of kappa (K) to kappa maximum (Kmax), agreement for the 
FS index was still higher than for the IDS index. 
Table 4-2a: IntelTater reliability test in the 1st study with two raters (N-39) 
%Agreement 
Both agreed 
Disagreed 
Kappa statistics 
Kappa 
Kappa Maximum (Kmax) 
KlKmax 
IDS 
N (%) 
25 (64) 
14 (36) 
IDS 
0.49 
0.64 
0.77 
FS 
N (%) 
36 (92) 
3 (8) 
FS 
0.g5 
0.85 
1.00 
ICED 
N [%1 
27 (69) 
12 (31) 
ICED 
0.57 
0.75 
0.76 
The other analysis to estimate reliability is derived from a random effects analysis of 
variance model. The intraclass correlation coefficient was calculated as the ratio of case 
variance to total variance. In this study, it was computed from a single-factor, repeated 
measures design analysis of variance. The result, like the kappa statistics, showed greater 
agreement for the FS index (0.7540) than for the IDS index (0.7132) and the ICED 
(0.7067). 
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2-1b. Second study with three raters 
Analysis of the cases in which disagreement occurred led to a greater understanding of the 
reasons for inter-rater differences. Having undertaken this analysis it was felt that it 
would be interesting to test two hypotheses: that the interrater reliability could be 
improved by more training of the raters as had occurred in discussing their differences; 
and that higher reliability would be achieved between doctors from the same specialty. A 
second trial was therefore undertaken. 
Three raters each examined 49 case notes. The third rater (rater C). an UK 011hopaedic 
registrar joined the two existing raters A and B. Rater C received the same training as 
given to rater B. The case notes were then examined by all three independently. 
All three raters agreed on the ICED category for 53% of the cases (26 out of 49 cases) 
(Table 4-2b-1). In a further 41 % of cases, two of the three raters agreed. However for 
6% of the cases, all three raters disagreed. At the subindex level, more agreement was 
obtained for functional severity (FS) scores than for the index of disease severity (IDS). 
Table 4-2b-l: % Agreement among three raters (2nd study: N=49) 
IDS FS ICED 
%Agreement N (%) N (%) N (%) 
All agreed 24 (49) 43 (88) 26 (53) 
Two agreed 18 (37) 6 (12) 20 (41) 
All disagreed 7 (14) 0 ( 0) 3 ( 6) 
At least two agreed 
42 (86) 49 (l00) 46 (94) 
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The level of agreement at subindex level was analysed using kappa statistics (Table -+- 2b-
2). Similar to the first study, the values of kappa for the IDS subindex were always 
smaller than those for FS subindex when any two raters were compared. In terms of the 
ratio of kappa (K) to kappa maximum (Kmax), the agreement in the FS index was still 
higher than in the IDS index. 
Table 4-2b-2: Kappa statistics among three raters (2nd study) 
Raters combinatiQn 
Kappa AlB AlC B/C 
IDS subindex 0.51 0.39 0.45 
FS subindex 0.97 0.73 0.64 
ICED 0.56 0.35 0.51 
--------------------------------------------------------
KlKmax 
IDS subindex 
FS subindex 
ICED 
AlB 
0.66 
1.00 
0.61 
AlC 
0.55 
0.85 
0.50 
B/C 
0.61 
0.78 
0.69 
The result of intrac1ass con-elation coefficient analyses is shown in Table 4-2b-3. 
Again like the kappa statistics, it showed the best agreement in the FS index. 
Table 4-2b-3: Tntrac1ass con'elation coefficient among three raters (2nd study) 
Indices 
IDS subindex 
FS subindex 
ICED 
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Intraclass 
con-elation 
coefficient 
0.604 
0.768 
0.569 
Among the three raters, raters A and B were more often likely to agree than the other two 
possible combinations (NC and B/C). The worst level of agreement for the IDS and 
ICED was NC and for the FS was B/C. As regards the IDS. differences between A and 
B and between Band C usually arose because B scored patients as having less severe 
comorbidity (Table 4-2b-4). There was no consistent pattem in the differences between A 
and C. In 11 cases rater A scored more severely than rater C at the IDS subindex level. 
while in 10 other cases their scores were reversed. 
Table 4-2b-4: Number of cases in which raters disagreed (N=49) (2nd study) 
Score 
IDS subindex 
FS subindex 
ICED 
Score 
IDS subindex 
FS subindex 
ICED 
A>B 
13 
1 
9 
A<B 
4 
1 
5 
Rater's score comparison* 
A>C 
11 
0 
9 
10 
4 
11 
*Raters with larger scores judged the comorbidity more severe. 
B>C 
4 
1 
4 
B<C 
15 
5 
11 
From these results, the first hypothesis that the interrater reliability could be improved by 
more training of the raters seemed unlikely to be true because apparently increased kappa 
for IDS and FS might have come from the different sample distribution in two trials. The 
result that the ratio of kappa to kappa maximum was not improved in the second trial also 
suggested to reject the first hypothesis. The second hypothesis that higher reliability 
would be achieved between doctors from the same specialty was similarly to be rejected 
from the results shown between raters A and C. 
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What relevance might such inter-rater differences have had in predicting outcomes? 
Eighteen out of the 49 cases were identified later as having had a serious in-hospital 
complication. Their distribution was compared with the classification of 49 patients by 
three raters (Table 4-2b-5). Because of the small sample size, it was difficult to evaluate 
their association with each rater's classification. In short, rater A stratified cases into four 
subgroups in which the complication rates ranged from 28% to 50% with a consistent 
gradient from level 1 to level 4. In the two other raters' classification, the complication 
rates were not so consistent. 
Table 4-2b-5: Relationship of each rater's classification with OCCUlTence of 
setious complications (2nd study) 
A B C 
complication N (%) complication N (%) complication N (0/0) 
ICED level 1 5 18 (28) 4 20 (20) 4 13 (31) 
ICED level 2 1 3 (33) 2 4 (50) 1 4 (24) 
ICED leve13 9 22 (41) 9 21 (43) 1 1 29 (38) 
ICED level 4 3 6 (50) 3 4 (75) 2 3 (67) 
2-2. Intra-rater reliability 
One reviewer (the author) rated 45 case notes twice at a mean interval of 82.5 (SD=0.5) 
days. As shown in Table 4-2c, ratings were very stable over time. Kappa statistics 
suggested almost perfect agreement both at subindex (lCD, FS) and at composite index 
(ICED) level, and so did the intraclass correlation coefficient. 
Not surptisingly, a result of this minimum change in stratification, both the distribution of 
comorbidity and the proportion of in-hospital complication were not affected (data not 
shown). 
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Table 4-2c: Summary statistics of intrarater reliability 
% Agreement between 1st and 2nd rating 
IDS 
FS 
ICED 
98% 
96% 
93% 
(44/45 agreed) 
(43/45 agreed) 
(42/45 agreed) 
------------------
-----------------------------------------------
Kappa statistics 
Kappa (K) 
IDS 
FS 
ICED 
0.969 
0.910 
0.905 
Kappa Maximum (Kmax) 
IDS 0.969 
FS 0.910 
ICED 0.969 
Intraclass correlation coefficient 
IDS 0.9908 
FS 0.8119 
ICED 0.9452 
2-3. Sources of disagreement 
(KlKmax) 
(1.00) 
(1.00) 
(0.93) 
The sources of disagreement between raters in assigning comorbidity were felt to arise for 
three reasons: the case notes; the raters; and the ICED protocol 
2-3a. Case notes 
Case notes in the UK are intended to be stored in chronological order. including both 
inpatient and outpatient records. Although this was not practiced well in most of the six 
British hospitals included in the study, all 49 notes studied in the reliability test with three 
raters were from a teaching hospital, and they were well organised and maintained. Fewer 
handwritten data were observed than in the other hospitals. Patients had been seen on 
89 
several occasions before surgery including pre-admission clerking by a house officer and 
presentation of the case to senior clinical staff. This sometimes led to conflicting 
.... 
information regarding the patient's comorbidity, because surgeons did not always agree 
with their colleagues in their assessment of a patient's risk for operation/anaesthesia. 
Also it could be the case that the patients present only their major co-existing 
diseases/disabilities to doctors, and whatever they think is tlivial, they mention only to the 
nursing staff. This self-selection of information by patients could lead to doctor's and 
nurse's records differing. For example, when patients had shortness of breath on exercise 
it could be written in either or both sections of the notes in a different wording. 
2-3b. Raters 
In this study, raters differed from each other in terms of their speciality. nationality. and 
country of training. In comparison with orthopaedic surgeons, general practitioners 
(OPs) see cardiorespiratory disorders more frequently. On the other hand surgeons are 
more likely to experience acute deterioration in patients perioperatively. These work 
habits might lead to different views of clinical severity. Seeing patients doing well in their 
daily life in the community despite their illness may encourage lower scores in 
physiological impailment categories (as used in the IDS), while witnessing serious in-
hospital problems may make surgeons cautious about every abnormal measurement 
found. 
As for differences in health care systems, Japan permits patient's direct referral to hospital 
care while in the UK this is limited via OP refenul. Blitish GPs select the patients to be 
seen by surgeons. who could be looked after by surgeons in Japan to some extent. From 
this difference in the range of patients, Japanese doctors might have intermediate view 
between BJitish surgeon and GPs. 
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The cultural upbringing of the raters might have led to their different concepts of 
acceptable health. Japanese care much about cleanliness, and even a minor disorder is 
viewed as a sickness whether it threatens one's ultimate survival or not. Nationwide 
health insurance coverage. effective health promotion. and the introduction of regular 
health check-ups have encouraged the Japanese to look for any change in their 
physiological status and then to seek treatment. Tn contrast in the UK. people prefer to 
maintain their independence. Assisted by the development of social welfare and 
community health services, the elderly and disabled can live on their own despite their 
health difficulties. The range of what 'health' means in the UK is wider than in Japan. 
This general difference may effect the rater's view of sickness. 
2-3c. ICED protocol 
The USA manual for using the ICED provided general guidance in the classification of 
specific problems and guidelines for individual diseases. In 20 pages, it covered 13 
physiological conditions and 10 physical conditions. Despite this several problems were 
encountered. 
c-l) Index of disease severity (IDS): 
Among the 13 diseases, cardiac disorders received most attention (4 out of the 13: organic 
heart disease. ischemic heart disease, plimary arrhythmias & conduction problems, 
congestive heal1 failure). The next most referred system/organ were vascular diseases 
(hypertension, cerebral vascular accident. peripheral vascular disease). Other conditions 
were not classified in as much detail. The ICED was therefore heavily weighted to 
circulatory risk. Among the four cardiac diagnoses, the instructions state that none of 
them overlap each other. For example. if an electrocardiogram showed ischemic change, 
it was suggested that 'primary arrhythmias & conduction problems' but not 'ischemic 
heart disease' should be atTilmed. 
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In practice, raters found the definition of each category of disorder was not extensive 
enough to cover the wide range of patients' conditions. For example, in respiratory 
problems which includes asthma, there was no indication as to which level to assign 
patients who used daily inhalation therapy for years without suffering an attack. 
Pre-symptomatic disease may be first detected on admission. such as a patient found to be 
hypertensive at hospital. The shorter the length of preoperative hospital stay, during 
which patient's blood pressure may be checked a few times by different hospital staff. the 
more difficult it would be to see if a patient had pathological hypeltension or was merely 
agitated (white-coat hypertension). Usually a preoperative check list of the 
pharmaceuticals that patients were taking before admission was helpful in figuring out the 
severity of any hypeltension, but raters had to rely on case notes which were not always 
complete in keeping every form. 
The length of the past history of a condition was also a potential problem of 
interpretation. In the malignancy category, a history of cancer was classified according to 
the number of years since the last treatment (more than 5 years' history was level 1. less 
than 5 but more than 1 year was level 2). In practice. medical records often failed to 
specify the period. 
Also, some peliods which were left open-ended caused difficulty. In hepatobiliary 
disease, a history of hepatitis of more than I year ago was classified as level 1. When a 
patient was recorded as having had childhood jaundice, raters disagreed as to how to 
classify the severity. 
There was also some concern about the relative severity of conditions in different 
physiological categOlies. For example. a history of one transient ischemic attack with no 
residual effect~ was classified as level 1 in the cerebro-vascular accident category and a 
history of cerebro-vascular accident was given level 2 or more. However. raters felt this 
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was not consistent with the levels for diabetes mellitus. For example, diabetes is 
classified regardless of the means of treatment CLevel 2=controlled diabetes on 
medications, insulin, or diet'). 
c-2) Functional severity (FS): 
The ICED considers functional severity as 'not diagnosed but relevant diseases' which 
'may have an impact on the function of the patient'. Severity was classified according to 
its absence or presence and its extent (level 1 was for mild/moderate and level 2 for 
serious/severe impairment). 
Raters found this subindex sometimes overlapped with the physiological impairment 
subindex. In assessing the severity of cardiorespiratory disorders, both subindices have 
matching categories. For example, when a patient with congestive heart failure and well 
controlled asthma had ankle edema and shortness of breath, the severity would be level 2 
in the congestive heart failure category in the disease severity subindex. But raters 
disagreed if they should or should not assign to level 1 in functional severity for hislher 
shortness of breath, because its cause had already been diagnosed. Also it was unclear 
whether it had to be in the circulation or respiration category of the IDS. 
It was felt that the subindex should refer to more conditions, including those that are 
relatively rare. In the neurological category, raters found no categories mentioned 
Parkinson's disease which was thought to give some degrees of functional severity. 
Sometimes selection of the appropriate severity level proved difficult For example, in the 
urinary category, incontinence was assigned level 2. When raters came to score the 
severity of stress incontinence, it was unclear whether it was level 2 or 1. Similar 
uncertainty occurred with 'occasional incontinence'. 
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Consistency in classification of severity was also questioned. As most of the patients in 
this study was elderly people, they often wore glasses and/or a hearing aid. In the vision 
category, level 0 was for those with no problems and level 2 was for severe blurring or 
blindness. Raters therefore assigned level 1 to those weating glasses. In most instances 
no infonnation was available as to how much patients needed glasses. On the other hand, 
a patient was classified as level 0 in the healing category even with healing aid. 
3. Summary 
# Health status measurement by Questionnaire: Internal consistency of health status 
measures was high in all countries, though lower for the indices made up of only 2 or 
3 questions than for those with 5 or 6 questions. Construct validity was moderately 
high in both countries. Responsiveness of the questionnaire to differences in function 
was also good. 
# Measurement of comorbidity by the ICED: Intrarater reliability was high for both 
subindices and the ICED. Interrater reliability was examined twice, with similar 
results. Lower agreement was observed with the subindex of co-existent disease 
(kappa 0.5) than with the functional severity subindex (kappa 0.64-0.97). 
Disagreements are thought to have arisen as a result of the poor quality of case notes, 
differences in the cultural and professional backgrounds of the raters, and difficulties 
in interpreting the rules for using the ICED. 
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· Chapter 5: Preoperative health status of patients and their clinical management 
In this chapter, patients are described in terms of their sociodemographics, disease 
severity, and comorbidity. Patients from Japan and from the UK are compared, as well as 
some comparisons with previously published data on USA patients. The clinical 
management of both Japanese and British patients is also described. Finally. some inter-
hospital comparisons in the UK are presented. Due to the small sample size in each 
hospital, similar analyses were not possible for Japanese data. 
********************************************************************** 
1 . Sociodemographic characteristics 
The characteristics of the patient~ who participated in the study are presented in Table 5-1. 
1-1. Age 
The age distribution was significantly different among the three countries. Japanese 
patients were the youngest and British patients the oldest. This contrasts with the 
difference in the average life spans in the three countties: Japanese expectation of life is 
about four years longer than that of the UK and the USA for both sexes. One possible 
explanation is cultural differences in illness behavior. In general, the Japanese are very 
concel11ed about any risk associated with an intervention and so tend to decline treatment 
if any possible complication is suggested. This attitude is observed not only in patients 
themselves but in their family and in their doctors. Thus, the observed age difference in 
this study may represent a preference among older (and therefore sicker) patients in Japan 
to forego surgery because of the greater risk they face compared with younger patients. 
Also younger people may have more access to health services in Japan which could 
facilitate more consultations with doctors at the very early stage of diseases, plus 
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extensive nationwide health promotion which might lead to increased attention to any 
change in their health status. 
1-2. Sex 
The gender distribution demonstrated another clear difference. The majority of Japanese 
patients were female, perhaps reflecting the different etiology of hip arthritis in Japan 
where congenital hip dislocation has been commoner. particularly among females. The 
proportion of female patients in the UK was similar to that in the USA. 
1-3. Married 
The proportion of married patients was higher in Japan than in the UK and the USA, 
reflecting the significant difference in their age distribution in which the older British 
patients are more likely to be widowed (25.3%) than the younger Japanese (15.6%). Also 
more Btitish patients were found to be separated or divorced (6.8%) than the Japanese 
(2.9%). 
1-4. Livin~ alone 
Fewer Japanese patients were living alone than was true for Btitish patients. This is 
consistent with the national preference of Japanese people who are more likely to stay 
together in an extended family. A Japanese national survey in 1989 showed 35.7% of 
households with an elderly person was an extended family including three generations 
(285). Although the number of cohabitants per household has been steadily decreasing in 
Japan, national statistics for 1992 showed that the proportion of the elderly (65 years or 
older) living alone was 11.2% (285). In the UK, 29% of those aged 65-74. and 48% of 
those aged 75 years or older were living alone in 1992 (2R6). These figures are similar to 
those found in this study. 
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1-5. Home ownership 
Because of the advanced age of the patients in this study, most of them were owner-
occupiers in both countries. National statistics for home ownership was not available in 
Japan, however, a British survey in 1992 suggested 66% of the households were owner 
occupied (286). In this study a similar figure was obtained for THR patients. 
1-6. Education 
Because of the difference in school education systems, patients' educational level was 
measured in different ways in each country. In Japan, patients were asked whether they 
finished primary education (usually 15 years of age) or received higher education, while 
in the UK patients were asked about the age at which they completed their full-time 
education. The questionnaire for the Japanese patients had a selection of five answers; 
primary education (15 years), high school (18 years), polytechnic (20 years), college (22 
years), postgraduate school (26 years). In the UK, answers were selected from; age 15 
years or under, 16-18 years, 19 years or over. 
When the patients were compared by the age at which they completed their education, a 
significant difference was observed. Japanese patients were more likely to have continued 
past 15 years of age. Similar proportion had gone on to higher education. 
1-7. Work status 
In general, most of the patients in both countries were not in employment, reflecting their 
advanced age. There was no statistically significant difference between the proportion of 
Japanese and British patients working. 
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1-8. Habit in drinking/smoking 
Information on drinking and smoking were obtained from the case notes and missing data 
were eliminated from analysis. The accuracy of the data were limited by patients' 
accuracy in reporting and whether or not a record was made in the case notes. As 
drinking and smoking were simply categorised as 'Yes' or 'No', it is not clear how 
someone who recently stopped was recorded. Overall, more Blitish patients were cUlTent 
smokers than Japanese. In contrast there was no significant difference in drinking habits 
(answered in terms of the usual amount consumed). 
Table 5-1; Comparison of patients' sociodemographic charactetisrics 
between Japan (N=256), UK (N=30 1) and USA (N=356) 
Number {%} of patients 
Probability* 
Patient charactetistics Japan UK Japan vs UK 
Mean age, years +/-SD 60+/-10 68+/-12 <0.0001 a 
Female 217 (84.8) 193 (64.1) <0.0001 b 
Married 188 (77.0) 173 (58.4) <0.0001 b 
Living alone 28 (11.4) 102 (34.8) <O.OOOlb 
House ownership 208 (84.6) 191 (64.5) <0.0001 b 
Education 
age of completion, years 
15~ 53 (21.4) 179 (61.9) <0.0001 c 
16 - 18 163 (65.7) 68 (23.5) 
19=:; 32 (12.9) 42 (14.5) 
Work status 
Working full/part time 66 (27.8) 59 (20.6) 0.0513b 
Habit 
Current dlinker 56 (25.0) 38 (19.9) 0.2174b 
Current smoker 27 (12.1) 83 (35.5) <0.0001 b 
USA 
64+/-13 
203 (57) 
228 (64) 
*; Probability was examined between Japan and the UK. a, based on t test; b, Chi square 
test; c, Mann-Whitney U test. 
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· 2. Severity of hip disease 
2-1 , Dia~nosis 
The primary diagnoses of hip arthritis were similar in the two countries (Table 5-2a). The 
majority of patients had osteoarthlitis, including both plimary and secondary causes. The 
proportions of the patients suffered from rheumatoid arthritis and avascular necrosis were 
relatively smaller than previous studies have reported. Other diagnoses included systemic 
connective tissue diseases such as osteogenesis impel1ecta and ankylosing spondylitis. 
2-2. Past history of hiplknee surgery 
The proportion of patients who had previously undergone surgery on either of their hips 
was significantly higher in the UK than in Japan. In both countries, about 6% of the 
patients had had surgery previously on the same hip as the index operation for this study. 
However, British patients were more likely to have had surgery on the other hip than in 
Japan. Most operations on the contralateral hip had been THR, either primary or revision. 
The result may reflect international difference in the practice of THR. which has been 
commoner in the UK than in Japan. For past history of knee surgery, significantly more 
British patients had undergone surgery than the Japanese. 
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Table 5-2a: Comparison of clinical profile of hip disea..~e between Japan. UK and USA 
Primary diagnosis 
Osteoarthritis 
Rheumatoid arthritis 
Avascular necrosis** 
Others 
Prior hip surgery (either side) 
on the same hip 
on the other hip 
THR in the other hip 
Prior knee surgery 
Japan 
N-249 
219 (88.0) 
12 ( 4.8) 
16 ( 6.4) 
2 ( 0.8) 
51 (20.5) 
15 ( 6.0) 
43 (17.3) 
31 (12.4) 
4 ( 1.6) 
Number (%) of patients 
UK Probability * USA 
N 268 Japan vs UK N 356 
244 (91.0) 0.1251 
15 ( 5.6) 
6 ( 2.2) 
3 ( 1.1) 
76 (28.4) 0.0376 (28) 
16 ( 6.0) 0.9794 
68 (25.4) 0.0249 
60 (22.4) 0.0030 
15 ( 5.6) 0.0160 ( 3) 
* Statistical significance was compared between Japan and the UK, based on Chi square 
test. 
** Avascular necrosis included both idiopathic and secondary causes. 
2-3. Patient self-evaluation of hip disability 
Preoperative hip disability was measured in telms of the sevetity of any limp and the need 
for walking supports (Table 5-2b). Patients were asked how much of a limp they had 
before the index operation. Limp was evaluated on a scale from 1 to 5, where 1 indicated 
no limp and 5 indicated patients could not walk. There was a striking difference between 
the two countries. British patients perceived that they were significantly more disabled 
with 59% severely affected or unable to walk compared with 28% of Japanese patients. 
Also, patients were asked the type of walking support they used before the operation. 
Most of the patients did not need any support or only used a single cane/crutch. Although 
the UK patients made more use of supports than Japanese patients, the difference was not 
as great as the difference in perceptions of the severity of their limp. 
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Table 5-2b: Patient perception of limp and the need for walkin!; SUppOl1 before THR 
Number Qf patient {%) 
JAPAN UK Probability 
N-256 N 301 (Mann-Whitney) 
Severity of limp 
l. None 5 ( 2.0) 9 ( 3.1) <0.0001 
2. Slight 64 (25.3) 28 ( 9.5) 
3. Moderate 114 (45.1) 85 (28.8) 
4. Severe 48 (19.0) 151 (51.2) 
5. Unable to walk 22 ( 8.7) 22 ( 7.5) 
Missing 3 6 
---------------------------------------------
-------------------------
Walking support 
None (or rarely) 91 (36.5) 75 (25.3) <0.0001 
Single care or crutch 123 (49.4) 136 (45.8) 
Two canes or crutches 20 ( 8.0) 54 (18.2) 
Walker 6 ( 2.4) 9 ( 3.0) 
Wheelchair 9 ( 3.6) 23 ( 7.7) 
Missing 7 4 
2-4. Obesity 
Because data on height and weight were missing from 228 (85.1 %) case notes of British 
patients, analysis was done on Japanese patients only. Data from the Japanese COh011 
were compared with those from a national survey (287), adjusted for age and sex. 
Among the 248 patient~ whose height and weight were known, nearly half of them were 
in the normal range (25 - 75 percentile) (Table 5-2c). About 10% of the patients were 
categorised into either 'fat' or 'thin'. In general, the Japanese patients were similar in 
distribution to the general population. 
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Table 5-2c: Distribution of patient obesity in Japan (N-249) 
Cate~ory of obesity 
Fat 
Moderately fat 
Nonnal 
Moderately thin 
Thin 
Missing 
3. Comorbidity 
Percentile in 
Japanese population 
<10 
10-25 
25-75 
75-90 
90< 
3-1. Distribution of patientl\ classified by TCED 
Number of 
patient 
25 
47 
121 
30 
25 
1 
% Total 
10.1 
19.0 
48.8 
12.1 
10.1 
In all three countries, the distribution of patients classified by the co-existent disease 
severity subindex was bi-phasic: there were fewer patients at level one than at level zero 
or two (Table 5-3a). This trend was partially changed when composing the ICED by 
adding in the other subindex, functional severity, which shifted some of the level two 
patients to lower levels. This was because of the predominance of level zero 
classifications in the functional severity sub-index. As a result. the ICED scores were 
closer to a nonnal distribution in the UK and the USA. however. the majority of Japanese 
patients were still dichotomised to either no or mild co-existent disease. A striking 
difference was observed in the proportion of patients with moderate to severe levels of 
cornorbidity. In Japan, 14.8% of patients were classified in level 3 and 4, while it was 
43.3% in the UK and 34.1 % in the USA. 
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TaQl~ 5-JiJ,: Number and 12ercent of 12atient~ classified b~ the two subindices (cQ-exist~nt 
diseas~ sevelit~ and functional ~verit~)1 and the ICED 
Levels N at each level {% total} 
of JAPAN UK USA 
Ind~x index N-249 N 26R N 356 
Co-existent 0 105 (42.2) 73 (27.2) 105 (29.5) 
disease severity 1 65 (26.1 ) 36 (13.4) 68 (19.1) 
subindex 2 74 (29.7) 116 (43.3) 172 (48.3) 
3 5 ( 2.0) 43 (16.0) 11 ( 3.1) 
Functional severity 0 204 (81.9) 162 (60.4) 213 (60.0) 
subindex 1 42 (16.9) 93 (34.7) 132 (37.2) 
2 3 ( 1.2) 13 ( 4.9) 10 ( 2.8) 
Unknown 1 
----------------------------------------------------------------------------------------------------------
Index of 1 105 (42.2) 70 (26.1 ) 103 (29.0) 
co-existent disease 2 107 (43.0) 82 (30.6) 131 (36.9) 
(ICED) 3 30 (12.0) 63 (23.5) 104 (29.3) 
4 7 ( 2.8) 53 (19.8) 17 ( 4.8) 
Unknown 1 
3-2. PreviJ,lence of co-existent diseases 
The variety of co-existent diseases in British patients was greater than in Japan (Table 5-
3b). In both countries, hypertension (about a third of patients) and arrhythmia (about a 
quarter of patients) were the most frequently observed. Significant differences were 
observed between the two countries in the prevalence of cardiovascular (organic heart 
disease, ischemic heart disease. congestive heart failure. hypertension, peripheral 
vascular disease), diabetes mellitus, renal disease, and gastrointestinal diseases. 95% 
confidence interval of the propOltion is shown in Table 5-3c for the diseases with 
significant differences observed between Japan and the UK. 
Due to the lack of use of a universal disease classification system, national health 
statistics are not comparable. However. the study results suggested similar findings to 
what was expected. For example, the results for cardiovascular and blood pressure 
disorders were in agreement with previous report, (288-292) which have suggested a 
10.t 
lower risk in the Japanese population. In contrast, similar levels of morbidity were 
expected for diabetes 0.6 in Japan, l.8 in the UK) (2RR.2R9) but this was not so with 
these study groups. 
TaQI~ ~-3b: Com{.Hllison of Qrevalence of co-existent diseases between JaQan and the UK 
Number of Qatients (%} Probability Co-~xistent disease JAPAN (N-249) UK (N-2oX) (Chi sQuare} 
Organic Heart Disease 3 ( l.2) 15 ( 5.6) 0.0131 
Ischemic Heart Disease 16 ( 6.4) 34 02.7) 0.0161 
Arrhythmia 67 (26.9) 67 (25.0) 0.6209 
Congestive Heatt Failure 2 ( 0.8) 38 04.2) <0.0001 
Hypertension 67 (26.9) 101 (37.7) 0.0089 
Cerebral Vascular Accident 5 ( 2.0) 7 ( 2.6) 0.8702 
Peripheral Vascular Disease 1 ( 0.4) 33 02.3) <0.0001 
Diabetes Mellitus 18 ( 7.2) 9 ( 3.4) 0.0481 
Respiratory Disease 10 ( 4.0) 18 ( 6.7) 0.1753 
Malignancy 8 ( 3.2) 6 ( 2.2) 0.4954 
Hepatobiliary Disease 3 ( l.2) 7 ( 2.6) 0.4002 
Renal Disease 10 ( 4.0) 23 ( 8.6) 0.0338 
Gastrointestinal Disease 6 ( 2.4) 34 02.7) <0.0001 
Table 5-3c: Mean QroQoltions (95% confidence intervals} of diseases showing 
significant differences between JaQan and the UK 
Co-existent disease 
Organic Heart Disease 
Ischemic Heart Disease 
Congestive Heatt Failure 
Hypertension 
Peripheral Vascular Disease 
Diabetes Mellitus 
Renal Disease 
Gastrointestinal Disease 
Mean QroQortion (95% contidence intervals) 
JAPAN UK 
1.2 ( 0.3 - 3.8) 5.6 ( 3.3- 9.3) 
6.4 ( 3.8 - 10.4) 12.7 ( 9.1 - 17.4) 
0.8 ( 0.1 - 3.2) 14.2 00.4 - 19.1) 
26.9 (21.6 - 33.0) 37.7 (31.9 - 43.8) 
0.4 ( 0.0- 2.6) 12.3 ( 8.7 - 17.0) 
7.2 ( 4.5 - 11.4) 3.4 ( 1.7- 6.5) 
4.0 ( 2.1 - 7.5) 8.6 ( 5.6 - 12.8) 
2.4 ( 1.0- 5.4) 12.7 ( 9.1 - 17.4) 
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· 3-3, Prevalence of functional sevelity 
As can been seen from the functional severity subindex results in Table 5-3a. more 
British patients suffered from condition that effected their functioning than Japanese 
patients. Particularly significant differences involved respiratory, neurological, urinary 
and fecal function (Table 5-3d). 95% confidence interval of the proportions is shown in 
Table 5-3e. Among those who had respiratory disability, asthma was the most frequent 
cause in the UK. 
Tabl~ ~-3d: ComQalison of Qrevalence of functional sevelit):: between laQun and th~ UK 
Number of l2utients {%} Probability 
Function JAPAN UK (Chi sQuare} 
Circulatory 0 ( 0) 1 ( 0.4) 0.9706 
Respiratory 2 ( 0.8) 29 (10.8) <0.0001 
Neurological 0 ( 0) 12 ( 4.5) 0.0021 
Mental Status 3 ( 1.2) 11 ( 4.1) 0.0787 
Ulinary 6 ( 2.4) 36 (13.4 ) <0.0001 
Fecal 4 ( 1.6) 36 (13.4) <0.0001 
Feeding 2 ( 0.8) 0 ( 0) 0.4466 
Vision 1 ( 0.4) 0 ( 0) 0.9706 
Hearing 28 (11.2) 22 ( 8.2) 0.2432 
Speech 0 ( 0) 0 ( 0) 
Table 5-3e: Mean proQoltions (95% confidence intervals) of functions showinf: 
significant differences between JaQun and the UK 
Function 
Respiratory 
Neurological 
Urinary 
Fecal 
Mean QroQortion {95% confidence intervals) 
lAPAN UK 
0.8 (0.1 - 3.2) 10,8 (7.5 - 15.3) 
0.0 (0.0 - 1.9) 4.5 (2.4 - 7.9) 
2.4 (1.0 - 5.4) 13.4 (9.7 - 18.2) 
1.6 (0.5 - 4.3) 13.4 (9.7 - 18.2) 
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4. Health status 
4-1. ASA-PS 
Unfortunately ASA-PS data were missing in 159 (59.3%) of British patients so no 
analysis were possible. 
In Japan and the USA, the distlibution of patients classified by ASA-PS (Physical Status 
classification by American Society of Anesthetists) resembled that for the ICED (Table 5-
4a). Few Japanese patients were in the moderate or severe levels, while in the USA 
almost the same number of patients were classified in level zero or level two. 
Table 5-4a: Number and percent of patientl\ classified by ASA PS (JapanIUSA) 
Levels Number at each level (% totan 
of JAPAN USA 
Index index N-249 N-350 
ASA-PS 1 107 (43.1 ) 55 (15.9) 
2 134 (53.6) 230 (06.5) 
3 8 ( 3.2) 55 (15.9) 
4 0 ( 0.0) 6 ( 1.7) 
Unknown 10 
4-2. General health status 
Table 5-4b shows the mean health status scores of patients in the three countries 
measured using the basic ADL, insu'umental ADL, social activity and a mental health 
scales. As the distribution of health status scores were not nOimal in Japan and the UK. 
statistical significance was examined using the Mann-Whitney test 
Comparison between Japan and the UK revealed signiticant ditTerence for instrumental 
ADL and mental health, in which preoperative health status was better in Japan for 
instrumental ADL and in the UK for mental health (Table 5-4c). Mental health in the UK 
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was significantly better than in Japan, inespective to the number of questions asked. 
Basic ADL and social activity were also different but not statistically significant 
Table 5-4b: Mean health status scores before THR (Japan/UK/USA) 
Preoperative Mean Scores (SD) 
Health Japan UK USA 
Status N-256 N-301 N 283 
Basic ADL 60.5 (25.7) 56.2 (20.8) 65 (24) 
Instrumental ADL 38.5 (24.9) 33.4 (22.7) 42 (21) 
Social Activity 39.5 (33.0) 44.3 (31.0) 60 (31 ) 
Mental health 33.0 (20.1) 57.4 (16.6) 
Table 5-4c: Preoperative health status scores before THR {japan/UK) 
Preoperative Probability 
Health 95% Confidence Japan vs UK 
Status Mean SE J nterval (Mann-Whitney) 
Basic ADL 
JAPAN 60.5 1.6 57.3 - 63.7 0.0551 
UK 56.2 1.2 53.9 - 5R.6 
Instrumental ADL 
JAPAN 38.5 1.6 35.4 - 41.7 0.0395 
UK 33.4 1.3 30.R - 36.0 
Social Activity 
JAPAN 39.5 2.2 35.2 - 43.9 0.0583 
UK 44.3 1.9 40.6 - 48.0 
Mental health * 
JAPAN 33.0 1.3 30.4 - 35.5 <0.0001 
UK (5 questions) 57.4 1.0 55.5 - 59.4 
UK (3 questions) 71.5 1.2 69.0 - 73.9 «0.0001) 
* Mental health status in Japan was compared with the UK. using the British answers to 
the original five questions. and to the same three questions as asked to Japanese patients. 
4-3. Relationship with patient characteristics 
Each of the three dimensions of health status (basic ADL. instrumental ADL. social 
activity) was analysed for any association with patient charactelistics. Mental health is not 
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included in the analyses because of the difference in the number of questions asked in 
Japan from that in the UK, and of lack of data from USA to compare with. Patient's age 
was quarterlised using all cases combined before grouping lower two quartiles. A 
summary of the bivariate analyses is shown in Table 5-4d. Patient's age was significantly 
related with social activity in both countries and with instrumental ADL in Japan. 
Significant associations were observed with patients' sex in the UK for two dimensions 
of activity, in that female patients had worse health than males. Education level was also 
significantly associated with basic ADL in both countIies, and with social activity in the 
UK. 
Table 5-4d: Relationshi12 between 12reo12erative health status 
and 12atient sociodemogra12hics 
JAPAN UK 
Variable# B-ADL J-ADL SA B-ADL J-ADL SA 
Age * 0.1474 0.0492 0.0222 0.3781 0.4733 0.0378 
Sex 0.6557 0.6898 0.1266 0.0646 0.0141 0.0299 
Marital status 0.7063 0.6926 0.0654 0.8539 0.2487 0.2237 
Living status 0.5977 0.1551 0.6495 0.2273 0.8036 0.0215 
Home ownership 0.3551 0.9102 0.4523 0.2346 0.4648 0.0148 
Education level 0.0481 0.1966 0.3379 0.0056 0.1379 0.0040 
B-ADL indicates basic ADL; J-ADL, instIl.lmental ADL: SA. social activity. 
* Age was classified into three groups: <66 years, 66 - 73 years, and "?73 years using 50 
and 75 percentiles. 
#: The number of patients was 249 in Japan and 268 in the UK for age~ for other 
variables, 256 in Japan and 301 in the UK. Significance was examined by Kruskal-
Wallis test (age and education level) and Mann-Whitney test (sex, marital, living, house). 
In both countries, the severity of hip disease was significantly associated with 
preoperative health status (Table 5-4e). A past history of hip surgery was a significant 
variable in Japan for all three measures of health status but only for basic ADL in the UK. 
In both countries, all dimensions of health status was significantly associated with 
preoperative limp and need for walking support. 
109 
Table 5-4e : Relationship between preoperative health status and severity of hip disea~e 
JAPAN UK 
Variable B-ADL I-ADL SA B-ADL J-ADL SA 
Previous hip surgery 0.0131 0.0012 0.0022 0.0493 0.2937 0.3216 
Limp <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Walking SUppOlt <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
B-ADL indicates basic ADL; I-ADL, instrumental ADL; SA, social activity. 
#: The number of patients was 249 in Japan and 26R in the UK for previous hip surgery: 
for limp and walking support, 256 in Japan and 30 I in the UK. Significance was 
examined by Mann-Whitney U test (previous hip surgery) and Kruskal-Wallis test (limp, 
walking SUPPOlt). 
The following Tables 5-4f and 5-4g show the analyses of variables significantly 
associated with preoperative health status (shown in bold letters in Tables 5-4d and 5-4e). 
Tabl~ :;-4f: Significant associations of valiables with preoperative health status in Japan 
Number of Change in health status Mean 
Vruiable patients Mean SE rank 
Basic ADL 
Education completed at 
53.5 3.7 101.8 ~15 years 52 
16 - 18 years 159 62.4 2.0 126.0 
~19 years 32 65.6 3.8 135.1 
With previous hip surgery 47 52.5 3.6 97.4 
Without prevo hip surgery 191 62.7 1.9 124.9 
No limp 4 100.0 0.0 226.5 
Slight limp 60 72.4 3.1 154.7 
Moderate limp 111 62.1 2.3 126.0 
Severe limp 46 50.0 2.9 92.5 
Unable to walk 22 35.R 4.8 55.3 
No walking support 88 75.1 2.4 159.3 
Single cane/clUtch 118 55.3 2.2 104.8 
Two canes/crutches 19 50.6 4.9 91.5 
Walker 6 3X.9 7.5 63.1 
Wheelchair 9 30.9 9.9 46.5 
I ] 0 
Number of Change in health status Mean Variable patients Mean SE rank 
Instrumental ADL 
<66 years 157 41.1 2.0 125.6 
66 - 73 years 55 33.1 2.9 104.4 ~73 years 23 32.5 5.5 98.9 
With previous hip surgery 48 28.9 3.3 89.8 
Without prevo hip surgery 187 40.8 1.X 125.3 
No limp 4 77.8 4.5 216.5 Slight limp 59 48.6 3.3 147.8 
Moderate limp 111 39.9 2.2 125.9 
Severe limp 45 29.2 2.7 96.0 
Unable to walk 21 16.8 4.7 49.2 
No walking support 88 51.0 2.5 154.6 
Single cane/crutch 115 34.4 2.1 106.4 
Two canes/crutches 19 24.5 4.5 75.7 
Walker 6 27.6 3.2 90.7 
Wheelchair 9 15.4 10.9 41.6 
Social activity 
<66 years 148 41.9 2.9 113.4 
66 - 73 years 46 39.5 4.9 108.9 
~73 years 22 23.0 6.5 74.4 
With previous hip surgery 42 25.8 4.3 82.2 
Without prevo hip surgery 174 42.7 2.5 114.9 
No limp 4 83.3 7.2 190.5 
Slight limp 54 55.6 4.3 141.8 
Moderate limp 104 38.0 3.2 109.1 
Severe limp 39 28.6 4.4 91.0 
Unable to walk 20 15.0 5.2 61.0 
No walking SUppOlt 82 58.7 3.2 145.1 
Single canelcrutch 106 31.2 2.9 92.8 
Two canes/crutches 15 25.6 7.7 80.3 
Walker 5 12.2 5.1 56.3 
Wheelchair 9 13.0 11.0 48.3 
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Tabl~ 5-4~: Significant associations of variabl~s with preo~rativ~ health status in th~ UK 
Number of Change in health status Mean 
Variable patients Mean SE rank 
Basic ADL 
Education completed at 
~15 years 177 53.3 1.5 130.6 
16 - 18 years 66 61.4 2.7 160.9 
2:19 years 41 62.1 3.4 164.3 
With previous hip surgery 75 60.7 2.6 146.3 
Without prevo hip surgery 188 54.8 1.5 126.3 
No limp 9 67.9 7.5 191.5 
Slight limp 27 74.1 3.3 215.0 
Moderate limp 84 65.2 1.8 182.4 
Severe limp 149 51.2 1.5 123.1 
Unable to walk 21 29.6 3.3 47.6 
No walking support 74 69.1 2.2 197.0 
Single cane/crutch 135 55.5 1.7 145.7 
Two canes/crutches 53 46.4 2.2 104.5 
Walker 8 50.0 8.4 113.9 
Wheelchair 23 44.4 4.4 102.9 
Instrumental ADL 
Female 187 31.0 2.3 136.6 
Male 103 37.8 2.3 161.8 
No limp 9 33.2 8.4 141.2 
Slight limp 25 58.9 4.2 229.2 
Moderate limp 83 45.0 2.2 188.1 
Severe limp 147 25.9 1.5 116.6 
Unable to walk 21 8.7 2.3 47.7 
No walking support 75 46.0 2.5 189.7 
Single cane/crutch 133 36.1 1.8 157.2 
Two canes/crutches 50 16.8 2.2 82.0 
Walker 8 26.1 11.3 101.3 
Wheelchair 22 14.5 2.9 71.9 
Social acti vity 133.2 <66 years 90 49.6 3.3 
66 - 73 years 75 42.9 3.7 118.2 
2:73 years 74 37.0 3.5 105.8 
Female 168 41.0 2.3 126.2 
Male 99 49.9 3.2 147.2 
Living alone 85 38.3 3.5 117.0 
Living with 179 47.3 2.3 139.9 
Home owned 173 47.8 2.4 140.7 
Home not owned 91 37.8 3.1 116.9 
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Number of Chan~e in health status Mean 
Variable patients Mean SE rank 
Education completed at 
~15 years 156 39.1 2.5 118.0 
16 - 18 years 64 54.2 3.8 153.2 
~19 years 39 48.3 4.8 139.7 
No limp 8 41.7 13.6 124.0 
Slight limp 22 80.6 4.6 214.3 
Moderate limp 78 52.8 3.5 153.8 
Severe limp 137 37.7 2.3 117.8 
Unable to walk 18 10.5 3.3 48.4 
No walking SUppOlt 71 62.8 3.4 178.1 
Single cane/crutch 122 46.4 2.6 140.1 
Two canes/clutches 44 10.2 2.9 70.9 
Walker 6 32.4 15.3 101.7 
Wheelchair 23 26.3 5.6 89.0 
4-4. Relationship with the lCED 
Preoperative health status was examined in relation to severity of comorbidity (Tables 5-
4h and 5-4i). Basic ADL and social activity were weakly associated with the ICED in 
Japan, but it was not statistically significant. In the UK, all three dimensions of health 
status was associated with co-existent disease subindex but not with the ICED. 
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Table 5-4h: Preoperative health status and severity of comorbiditv in Japan 
Heal th status scales Levels Mean (SE) 
of change Probability 
by comorbidity index index in health status (KlUskal-Wallis) 
Basic ADL 
Co-existent 0 63.8 ( 2.3) 0.2514 
disease sevel;ty 1 60.0 ( 3.7) 
subindex 2 58.4 ( 3.0) 
3 40.0 (11.4) 
Functional severity 0 61.5 ( 1.8) 0.1633 
subindex 1 58.8 ( 4.3) 
2 29.6 (16.1) 
Index of 1 63.8 ( 2.3) 0.0568 
co-existent disease 2 60.6 ( 2.6) 
(ICED) 3 56.7 ( 5.2) 
4 33.3 ( 9.7) 
----------------------------------------------------------------------
Instrumental ADL 
Co-existent 
disease sevetity 
subindex 
Functional sevel;ty 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
2 
3 
4 
40.7 ( 2.5) 0.4148 
36.8 ( 3.2) 
37.3 ( 2.9) 
25.8 (12.2) 
38.6 ( 1.8) 0.8510 
37.4 ( 4.0) 
33.3 (33.3) 
40.7 ( 2.5) 0.1864 
38.1 ( 2.4) 
34.6 ( 4.6) 
21.5 (10.8) 
----------------------------------------------------------------------
Social activity 
Co-existent 
disease severity 
subindex 
Functional sevel;ty 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
'1 
3 
4 
44.9 ( 3.4) 0.1664 
35.1 ( 4.4) 
36.2 ( 4.1) 
34.7 (12.5) 
40.7 ( 2.4) 0.3677 
33.8 ( 5.6) 
27.8 (27.8) 
44.9 ( 3.4) 0.0701 
37.8 ( 3.4) 
29.4 ( 6.5) 
27.8 (11.9) 
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Tgbl~ 5-4i: Preo~rative health status and severi~ of comorbidi~ in th~ UK 
Health status scales Levels Mean (SE) 
of change Probability 
by comorbidity index index in health stanIS (Kruskal-Wallis) 
Basic ADL 
Co-existent 0 56.0 (2.7) 0.0187 
disease sevelity 1 62.8 (3.5) 
subindex 2 52.4 (1.8) 
3 56.4 (3.6) 
Functional sevelity 0 57.0 0.7) 0.8125 
subindex 1 56.0 (2.1) 
2 53.0 (6.3) 
Index of 1 59.5 (2.7) 0.4623 
co-existent disease 2 54.4 (2.2) 
(ICED) 3 56.3 (2.5) 
4 56.0 (3.2) 
----------------------------------------------------------------------
Instrumental ADL 
Co-existent 0 35.7 (2.7) 0.0077 
disease sevelity 1 43.3 (3.5) 
subindex 2 29.4 (2.1) 
3 33.3 (3.7) 
Functional sevelity 0 35.1 (1.9) 0.2630 
subindex 1 32.4 (2.4) 
2 23.5 (5.9) 
Index of 1 35.4 (2.8) 0.8591 
co-existent disease 2 33.1 (2.6) 
(ICED) 3 33.8 (2.9) 
4 31.6 (3.3) 
Social acti vity 
Co-existent 0 50.3 ( 3.6) 0.0051 
disease sevelity 1 55.6 ( 5.7) 
subindex 2 37.3 ( 2.9) 
3 34.1 ( 5.9) 
Functional severity 0 46.1 ( 2.5) 0.2558 
subindex 1 39.6 ( 3.6) 
2 38.9 (11.0) 
Index of 1 50.0 ( 3.7) 0.1655 
co-existent disease 2 43.4 ( 3.5) 
(ICED) 3 41.1 ( 4.3) 
4 37.7 ( 5.2) 
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· 5. Clinical management 
5-1 . Anaesthesia 
Nearly all British patients underwent general anaesthesia (Table 5-5a). Japanese patienL~ 
were more likely to have lumbar or epidural anaesthesia, partly reflecting the shortage of 
anaesthesiologists. The other reason could be that more Japanese anaesthesiologists 
judged regional anaesthesia to be less risky for elderly patients. 
5-2. Duration of surgery 
The average duration of surgery was longest in the USA and shortest in the UK. This 
difference may even have been underestimated because the British data may not be 
exactly comparable due to a lack of precise infOimation in the case notes. The duration of 
anaesthesia but not of surgery was often recorded so that the actual time required for 
surgery in the UK was believed to be shorter than shown (personal communication - Mr 
Middleton). In Japan a considerable proportion of patients (34.5%) underwent a bone 
graft from the femoral head, because of the lack of bone stock in the acetabulum in many 
Japanese patients. As bone grafting was rarely practiced in the UK. this extra procedure 
in Japan may have contdbuted to the longer operating time. 
5-3. Surgical approach 
Anterior or anterolateral approach was significantly commoner in Japan than in the UK, 
however, due to considerable propOition of missing data in Japanese case notes (32.7% 
was missing in Japan, while 7.5% in the UK) further analysis was difficult. 
5-4. Transfusion 
Blood transfusion was more often used in Japan than in the UK and the USA, two 
countries where the risk of blood transmitted diseases such as hepatitis and HIV is 
perceived to be greater. 
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5-5. Cementing 
Use of bone cement showed a marked difference between Japan and the UK. Cement 
was used in 89% of patients in the UK, while in Japan it was used in only 41 %. 
Cementless THR was the major procedure in Japan. though the use of hybrid THR has 
increased (Table 5-5b). In the USA, procedures were classified as with or without 
cement, with hyblid THR included in the cemented category in the USA. The majOlity of 
'cemented' THRs in the USA today are of the hyblid type (personal communication - Dr 
Poss). In the history of THR. cement was first employed in the UK. On the other hand it 
was in the USA that cementless and hybrid THR were developed. Therefore the use of 
cement in the three countries appears to reflect historical antecedents. 
Cement use was significantly associated with patient age in both countlies. In Japan. the 
mean age of patients was closer for the three type of cement use. however in the UK the 
mean age of patients with a cemented THR was much higher than for either hybrid or 
cementless THRs. Current opinion of cementless (and recently hybrid) THR as the first 
choice for younger patients in consideration of the possible future need for revision, and 
the shorter life expectancy in the UK may be the reasons why the mean ages for use of 
cementless and hybrid THR differ. 
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Table 5-5a: lntelllational comparison of clinical management 
General anaesthesia 
Mean duration of surgery 
(mins+/-SD) 
Surgical approach 
(anterior/anterolateral ) 
Transfusion 
Cemented prosthesis 
Number (%) of patients 
Probability* 
Japan UK Japan vs UK 
200 (80.3) 260 (97.0) 
143+/-52 105+/-29 
86 (50.4) 60 (24.2) 
238 (96.0) 20R (77.6) 
101 (40.6) 232 (88.5) 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
USA 
(R6) 
190+/-60 
(73) 
(54) 
Duration of surgery was not examined statistically due to different definitions of duration. 
*: based on Chi square test. 
Table 5-5b: International compatison of cement use 
Probability 
Japan UK Japan vs UK USA 
Cementing profile 
both cemented 
hybrid 
cementless 
mlssmg 
Age by cement use (years) 
both cemented 
hybrid 
cementless 
61 (24.5) 
40 (16.1) 
148 (59.4) 
o 
66.2 (0.9) 
62.9 (1.4) 
57.4 (0.8) 
Number (%) of patients 
209 (79.8) <0.0001 a 
23 ( R.8) 
30 (11.5) 
6 
Mean age, years (SE) 
72.5 (0.6) <0.0001 b 
55.0 (2.1) 
48.0 (2.2) 
-------------------------------------------------
Probability (within country) 
(54) 
(46) 
a: based on Chi square test. b: based on F-test from two-way analysis of variance, c: 
based on F-test from one-way analysis of variance. 
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· 6. Length of stay in the UK 
Differences in the health care systems account for much of the difference in the length of 
-.; 
stay between Japan and the UK. In Japan there is a strong financial incentive leading to 
Japanese patientl\ staying much longer (average 69.0 days). Length of hospital stay was 
therefore only studied in the UK hospitals. 
6-1. Preoperative and total length of stay 
The mean total length of stay was 14.2 days, the median total length of stay was 14.0 
days, and the median preoperative stay was 1.0 day. When total length of stay was 
classified by preoperative stay, statistically significant relationship was observed (Table 
5-6a). The majority of patients were operated on the day after admission. Patient's 
postoperative length of stay tended to be significantly associated with their preoperative 
length of stay. 
Table 5-6a: Relationship between preoperative and total length of stay (UK) 
Preoperative 
len~th of stay. days 
~1 
2 
3 
4~ 
Total 
Missing 
Number of 
patients 
136 
91 
20 
18 
265 
3 
Probability (Kruskal-Wallis) 
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Mean length of stay. days (SE) 
Postoperative Total 
14.4 (0.8) 
12.8 (0.6) 
16.6 (1.3) 
17.1 (3.3) 
14.2 (0.5) 
0.0027 
15.4 (0.8) 
14.8 (0.6) 
19.6 (1.3) 
24.9 (3.3) 
16.1 (0.5) 
<0.0001 
6-2. Relationship with patient characteristics 
The relationship of length of stay and the sociodemographic characteristics of patients 
(age, sex, marital status, living alone, home ownership and education level) was 
examined. Only patient age was significantly associated (Table 5-6b). Older patients (in 
the top quartile, 76 years or older) tended to stay longer than younger ones, although 
there was no significant difference in their preoperative length of stay. 
Table 5-6b: Length of stay and patient age dichotomised at 76 years (UK) 
Preoperative 
Postoperati ve 
Total 
Mean length of stay, days (SE) 
Younger Older Total 
(N-18R) (N-77) (N-265) 
1.8 (0.1) 
13.2 (0.5) 
15.0 (0.5) 
2.3 (0.4) 
16.6 (1.3) 
18.9 (1.3) 
1.9 (0.1) 
14.2 (0.5) 
16.1 (0.5) 
6-3. Relationship with clinical management 
Probability 
(Mann-Whitney) 
0.1183 
<O,QOOI 
0,0001 
A significant difference was observed in relation to the use of cement (Table 5-6c). 
Patients who received a hybrid THR were discharged earlier. As has already been shown 
in Table 5-5b, the average age of patients for hybrid THRs was younger than the 
cemented, but older than the cementless. Thus age may not be the only cause of a shorter 
length of stay for hybrid THR patients. 
Other treatment profiles examined were duration of anaesthesia, general anaesthesia, 
amount of transfusion, and surgical approach. None of them were significantly associated 
with length of stay. 
120 
Table 5-hC: Relationship between cement use and totallen~th of stay (UK) 
Number of Mean length of stay Probability 
Cement use patients days (SE) (Kruskal-Wallis) 
Cemented 206 16.7 (0.6) 0.0012 
Hyblid 23 12.4 (0.6) 
C~m~ntl~ss 30 15.1 (l.l} 
Total 259 16.2 (0.5) 
Missing 9 
6-4. Relationship with comorbidity 
When total length of stay was classified by severity of comorbidity. a statistically 
significant association was observed for the co-existent disease subindex and the ICED 
(Table 5-6d). Both indices stratified patients into four subgroups in which the total length 
of stay was longer with increasing severity of comorbidity. Such an association with 
comorbidity was not found for preoperative length of stay but was confined to the 
postoperative peliod (p<0.005 for co-existent disease subindex. and the ICED: data not 
shown). 
Table 5-6d: Totallen~th of stay classified by sevet;ty of comorbidity (UK) 
Levels Number Mean (SE) 
of of length of stay Probability 
Index index patient~ days (Kruskal-Wallis) 
Co-existent 0 73 14.4 (0.7) 0.0001 
disease 1 36 13.9 (0.5) 
subindex 2 114 17.2 (1.0) 
3 42 18.1 (1.2) 
Missing 3 
Functional sevelity 0 159 16.2 (0.8) 0.1935 
subindex 1 93 16.1 (0.6) 
2 13 15.5 (1.3) 
Missing 3 
----------------------------------------------------------------------
Index of 1 70 14.4 (0.8) 0.0002 
co-existent diseLL~e 2 80 16.7 (1.4) 
(ICED) 3 63 16.1 (0.7) 
4 52 17.7(1.0) 
Missin~ 3 
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6-5. Relationship with in-hospital complication 
The postoperative length of stay was significantly associated with serious and minor 
complications (Table 5-6e). However. preoperative length of stay did not con'elate with 
any complication. 
Table 5-6e: Relationship between length of stay and in-hospital complications (UK) 
Number 
In-hospital of Mean (SE) length of stay, days 
complication patients Postoperati ve Total 
Serious 
With 52 15.9 (1.1) 17.4 (1.1) 
Without 213 13.R (0.6l 15.8 (Q.6) 
Probability 0.0362 0.0850 
(Mann-Whitney) 
Minor 
With 55 18.5 (2.0) 20.8 (2.0) 
Without 210 13.1 (O.3l 14.9 CQ.4l 
Probability 0.0006 0.0002 
(Mann-Whi tney) 
Overall 
With 94 16.6 0.2) 18.6 (1.3) 
Without 171 12.9 ~O.4l 14.R (Q.4) 
Probability 0.0023 0.0019 
(Mann-Whitney) 
6-6. Relationship with change in health status 
Change in health status had a significant association with length of stay. In Table 5-6f. 
patient health status was examined by dichotomised length of stay groups. using the top 
quartile of the length of stay distribution (17 days) as the cut-off. Improvement in both 
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instrumental ADL and social activity were significantly greater in the shorter than in the 
longer stay group. It suggests the former had more physiological resources to recover 
from surgery and achieve improvement in their health status during their convalescent 
period. 
TabI, 5-6f: Change in health status and length of sta~ dichotomised at I 7 da~s (UK) 
Health Length Number 
status of of Mean (SE) change Probability 
indic,s sta~ patient" in health status (Mann-Whitne~) 
Basic ADL Shorter 189 29.1 (1.6) 0.1343 
Longer 70 24.2 (3.6) 
Missing 9 
Instrumental ADL ShOlter 188 34.8 (2.0) 0.0108 
Longer 68 23.6 (4.2) 
Missing 12 
Social activity ShOlter 179 34.3 (2.5) 0.0264 
Longer 65 24.4 (5.6) 
Missing 24 
..... 
7 . Interhospital differences in the UK 
7 -1, Sociodemographic charactetistics 
Table 5-7a shows interhospital differences in the sociodemographic characteristics of 
patients in the UK. The differences were statistically significant among the six hospitals 
as regards age. home ownership and education level. but not for sex. marital status, and 
living alone. 
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Table 5-7a: Tnterhospital difference in patient sociodemographic characteristics (UK) 
Age 
Hospital 
A 
B 
C 
o 
E 
F 
Total 
Mean (SE) 
years 
70.4 (1.4) 
70.6 (1.8) 
69.4 (2.5) 
70.1 (2.1) 
64.6 (1.4) 
6R.6 (2.5) 
68.3 (0.8) 
Probability Si gnificance test 
0.0336 Kruskal-Wallis 
----------------------------------------------------------------------
Male 
Married 
Hospital 
A 
B 
C 
o 
E 
F 
Total 
Hospital 
A 
B 
C 
o 
E 
F 
Total 
Number (%) 
of male 
23 (35.4) 
19 (39.6) 
14 (40.0) 
14 (38.9) 
28 (29.5) 
10 (45.5) 
108 (35.9) 
Number (%) 
ofmanied 
34 (52.3) 
26 (55.3) 
16(47.1) 
19 (52.8) 
61 (64.9) 
17 (85.0) 
173 (5R.4) 
Probability Significance test 
0.6593 Chi square 
Probability Significance test 
0.0533 Chi square 
----------------------------------------------------------------------
Living alone 
Hospital 
A 
B 
C 
o 
E 
F 
Total 
Number (%) 
of living alone 
25 (39.7) 
19 (40.4) 
15 (45.5) 
13(36.1) 
28 (29.8) 
2 (10.0) 
102 (34.8) 
Probability Significance test 
0.0922 Chi square 
-----------------------
-----------------------------------------------
Home 
ownership Hospital 
A 
B 
C 
o 
E 
F 
Total 
Number (%) 
of owners 
36 (55.4) 
30 (63.8) 
20 (58.8) 
14 (38.9) 
75 (79.8) 
16 (80.0) 
191 (64.5) 
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Probability Si!;niticance test 
0.0002 Chi square 
----------------------------------------------------------------------
Education 
Hospital 
A 
B 
C 
D 
E 
F 
Total 
Number of patients (lk) 
<15 
50 (76.9) 
27 (57.4) 
11 (33.3) 
19 (54.3) 
55 (61.1) 
17 0\9.5) 
179 (61.9) 
Age completed 
16 - 18 
13 (20.0) 
11 (23.4) 
9 (27.3) 
12 (34.3) 
22 (24.4) 
1 ( 5.3) 
68 (23.5) 
19< 
2 ( 3.0) 
9 (19.1) 
13 (39.4) 
4 (11.4) 
13 (14.4) 
1 ( 5.3) 
42 (14.5) 
Probability 
<0.0001 
Chi square 
When the data were classified according to the teaching status of the hospital, patients at 
teaching hospitals were significantly more likely to have continued in full-time education 
longer (Table 5-7b). There was no significant difference in their age, sex, marital and 
living status. 
Table 5-7b: Difference in patient charactelistics by teaching status (UK) 
Patient 
characteristics 
Age 
Male 
Married 
Living alone 
Education, age completed 
15~ 
16 - 18 
19~ 
Hospital 
Teaching Non-teaching 
Mean age, years (SE) 
66.7 (1.1) 70.2 (1.0) 
Number of patients (%) 
56 (33.7) 
96 (58.5) 
56 (34.4) 
85 (53.8) 
43 (27.2) 
30 (19.0) 
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52 (38.5) 
77 (58.3) 
46 (35.4) 
94 (71.8) 
25 (19.]) 
12 ( 9.2) 
Probability (test) 
0.0568 (Mann-Whitney) 
0.3895 (Chi square) 
0.9719 (Chi square) 
0.8543 (Chi square) 
0.0053 (Chi square) 
7-2. Severity ofhip disease 
Hip disease was compared among the six hospitals in terms of primary diagnosis. past 
history of hip surgery, and patient need for walking support and limp (Table 5-7c). 
Significant differences were observed for the proportions of primary diagnoses and past 
history of hip surgery, but not for those of need for walking support and limp. 
Table 5-7c: Interhospital difference in severity of hip disease (UK) 
Primary diagnosis 
Hospital 
A 
B 
C 
D 
E 
F 
Total 
Osteo-
arthritis 
62 (96.9) 
36 (97.3) 
31 (86.1) 
20 (76.9) 
79 (91.9) 
16 (84.2) 
244 (91.0) 
Number of patients (%) 
Rheumatoid A vascular 
aIthlitis necrOSIS 
1 ( 1.6) 1 ( 1.6) 
1 ( 2.7) 0 ( - ) 
2 ( 5.6) 3 ( 8.3) 
5 (19.2) 0 ( - ) 
4( 4.7) 2( 2.3) 
2 (10.5) 0 ( - ) 
15 ( 5.6) 6 ( 2.2) 
Others 
o ( - ) 
o ( - ) 
o ( - ) 
1 ( 3.8) 
1 ( 1.2) 
1 ( 5.3) 
3 ( 1.1) 
Probability 
0.0264 
(Chi square) 
----------------------------------------------------------------------
Previous hip surgery 
Hospital 
A 
B 
C 
D 
E 
F 
Total 
Either hip 
14 (21.9) 
9 (24.3) 
15 (41.7) 
5 (19.2) 
32 (37.2) 
1 ( 5.3) 
76 (28.4) 
Number (%) of patients 
Same hip Other hip 
o ( -) 14 (21.9) 
1 ( 2.7) 8 (21.6) 
2 ( 5.6) 15 (41.7) 
o ( - ) 5 (19.2) 
13 (15.1) 25 (29.1) 
o ( - ) 1 ( 5.3) 
16 ( 6.0) 68 (25.4) 
---------------------------------------------------------------------------
Probabili ty 
(Chi square) 
0.0148 0.0010 0.0523 
Total 
64 
37 
36 
26 
86 
19 
268 
----------------------
------------------------------------------------
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Walking 
support Number (%} of Qatients at each hosQital Probability 
Unable (Kruskal -
HQ~llital None Slight Moderate Severe to walk Wallis) 
A 10 (15.4) 36 (55.4) 9 (13.9) 3 ( 4.6) 7 (lO.R) 0.7555 
B 14 (29.8) 20 (42.6) 9 (19.2) 2 ( 4.3) 2 ( 4.3) 
C 11 (31.4) 14 (40.0) 6 (17.1) 2 ( 5.7) 2 ( 5.7) 
D 10 (28.6) 16 (45.7) 7 (20.0) o ( 0.0) 2 ( 5.7) 
E 26 (27.7) 38 (40.4) 19 (20.2) 2 ( 2.1) 9 ( 9.6) 
F 4 (19.1) 12 (57.]} 4 (19.1) o ( 0.0) 1 ( 4.X} 
Total 75 (25.3) 136 (45.R) 54 (18.2) 9 ( 3.0) 23 ( 7.7) 
----------------------------------------------------------------------
Limp 
Number (%} of patients at each hospital Probability 
Unable (Kruskal -
HQsQital None Slight Moderate Severe to walk Wallis) 
A O( - ) 5 ( 7.8) 20 (31.3) 35 (54.7) 4 ( 6.3) 0.1117 
B 5(10.4) 7 (14.6) 14 (29.2) 20 (41.7) 2 ( 4.2) 
C 2 ( 5.7) 3 ( 8.6) 11 (31.4) 15 (42.9) 4 (11 A) 
D O( - ) 4 (11.4) 13 (37.1) 16 (45.7) 2 ( 5.7) 
E 1 ( 1.1) 8 ( 8.7) 22 (23.9) 53 (57.6) 8 ( R.7) 
F 1 ( 4.8) 1 ( 4.8) 5 (23.R) 12 (57.]) 2 ( 9,5) 
Total 9 ( 3.1) 28 ( 9.5) 85 (28.8) 151 (51.2) 22( 7.5) 
Table 5-7d shows the diagnosis of primary hip disease classified by the teaching status of 
the hospitals. Although there was no statistically significant difference in the distribution 
of primary diagnoses between teaching and non-teaching hospitals, more rheumatoid 
arthritis and avascular necrosis patients were treated at teaching hospitals, suggesting the 
patients may have required specialty care. 
Regarding a past history of hip surgery, significant differences were observed in the 
proportion of patients between teaching and non-teaching hospitals. Patients treated at the 
teaching hospitals were more likely to have had previous surgery on both hips, 
suggesting a more complicated. long term disease burden and greater clinical challenge. 
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Need for walking SUpp0l1 and patient perceived limp were not significantly different 
between teaching and non-teaching hospitals. 
Table 5-7d: Clinical profiles of primary hip disease by teaching status of the hospital 
(UK) 
Primary diagnosis 
Osteoarthritis 
Rheumatoid artluitis 
Avascular necrosis 
Others 
Past history 
Prior hip surgery (either side) 
on the same hi p 
on the other hip 
Number of patients (%) 
Teaching Non-teaching 
130 (87.8) 
11(7.4) 
5 ( 3.4) 
2( 1.4) 
52 (35.1) 
15(10.1) 
45 (30.4) 
114 (95.0) 
4 ( 3.3) 
1 ( 0.8) 
1 ( 0.8) 
24 (20.0) 
1 ( 0.8) 
23 (19.2) 
Probability 
0.2178 
(Chi square) 
0.0063 
0.0014 
0.0355 
(Chi square) 
----------------------------------------------------------------------
Walking support 
None 
Slight 
Moderate 
Severe 
Unable to walk 
47 (28.7) 
68 (41.5) 
32 (19.5) 
4 ( 2.4) 
13 ( 7.9) 
2R (21.1) 
6R (51.1) 
22 (16.5) 
5 ( 3.8) 
10( 7.5) 
0.5037 
(Mann-Whitney) 
----------------------------------------------------------------------
Limp 
None 
Slight 
Moderate 
Severe 
Unable to walk 
3 ( 1.9) 
15 ( 9.3) 
46 (28.4) 
84 (51.9) 
14 ( 8.6) 
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6 ( 4.5) 
13 ( 9.8) 
39 (29.3) 
67 (50.4) 
7 ( 6.0) 
0.3044 
(Mann-Whitney) 
7-3. ComQrbidity 
Interhospital differences in seveIity of comorbidity were statistically significant (Table 5-
7e). However, the differences were not significantly related to their teaching status 
(p=O. 1835, based Qn Mann-Whitney U test). 
Table 5-7e: Tnterhospital differences in seveIity Qf comorbidity (UK) 
Number (%) of patients Probability 
ICED (Kruskal-
Hospital Levell Level 2 Level 3 Level 4 Wallis) 
A 8 (12.5) 19 (29.7) 19 (29.7) 18 (28. I) 0.0152 
B 14 (37.8) 12 (32.4) 8 (21.6) 3 ( 8. I ) 
C 8 (22.2) 12 (33.3) 7 (19.4) 9 (25.0) 
D 7 (26.9) 10 (38.5) 4 (15.4) 5 (19.2) 
E 27 (31.4) 25 (29.1) 22 (25.6) 12 (14.0) 
F 6 (31.6) 4 (21.1) 3 (15.8) 6 {31.6) 
Total 70(26.1) X2 (30.6) 63 (23.5) 53 (l9J~) 
7 -4. Clinical management 
Most of the hospitals used general anaesthesia, though in hQspital F over a quarter of 
patients underwent regional anaesthesia (epidural or spinal) (Table 5-7f). As shown in 
Table 5-7e, almost a third Qf patients in this hospital were of ICED level 4, which 
suggested general anaesthesia was less appropriate. 
Striking difference was observed in surgical approach. More than a third of the patients in 
hospitals A and E were operated thrQugh anteriQr or anterolateral approach whereas nQt 
any patients in hQspitals B and F. HQwever. the prQportiQn Qf surgical approach was nQt 
associated with the teaching status of hospitals. 
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Transfusion practice also showed remarkable differences among hospitals. The 
proportion of patients transfused ranged from 63% to 90%. Likewise, the number of 
units transfused varied. 
Use of cement was analysed in terms of the proportion of cemented, hybrid, and 
cementless THRs. There was a consistent percentage of cemented THR of around 80% . 
In contrast, the ratio varied among hospitals in the use of hyblid and cementless implant 
When clinical management was compared in association with the teaching status of 
hospitals, no significant differences were observed. 
Table 5-7f: Interhospital differences in clinical management among the UK hospitals 
General 
anaesthesia Hospital 
A 
B 
C 
D 
E 
F 
Total 
Number (%) 
of patients 
64 (100.0) 
37 (100.0) 
36 (100.0) 
26 (100.0) 
83 ( 96.5) 
14 ( 73.7) 
260 ( 97.0) 
Probabi lity Significance test 
<0.0001 Chi square 
----------------------------------------------------------------------
Anterior/Anterolateral 
approach 
Hospital 
A 
B 
C 
D 
E 
F 
Total 
Number (%) 
of patients 
25 (44.6) 
o ( 0.0) 
4(11.1) 
1 ( 4.3) 
30 (36.6) 
o ( 0.0) 
60 (24.2) 
Probability Si~ificance test 
<0.0001 Chi square 
---------
-------------------------------------------------------------
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Transfusion 
Cement use 
Hospital 
A 
B 
C 
D 
E 
E 
Total 
Hospital 
A 
B 
C 
D 
E 
F 
Total 
Number (%) of 
Transfused patients 
53 (82.8) 
25 (67.6) 
24 (66.7) 
17 (65.4) 
77 (89.5) 
12 (63.2) 
208 (77.6) 
Probability 
(Chi square) 
0.0042 
Number (%) Qf patients 
Cemented Hybrid Cementless 
55 (88.7) 6 ( 9.7) 1 ( 1.6) 
28 (77.8) 1 ( 2.8) 7 (19.4) 
28 (80.0) O( - ) 7 (20.0) 
20 (80.0) 5 (20.0) O( - ) 
62 (72.1) 10 (11.6) 14 (16.3) 
16 (88.2) 1 ( 5.6) 1 ( 5.6) 
209 (79.8) 23 ( 8.8) 30 (11.5) 
7 -5. Len&th of stay 
Mean (SE) number of 
Transfused units 
2.5 (0.2) 
1.8 (0.3) 
1.8 (0.3) 
1.4 (0.2) 
2.8 (0.2) 
1.8 (0.4) 
2.2 (0.1) 
0.0007 
Probability 
Total (Chi square) 
62 0.0048 
36 
35 
25 
86 
18 
262 
There was a statistically significant interhospital difference in the unadjusted length of 
stay in the UK, at preoperative, postoperative and total period (Table 5-7g). When 
classified by their teaching status, the total and postoperative length of stay were 
significantly longer in non-teaching hospital but not the preoperative stay. 
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Table 5-7&: Interhospital differences in length of stay (UK) 
Number of 
patients 
Hospitals 
A 64 
B 37 
C 36 
D 25 
E 85 
F 18 
Total 265 
Missing 3 
Probabili ty (Kruskal-Wallis) 
Teaching status 
Teaching 146 
Non-teaching 119 
Total 265 
Missing 3 
Probability (Mann-Whitney) 
Mean len!!th of stay. days (SE) 
Preoperati ve 
1.8 (0.1) 
2.5 (0.5) 
1.7 (0.3) 
1.5 (0.3) 
2.2 (0.3) 
0.9 (0.1) 
1.9 (0.1) 
<0.0001 
2.0 (2.5) 
1.9 (1.8) 
1.9 (2.2} 
0.2189 
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Postoperative 
14.6 (0.8) 
16.9 (2.4) 
15.0 (0.9) 
14.8 (2.4) 
11.9 (0.5) 
15.4 (1.6} 
14.2 (0.5) 
<0.0001 
13.2 ( 6.8) 
15.5 ( 9.7) 
14.2 ( 8.3} 
0.0004 
Total 
16.5 (0.8) 
19.5 (2"+) 
16.7 (1.0) 
16.3 (2.6) 
14.1 (0.6) 
16.3 (1.6} 
16.1 (0.5) 
<0.0001 
15.1 ( 7.5) 
17.4 ( 9.7) 
16.1 ( 8.6} 
0.0002 
8. Summary 
# Patient sQciodemographics: Japanese patients were younger and more likely tQ be 
female, married, living with others. finished education at an older age and not smoke. 
than British patients. 
# Hip disease: More severe in British patients in terms of a history of previous hip 
surgery and perception of limp. The need fQr a walking SUppOit was only slightly 
greater in British patients. The mix of underlying diagnoses were similar. 
# ComQrbidity: Japanese patients were more likely to be classified to lower severity 
levels than British patients. Arrhythmia and hypertension were common in both 
countries; organic and ischaemic heart disease. congestive heart failure, peripheral 
vascular disease. renal disease. and gastrointestinal disease were commoner in the 
UK, and diabetes mellitus was CQmmQner in Japan. 
# Health status: Japanese patients had better health status as regards instrumental ADL 
and worse as regards mental health. There was no significant difference in telIDS of 
basic ADL and social activity. Health status was assQciated with patient's age and 
severity Qf hip disease in Japan and with patient's sex. living alone and home 
ownership in the UK. No assQciation was observed between health status and 
comQrbidity (the ICED). 
# Clinical mana&ement: General anaesthesia was commQner. the duration of surgery was 
less, and the anteIior/anternlateral approach and blood transfusion were less frequently 
used in the UK than in Japan. Cement was used more often in the UK and in older 
patients. 
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# Len~th of stay in the UK: Preoperative stay was associated with the total length of 
stay. Longer postoperative stay was observed in patients who were older, had a non-
hybrid THR, had severe comorbidity, had an in-hospital complication and 
subsequently reported a poorer improvement in their health status. 
# Interhospital differences: Significant differences were found as regards patient's age, 
educational level, home ownership, primary diagnosis, past history of hip surgery, 
and comorbidity. There was no statistically significant difference in severity of hip 
disease (limp and use of walking support). Patients in teaching hospitals only differed 
significantly from non-teaching in that they were more likely to have received higher 
education and undergone previous hip surgery, both on the same and the contralateral 
hip. Use of general anaesthesia, surgical approach, transfusion and cement differed 
among the six hospitals, but not between teaching and non-teaching hospitals. Mean 
length of stay differed between the six UK hospitals, and was shorter in teaching 
hospitals. 
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Chapter 6: Outcome of THR 
This chapter describes the outcomes of patients in terms of in-hospital complications, 
change in health status and mobility, readmissions and patient satisfaction. Where 
applicable, data are compared before and after surgery. Having presented univariate 
analyses of these outcomes, the association between comorbidity and the two outcomes 
of major interest (in-hospital complications and health status) are examined. Finally. the 
relationships between these outcomes and other independent variables are described. 
********************************************************************** 
1. Outcomes 
1-1. Mortality 
During the follow-up period, 2 patients in Japan and 6 patients in the UK died. Among 
them, 1 patient in Japan and 4 patients in the UK were known to have died within one 
year of the index operation. The other 3 deaths occurred just over 12 months after the 
operation. Thus one-year m011ality was 0.3% in Japan and 1.1 % in the UK. Due to the 
difficulty of getting further mortality information, their cause of death and the relevance to 
the index admission were not available. The small number of deaths also limited further 
analyses. In addition, failure to trace 12 eligible patients in Japan and 5 in the UK (Table 
3-2) make any assessment of post-operative mortality uncertain. 
1-2. Sedous complications 
The total number of the patients with serious in-hospital complications was 11 (4.4%; 
95% confidence interval=2.3% - 8.0%) in Japan. 52 (19.4%; 95% confidence interval 
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=15.0% - 24.8%) in the UK, and 38 (10.7%; 95% confidence interval=7.8% - 14.59C) in 
the USA. Table 6-1 a shows the types and numbers of serious in-hospital complications. 
Serious complications found in Japanese patients were limited mostly to neuropathy. 
Relatively more cardiac disorders were observed in the USA. while postoperative 
hypotension was more common in the UK. Possible reasons for this will be discussed 
later in this chapter. 95% confidence interval of the hypotension rate was 0.1 % - 3.2% in 
Japan and 8.7% - 17.0% in the UK. 
Table 0-1 a: Number and 12ercent of selious in-hos12ital com12lic~tions 
Number {%) of 12atients 
Serious Japan UK Probability* USA 
CQmpli~atiQns N=242 N=268 JaQan vs UK N=356 
General 
Shock o ( - ) o ( - ) 1 ( 0.3) 
Septicemia o ( - ) 1 ( 0.4) 0.9706 O( - ) 
Cardiovascular 
Cardiac atTest O( - ) 1 ( 0.4) 0.9706 O( - ) 
Myocardial infarction O( - ) 1 ( 0.4) 0.9706 5 ( 1.4) 
Congestive heru1 failure o ( - ) o ( - ) 5( 1.4) 
Hypotension 2 ( 0.8) 33 (12.3) <0.0001 12 ( 3.4) 
Peripheral vascular 
o ( ) 2 ( 0.6) Pulmonary em bolism o ( - ) -
Deep vein thrombosis o ( ) 2 ( 0.7) 0.5113 o ( - ) 
Respiratory failure O( ) 1 ( 0.4) 0.9706 O( - ) 
Neurological 
O( O( ) 1 ( 0.3) Coma - ) -
Neuropathy 7 ( 2.8) 6 ( 2.2) 0.8932 11 ( 3.1) 
Renal failure 2 ( 0.8) 1 ( 0.4) 0.9491 2 ( 0.6) 
Gastrointestinal O( ) Acute abdomen o ( ) 1 ( 0.4) 0.9706 -
Gastrointestinal bleeding O( ) 2 ( 0.7) 0.5113 O( - ) 
Others O( ) 7 ( 2.6) 0.0288 O( - ) 
*: Probability based on Chi square test with continuity correction. 
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1-3. Minor complications 
The proportion of patients with minor in-hospital complications was similar in all three 
countries; 52 (20.9%; 95% confidence interval= 16.1 % - 26.6%) in Japan. 56 (20.9%: 
95% confidence interval = 16.3% - 26.4%) in the UK, and 87 (24.4lk: 95lk confidence 
interval =20.1% - 29.3%) in the USA. 
The frequency of specific minor in-hospital complications is shown in Table 6-1 band 
95% confidence interval of complication rates with significant differences in Table 6-lc. 
The only data available for the USA was for fever (reported in 160 cases) and pneumonia 
(85 cases), neither of which were often reported in Japan and the UK. Wound related 
problems such as infection and delayed healing were commonly reported both in Japan 
and the UK. Dislocation, and gastrointestinal symptoms were more frequently observed 
in Japan, whereas in the UK bed sores and suspected deep vein thrombosis were 
significantly more frequent. 
Special caution should be taken in comparing these data. For example, postoperative 
fever was in fact very commonly found both in Japanese and in UK hospitals. However, 
because of the definition of fever (> 10 1°F) most of the episodes were not counted in this 
study as they did not reach this temperature. Also reporting bias is likely to be a problem 
with minor complications as they may be ignored by health care workers and even if 
noticed, the description in the case notes may not provide as much detail as for serious 
complications. 
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Table 0-1 b: Number and percent of minor in-hospital complications 
Numb~r {~} of patients Probabili ty 
Minor Japan UK Japan vs UK CQmplications N-249 N-26R {Chi sQuare*) 
General 
Fever 9 (3.6) 9 (3.4) 0.8738 
Cardiovascular 
Angina / An-hythmia 1 (0.4) 6 (2.2) 0.1541 
Peripheral vascular 
Suspected deep vein thrombosis o ( - ) 10 (3.7) 0.0058 
Respiratory 
Pneumonia 1 (0.4) 4 (1.5) 0.4141 
Mental 
Confusion 2 (0.8) 3(1.1) 0.9341 
Renal 
Urinary tract infection 8 (3.2) 3 (1.1) 0.1792 
Gastrointestinal symptoms 10 (4.0) o ( - ) 0.0028 
Local 
Wound infection / oozing 15 (6.0) 13 (4.9) 0.5559 
Bed sores 1 (0.4) 13 (4.9) 0.0045 
Dislocation 11 (4.4) 3(1.1) 0.0416 
Others 1 (0.4) o ( - ) 0.9706 
*: Probability based on Chi square test with continuity cOITection. 
Table 6-1 c: 95% confidence interval of the propcH1inns of minor complications 
of significant ditl'erences between Japan and the UK 
MinQr complication 
Suspected deep vein thrombosis 
Gastrointestinal symptoms 
Bed sores 
Dislocation 
Mean proportion (95% confidence interval} 
JAPAN UK 
0.0 (0.0 - 1.9) 
4.0 (2.1 - 7.5) 
0.4 (0.0 - 2.6) 
4.4 (2.3 - 8.0) 
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3.7 (1.9 - 7.0) 
0.0 (0.0 - 1.8) 
4.9 (2.7 - 8.4) 
1.1 (0.3 - 3.5) 
1-4, Overall complications 
Serious and minor in-hospital complications combined were reported in 61 (24,5%; 95% 
confidence interval=19.4% - 30.4%) patients in Japan and 108 (40,3%; 95% confidence 
interval=34.4% - 46,5%) in the UK, Among Japanese patients. two cases were reported 
to have had both serious and minor complications whereas in the UK, there were no such 
cases, 
1-5, Health status 
Table 6-1d shows the mean health status scores before and one year after THR in the 
three countries, The postoperative scores were higher (indicating an improvement) in all 
dimensions examined, in all countries, Both preoperative and postoperative scores were 
consistently higher in the USA than in Japan and the UK, 
Table 6-1d: Mean health status score before and after THR (Japan/UKNSA) 
Health status Preoperative Postoperati vs:: 
by counto' N Mean (SD) N Ms::an (SD) 
BasicADL 
JAPAN 245 60,5 (25,7) 245 87,7 (19,8) 
UK 295 56,2 (20,8) 290 84,0 (18,7) 
USA 65 (24) 90 (15) 
Instrumental ADL 
JAPAN 242 38,5 (24,9) 245 65.9 (26,0) 
UK 290 33.4 (22,7) 285 65,2 (28,3) 
USA 42 (21) 74 (25) 
Social activity 
JAPAN 222 39,5 (33,0) 226 64,3 (35,9) 
UK 267 44,3 (31.0) 259 74,7 (31.9) 
USA 60 (31) 87 (25) 
Mental health 
JAPAN 240 33,0 (20,1) 241 55,6 (16,8) 
UK 289 57.4 (16,6) 282 62,4 (14,7) 
USA 
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As the health status scores were not normally distributed, the significance of changes in 
scores following surgery were tested using the Wilcoxon matched-pairs test (Table 6-1 e). 
In the four dimensions examined, the health status of both Japanese and British patients 
were significantly improved following surgery. The extent of this change in health status 
was also compared between Japan and the UK, using the Mann-Whitney U test. 
Although there was no significant difference observed in the changes in basic ADL. 
social activity, and instrumental ADL, mental health improved more in Japanese than in 
British patients. Particular difference was observed in the change in mental health, in 
which preoperative score was significantly lower in Japan (Tables 5-4b and 5-4c). 
Improvement in mental health in the UK (mean change=5.6. SE=1.l) was similar when 
the same three questions were analysed as in Japan. 
Table 6-1e: Change in health status in Japan and the UK 
Health 
status 
scales 
BasicADL 
Mean change (SE) 
Probability (Wilcoxon) 
Instrumental ADL 
Mean change (SE) 
Probability (Wilcoxon) 
Social activity 
Mean change (SE) 
Probability (Wilcoxon) 
Mental health 
Mean change (SE) 
Probability (Wilcoxon) 
JAPAN 
27.6 (1.7) 
<0.0001 
27.6 (2.0) 
<0.0001 
26.9 (2.7) 
<0.0001 
27.6 (1.8) 
<0.0001 
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UK 
28.0 (1.4) 
<0.0001 
32.1 0.7) 
<0.0001 
31.5 (2.1) 
<0.0001 
4.8 (0.9) 
<0.0001 
Probability 
(Mann-Whitney) 
Japan vs UK 
0.5963 
0.0523 
0.2682 
<0.0001 
1-6. Mobility 
Patients were asked about the average amount of pain they expetienced when pelforming 
particular activities one year after the operation (Table 6-1 f). Pain was scored from 0 to 7. 
where 0 indicated no pain and 7 indicated severe pain. For most activities. Japanese 
patients had a higher mean pain score than the British patients. However. the difference 
was statistically significant only for climbing stairs. 
Table 6-1 f: Mean level of pain rep0l1ed for different activities one year after surgelY 
by Japanese (N=25fl) and Btitish (N-30 1) patients 
Mean level of pain {SE} Probability 
Activity JAPAN UK (Mann-Whitney} 
Getting in/out of bed 1.5 (0.1) 1.3 (0.1) 0.0661 
Rising from a sitting position 1.6(0.1) 1.7 (0.1) 0.7772 
Walking inside the house 1.3 (0.1) 1.1 (0.1) 0.0510 
Walking outside the house 1.8 (0.1) 1.8 (0.1) 0.6230 
Clim bing stairs 2.3 (0.1) 1.8 (0.1) 0.0031 
Doing yard work/shopping 2.2 (0.1) 2.0 (0.1) 0.1244 
Putting on stockings/pants 2.0 (0.1) 1.8 (0.1) 0.0635 
Changes in limp and the need for a walking support were examined using the Wilcoxon 
matched-pairs test. Significant improvements were detected in both countries (Table 6-
Ig). Preoperatively, there had been a significant difference between Japan and the UK in 
both limping and the need for a walking support (Chapter 5). Although postoperative 
limping remained significantly more severe in the UK than in Japan. the difference 
disappeared for walking support. 
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Table f)-I g: Change in limp and walkin!; Sl1PPOltS followin~ THR 
Num ber of patients ( %) 
Japan UK 
Pre-Qp Post-QP Pre-op Post-op 
Limp 
None 5 ( 2.0) 69 (27.5) 9 ( 3.1) 67 (22.8) 
Slight 64 (25.3) 151 (60.2) 28 ( 9.5) 145 (49.3) 
Moderate 114 (45.1) 24 ( 9.6) 85 (28.8) 60 (20.4) 
Severe 48 (19.0) 3 ( 1.2) 151 (51.2) 18 ( 6.1) 
Unable to walk 22 ( 8.7) 4( 1.6) 22( 7.5) 4 ( 1.4) 
Missing 3 5 f) 7 
Probability (WilcQxon) <0.0001 <0.0001 
Probability 
Japan vs UK 
PQst-QP 
0.0006* 
----------------------------------------------------------------------
Walking SUppOlt 
None (or rarely) 91 (36.5) 95 (38.2) 75 (25.3) 131 (44.7) 0.6965* 
Single cane/clutch 123 (49.4) 136 (54.6) 136 (45.8) 121 (41.3) 
Two canes/crutches 20 ( 8.0) 13 ( 5.2) 54 (18.2) 23 ( 7.8) 
Walker 6 ( 2.4) 1 ( 0.4) 9 ( 3'()) 7 ( 2.4) 
Wheelchair 9 ( 3.6) 4( 1.6) 23 ( 7.7) 11 ( 3.8) 
Missing 7 7 4 8 
Probability (Wilcoxon) 0.0338 <0.0001 
* : Postoperative limp and walking support compared between Japan and the UK, using 
Mann-Whitney U test. 
1-7. Global measures 
The proportion of patienl~ who were emplQyed declined in bQth countries (Table 6-lh). 
Although similar prQPOltiQn Qf patienl~ were emplQyed postoperatively, this change was 
significantly mQre evident in Japan than in the UK due tQ their relatively higher ratio Qf 
preoperative employment. 
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Table 6-1h : Number and percent of patients employed before and after TIlR 
in Japan and the UK 
Work status 
Preoperative 
Postoperative 
Probability (Chi square) 
Number C%) of patients 
Japan UK 
66 (27.8) 
4207.9) 
0.0193 
59 (20.6) 
52 (18.0) 
0.4353 
Probability 
(Chi square) 
0.0513 
0.9895 
Patients were asked for their views on the overall change in their health by means of some 
global questions (Table 6-1 i). In both countlies. the majority of patients perceived their 
health improved and improved beyond their expectation. Also most patients felt 
somewhat or much better and were happy about having had the operation. 
Comparing the two counuies, Japanese patients were more likely to describe their health 
as better and thought it better than they had expected. This suggests Japanese patients 
may have had lower expectations as to the effect of the operation. On the other hand, 
British patients were more likely to feel the operation had made them feel better and to 
state that they were very happy about having had the operation. 
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Table 6-1 i : Patient perception of global chanoe in health: 
significance examined by Mann-WhitneyU test 
Questions about Number of patients {Ck} 
~han~~ in health JAPAN UK 
My health now is: 
1. Better 187 (75.7) 194 (65.5) 
2. Same 46 (18.6) 80 (27.0) 
3. Worse 14( 5.7) 22 ( 7..+) 
Missing 9 5 
My health is: 
1. Much better than I expected 125 (50.6) 114 (3X.5) 
2. Somewhat better than I expected 79 (32.0) 71 (24.0) 
3. What I expected 23 ( 9.3) 61 (20.6) 
4. Somewhat worse than I expected 16 ( 6.5) 40 (13.5) 
5. Much worse than I expected 4 ( 1.6) 10 ( 3.4) 
Missing 9 5 
Operation changed the way I feel: 
1. Much better 98 (39.4) 185 (62.1) 
2. Somewhat better 108 (43.4) 57 (19.1) 
3. A little better 37 (14.9) 20 ( 6.7) 
4. About the same 1 ( 0.4) 16 ( 5..+) 
5. A little worse 3 ( 1.2) 4 ( 1.3) 
6. Somewhat worse 1 ( 0.4) 9 ( 3.0) 
7. Much worse 1 ( 0.4) 7 ( 2.3) 
Missing 7 3 
About having had the operation: 
1. I'm very happy 121 (48.6) 201 (67.7) 
2. I'm happy 118 (47.4) X I (27.3) 
3. I'm not so happy 8 ( 3.2) 9 ( 3.0) 
4. I'm not happy at all 2 ( 0.8) 6 ( 2.0) 
Missing 7 4 
Probability 
0.0348 
<0.0001 
<0.0001 
<0.0001 
These types of global outcomes can be effected by the outcomes of postoperative 
complications. To explore the impact of such factors, the outcomes of patients who 
experienced a dislocation of the joint were compared with those who did not. Once 
dislocated, a manual or open reduction under general anaesthesia is required and patient~ 
experience extreme pain and immobility. Moreover. after successful reduction patients 
have to fix the hip for some time with appliances until the joint stabilises. Thus it's highly 
likely to leave patienL~ dissatisfied. This was the case in the UK (Table 6-lj). 
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Table o-l.i : ~~stoperative dislocation and patient perception of health: 
slgmftcance level examined by Mann-Whitney U test 
Range * 
of Mean score (SE) 
QY~~liQn abollt health score Dislocated Not dislocated Pmbability 
JAPAN 
My health is better than before 1 - 3 1.6 (0.2) 1.3 (0.0) 0.0112 
Operation changed the way T feel 1 - 7 2.1 (0.3) 1.8 (0.1) 0.6013 
I'm happy to have had operation 1 - 4 1.7 (0.2) 1.6 (0.0) 0.4687 
UK 
My health is better than before 1 - 3 1.8 (0.2) 1.4 (0.0) 0.0168 
Operation changed the way I feel 1-7 3.1 (0.6) 1.7 (0.1) 0.0177 
I'm happy to have had operation 1 - 4 2.0 (0.3) 1.4 (0.0) 0.0027 
* Score of health is as shown in Table 6-1 i. 
1-8. Readmission rate 
Patients were asked if they had been admitted to any hospital in the peliod between the 
index admission and the follow-up questionnaire one year later. All readmissions were 
included due to the difficulties in identifying their relevance to the index operation. 
The number of patients who were readmitted to hospital was 33 (12.9%) in Japan and 65 
(21.6%) in the UK. If limited to readmissions within 3 months of their operation, the 
readmission rates were similar: 14 (5.5%) patients in Japan and 18 (6.0%) in the UK. 
Compalison are difficult however due to the long lengths of postoperative stay in Japan 
and because patients in Japan may be u'ansfen'ed to another hospital for convalescence 
and this would be counted as a readmission. 
146 
Table 6-1k shows the reasons for readmission. In both Japan and the UK, there were a 
substantial number of patients readmitted because of problems related to the other hip or 
the knees. Dislocation was frequent during the first 3 months in the UK (..t patients out of 
7), suggesting their hips were unstable dUIing the early stage of convalescence. Similar to 
the differences observed in the data on preoperative comorbidity (Chapter 5), cardio-
pulmonary disorders were commoner in the UK, while in Japan gastrointestinal disease 
was more of a problem. Included in 'others' in Japan were those who were transferred to 
other hospitals for convalescence (9 patients). 
Table 6-lk: Reasons for readmission in Japan and the UK 
Reason 
Joint 
Dislocation 
Other hiplknee related 
Cardiac disorders 
Vascular system 
Cerebrovascular 
Pedpheral vascular 
Respiratory 
Renal disease 
Malignancy 
Hepatobiliary 
Gastrointestinal 
Mental disorder 
Vision 
Others 
Number of readmission (%) 
JAPAN UK 
I ( 3.0) 7 (IO.R) 
9 (27.3) 20 (30.X) 
1 ( 3.0) 5 ( 7.7) 
1 ( 3.0) o ( - ) 
0(- ) 7 (10.8) 
0(- ) 3 ( 4.6) 
1 ( 3.0) 7 (10.8) 
o ( - ) 1 ( 1.5) 
o ( - ) 1 ( 1.5) 
5 (15.2) 3 ( 4.6) 
o ( - ) 1 ( 1.5) 
3 ( 9.l) 3 ( 4.6) 
12 (36.4) 7 (10.8) 
-----------------------------------------------------------
----------------------------------------------
Total 33 65 
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When patient characteristics were examined in relation to the readmission rate. no 
sociodemographic vatiables showed significant association in either country. In the UK. 
patients were more likely to be readmitted if they had had no previous hip surgery. did 
not undergo a hybrid THR. and had their surgery under regional anaesthesia (Table 6-11). 
Decreased daily activity by the patients who had had a previous hip surgery could be part 
of the reason why they had a lower readmission rate, as well as being relatively more 
conscious about their health. Regional anaesthesia is more likely to be used in older. 
sicker patients at higher operati ve risk. 
Table 6-11 : Patient charactelistics and readmission in the UK 
Number Number Readmission 
Patient of of rate. % Probability 
charactetistics patients readmissions (95% Conf.TnO (Chi square) 
Previous hip surgery 
Same hip (not THR) 16 1 6.3 ( 0.3-32.3) 0.1595 
Other hip (not THR) 8 0 0.0 ( 0.0-40.2) 0.1530 
Other hip (THR) 60 8 13.3 ( 6.3-25.1) 0.1506 
No surgery 191 45 23.6 (17.9-30.3) 0.0160 
Cement use 
Cemented 208 46 22.1 (16.8-28.5) 0.0365 
Hybrid 23 0 () ( 0.0-17.8) 
Cementless 30 5 16.7 ( 6.3-35.5) 
General anaesthesia 
Yes 259 48 18.5 (14.1-23.9) 0.0021 
No 8 5 62.5 (25.9-89.8) 
Among the six UK hospitals. the readmission rate ranged from 17 to 38%. though this 
was not statistically significant (Table 6-1 m). The range in the UK (21 Cfc) was larger than 
that reported in the USA (14%). There was no significant difference in readmission rate 
between teaching and non-teaching hospitals. 
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Table 6-1 m: Jnt~rhospital differ~nce in r~admission rate (UK) 
Number Number Readmission 
of of rate, % Probability 
HQSl2ital patients readmission (95% Conf.Jnt) (Chi square) 
A 65 11 16.9 ( 9.2-28.7) 0.1644 
B 48 10 20.8 (11.0-35.4) 
C 35 7 20.0 ( 9.6-37.5) 
D 36 12 33.3 (19.1-51.1) 
E 94 17 18.1 (ll.2-27.7) 
F 21 8 38.1 (19.0-n1.3) 
Total 299 65 21.7 (17.3-26.9) 
Missing 2 
Teaching status 
Teaching 165 36 21.8 (15.9-29.1) 0.9707 
Non-teaching 134 29 21.6 (15.2-29.8) 
Missing 2 
1-9. Satisfaction 
Questions were asked about patients' satisfaction with the information they received in the 
hospital, the management of their pain. and their overall satisfaction with care. Answers 
were on a five-point scale (1 indicated very satisfied: 5, very dissatisfied). As the 
distribution of the three scores were similar in both countries, they were averaged and 
compared to each other. 
There was a high degree of satisfaction in all three countries (mean score in Japan was 
1.7; in the UK, 1.5; in the USA, 1.3-l.5). Ratings were typically around 1.5. suggesting 
an average rating between "very satisfied" and "somewhat satisfied." The difference in 
satisfaction with care between the UK and Japan was statistically significant (p<O.OOOl. 
based on Mann-Whitney U test) with the UK patients more satisfied than the Japanese. 
In the UK. patients who had regional anaesthesia were less satisfied (mean satisfaction 
score 2.0; SE=OA) than those with general anaesthesia (1.5: SE=O.I) (p=O.0466 based 
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on Mann-Whitney U test). There was no significant association found in Japanese 
patients. 
Satisfaction with care differed significantly between the six UK hospitals (Table 6-1 n). 
When classified by their teaching status, satisfaction was significantly higher in teaching 
hospitals than in non-teaching hospitals. 
Table 6-1 n : Tnterhospital difference in care satisfaction (UK) 
Hospital 
A 
B 
C 
D 
E 
E 
Total 
Teaching status: 
Teaching 
Non-teaching 
Number 
of 
patients 
64 
48 
35 
33 
95 
22 
296 
162 
134 
Mean (SE) 
score of 
satisfaction 
1.6 (0.1) 
1.6 (0.1) 
1.2 (0.1) 
1.6 (0.1) 
1.4 (0.1) 
1.7 {0.2l 
1.5 (0.0) 
1.4 (0.1) 
1.6 (0.1) 
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Probability 
0.0293 
(KJ-uskal-Wallis) 
0.0081 
(Mann-Whitney) 
2. Relationship between outcomes and comorbidity 
Only some outcomes were considered further for the following rea..I\ons: 
(1) there were too few deaths to analyse the relationship between mortality and 
comorbidity~ 
(2) the ICED was designed pt;mm;ly to predict postoperative complications~ and 
(3) one of the aims of this study is to test the predictive power of the rCED for change 
in health status. which is the plincipal objective of THR. 
Therefore, the following analyses and discussions focus on two outcomes: in-hospital 
complications and change in health status. 
2-1. Serious complications 
The rate of serious in-hospital complications by the level of comorbidity is shown in 
Table 6-2a. When classified by the co-existent disease severity subindex, serious in-
hospital complications were most frequently observed in level 3 in all three countries. In 
Japan there was no clear trend. Complications were rare in levels 0, I and 2 and common 
in level 3. In the UK. there was significant evidence of increasing complications with 
increasing severity (Chi square for trend=5.8~ p<0.05). In the USA there was a 
statistically significant increasing l;sk of serious complications with increasing severity 
(Chi square for trend= 10.3; p<O.005). 
There was no clear association between complications and functional severity in Japan or 
the UK. In Japan. all the patients with serious complications were classified at level 0 
while in the UK complications were more likely to occur in patient~ with the middle level 
of functional severity. In contrast. in the USA the rise in prevalence was in good accord 
with the increment in functional sevelity (Chi square for trend= 15. 9~ p<O.OO I). 
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The composite index, the ICED, encompassed these observed differences in the 
distributions of complications by levels of severity of co-existent disease and function. 
The relative risk of a serious complication OCCUlTing in a patient with ICED level -+ 
compared with the ICED level 1 varied between the three countries. In Japan the risk was 
about four times greater, in the UK twice as great and in the USA over 14 times as great. 
For Japanese patients, a similar pattern to that seen with the co-existent disease severity 
subindex was seen in which there was no clear trend. In the UK, a significant trend 
emerged in a dichotomised pattern in which complication rates in levels 1 and 2 were 
similar and those in levels 3 and 4 were similar (Chi square for trend=4.2; p<O.05). In 
the USA, the complication rates ranged from 3 to 41 % with a consistent and statistically 
significant exponential increase from level 1 to level 4 (Chi square for trend=22.6; 
p<O.OOl). 
A similar pattern was observed with the ASA PS in Japanese and American patients. As 
with the ICED, the complication rate in Japan was low in grades 1 and 2 and high in 
grade 3. In the USA the prevalence of complications increased exponentially from lower 
to higher levels of ASA PS severity (p=O.06). 
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Table 6-2a: Number an~ psrcent of p~tients .with Seri()ll~ in-hospital complications for 
the two submdtc~s. (co-~xtstent dts~ase sev~nty .and functional sevetity), for 
the .ICED (combmmg dIsease seventy and tunctlonal st'vt'lity)' and for ASA 
PS 10 Japan, the UK and the USA 
Index 
Co-existent 
disease seveIity 
subindex 
Functional seveIity 
subindex 
Index of 
co-existent disease 
(ICED) 
Levels 
of 
index 
0 
1 
2 
3 
o 
1 
2 
1 
2 
3 
4 
Number (%) of patients with compli~i!tion* 
JAPAN UK USA 
N-249 
7 ( 6.7) 
0 ( 0.0) 
2 ( 2.7) 
2 (40.0) 
11 (5.4) 
o (0.0) 
o (0.0) 
7 (6.7) 
2 ( 1.9) 
o (0.0) 
2 (2X.6) 
N-2()R 
10 (l3.7);) 
7 (l9.4) 
21 (lX.I) 
14 (32.6) 
26 (16.0) 
24 (25.X) 
2 (15.4) 
10 (14.3);) 
11 (13.4) 
17 (27'(» 
14 (26.4) 
N 35() 
4 ( 3.8)° 
7 (10.2) 
23 (13.4 ) 
4 (36.4) 
14 (6.6)C 
19 (14.4) 
5 (50.8) 
3 (2.9)C 
11 (8.4) 
17 (16.3) 
7 (41.2) 
----------------------------------------------------------------------
ASAPS 1 
2 
3 
6 (8.4) 
3 (2.2) 
2 (40.0) 
3 (5.0) 
22 (10.0) 
11 (20.0) 
*: Percent of patients with in-hospital complications in total number of patients classified 
at each level of seveIity. 
a; p<0.05, b; p<0.005, c; p<O.OO 1 based on Chi square for trend (df= 1). 
The relationship between serious in-hospital complications and the ICED was clearly 
different between the three countlies (Fig6-2a). In Japan, the curve showed a sharp lise at 
the highest ICED level suggesting a threshold effect. In the UK. the figure was almost 
dichotomised between levels 1 and 2 and levels 3 and 4. In the USA, an exponential 
relationship was apparent. 
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Fi!;ure o-2a: Selious in-hospital complication rate in Japan. UK. and USA 
Complication 
Rate (%) 
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2-2. Minor complications 
30 
20 
10 
o 
The distribution of minor complications by level of comorbidity is shown in Table 6-2b. 
Compared with the distribution of serious complications, significant trends were 
observed in Japan with classification by the co-existent disease severity subindex (Chi 
square for trend=6.357: p<0.05), the ICED (Chi square for trend= 12.096; p<O.005) and 
the ASA PS (Chi square for trend=? .911: p<O.005). In the UK. the pattern was similar 
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to that for serious complications - the rates among the two lower levels were similar as 
were the rates among the two higher levels. 
Table 6-2b: Number and percent of patients with minor in-hospital complications for the 
tWQ subindices (co-existent disease severity and functional severity), fQr the 
ICED (combining disease sevetity and functional severity), and fQr ASA PS 
in Japan and the UK 
Index 
Co-existent 
disease severity 
subindex 
Functional sevetity 
subindex 
Index of 
co-existent disease 
(ICED) 
Levels 
of 
index 
0 
1 
2 
3 
o 
1 
2 
1 
2 
3 
4 
Number (%) of patient" with complicatiQn* 
JAPAN 
N-249 
17 (16.2)a 
12 (18.5) 
21 (28.4 ) 
2 (40.0) 
40 (19.6) 
10 (23.8) 
2 (66.7) 
17 ( 16.2)b 
24 (22.4) 
7 (23.3) 
4 (57.1 ) 
UK 
N-26R 
10 (13.7) 
7 (19.4) 
29 (25.0) 
10 (23.3) 
31 (19.1) 
21 (22.6) 
4 (30.8) 
10 (14.3) 
15 (18.3) 
18 (28.6) 
13 (24.5) 
----------------------------------------------------------------------
ASAPS 1 
2 
3 
15 (14.0)b 
33 (24.7) 
4 (50.0) 
*: Percent of patients with in-hQspital cQmplicatiQns in total number Qf patients classified 
at each level of sevelity. 
a; p<0.05, b; p<0.005. based on Chi square fQr trend (df=l). 
The following figure shows the relatiQnship between the minor in-hospital complication 
rate and the ICED, again demQnstrating the threshQld effect in Japan (Fig 6-2b). There 
was no clear pattern observed in the UK data. 
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Figure n-2b: Minor in-hospital complication rate in Japan and the UK 
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Rate (%) 
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2-3. Overall complications 
Table 6-2c shows the distribution of the overall complication rates by level of severity of 
comorbidity. Both in Japan and the UK. the association of overa11 complications with 
severity of comorbidity was significant when classified by the co-existent disease 
subindex (Japan: Chi square for trend=4.52: p<O.05 and UK: Chi square for 
trend=9.139; p<0.005). the ICED (Japan: Chi square for trend=5,46: p<O.05 and UK: 
Chi square for trend=8.226: p<0.005). In addition. in Japan there was a significant 
association with the ASA PS (Chi square for trend=8.59:p<0.005). Figure 6-2c shows 
the relationship between overall in-hospital complication rate and the ICED. 
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Table 6-2c: Number and percent of patients with overall in-hospital complications for the 
two subindices (co-existent disease severity and functional severity), for the 
ICED (combinin~ disease sevetity and functional severity), and for ASA PS 
in Japan and the UK 
Index 
Co-existent 
disease sevetity 
subindex 
Functional severity 
subindex 
Index of 
co-existent disease 
(ICED) 
Levels 
of 
index 
0 
I 
2 
3 
0 
1 
2 
1 
2 
3 
4 
Number (lk) of patients with complication * 
JAPAN UK 
N=249 
23 (21.9)a 
12 OR.5) 
23 (3l.1) 
3 (60.0) 
49 (24.0) 
10 (23.R) 
2 (66.7) 
23 (21.9)a 
26 (24.3) 
7 (23.3) 
5 (71.4) 
N-2()R 
20 (27.4)b 
14 (38.9) 
50 (43.1 ) 
24 (55.8) 
57 (35.2) 
45 (48.4) 
6 (46.2) 
20 (28.6)b 
26 (3l.7) 
35 (55.6) 
27 (50.9) 
----------------------------------------------------------------------
ASAPS 1 
2 
3 
20 08.7)b 
36 (26.9) 
5 (62.5) 
*: Percent of patients with in-hospital complications in total number of patients classified 
at each level of sevetity. 
a; p<0.05, b; p<0.005, based on Chi square for trend (df=l). 
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Figure n-2c: Overall in-hospital complication rate in Japan and the UK 
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Rate (%) 
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2-4. Change in health status 
Among the four dimensions in health status described in Chapter 6-1-5, basic ADL. 
instrumental ADL and social activity was compared before and after THR. Mental health 
was not included because of the difference in the number of questions asked in Japan 
from the UK. 
Change in health status following THR was examined in relation to the severity of 
comorbidity measured by the ICED. For each of the three dimensions of health status, 
there was no significant association with the ICED in Japan (Table 6-2d). In contrast a 
significant association was found in the UK with both the functional severity subindex 
and the ICED (Table 6-2e). For all three dimensions of health status. patients with less 
comorbidity repOited greater improvement in their health status. 
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Table 6-2d: Change in health status and severity of cnmorbidity in Japan 
Health status scales Levels Mean (SE) 
of change Probability 
by comorbidity index 
.... 
index in health status (Kruskal-Wallis) 
BasicADL 
Co-existent 0 24.4 ( 2.4) 0.1689 
disease sevel;ty 1 27.7 ( 4.2) 
subindex 2 29.4 ( 3.2) 
3 53.3 (12.4) 
Functional sevet;ty 0 26.7 ( 2.0) 0.6870 
subindex 1 29.3 ( 4.1) 
2 44.4 (25.7) 
Index of 1 24.4 ( 2.4) 0.1645 
co-existent disease 2 27.4 ( 3.0) 
(ICED) 3 31.7 ( 5.0) 
4 50.8 (13.0) 
----------------------------------------------------------------------
Instrumental ADL 
Co-existent 
disease sevel;ty 
subindex 
Functional sevel;ty 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
2 
3 
4 
28.1 ( 3'() 0.4801 
24.7 ( 4.7) 
28.0 ( 3.0) 
49.8 (12.6) 
27.1 ( 2.2) 0.5939 
30.0 ( 4.8) 
41.7 (13.9) 
28.1 ( 3.0) 0.2127 
24.9 ( 3.1) 
31.3 ( 5.3) 
50.7 (l0.4) 
----------------------------------------------------------------------
Social activity 
Co-existent 
disease severity 
subindex 
Functional sevetity 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
2 
3 
4 
24.7 ( 4.0) 0.5496 
22.3 ( 6.2) 
31.4 ( 4.3) 
44.4 (20.4) 
24.4 ( 3.0) 0.1049 
38.4 ( 6.0) 
5.6 ( 5.6) 
24.7 ( 4.0) 0.1702 
23.4 ( 4.3) 
42.0 ( 6.6) 
35.6(18.1) 
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Table 6-2e: Change in health status and seve,;!)' of comorhidity in the UK 
Health status scales Levels Mean (SE) 
of channe Probability 
by comorbidity index 
:: 
index in health status ( Kruskal-Wallis) 
BasicADL 
Co-existent 0 24.8 (3.1) 0.1617 
disease severity 1 25.5 (3.8) 
subindex 2 31.0 (2.2) 
3 25.8 (3.2) 
Functional sevel;ty 0 30.6 (1.9) 0.0572 
subindex 1 24.7 (2.4) 
2 15.4 (8.3) 
Index of 1 27.1 (2.9) 0.0350 
co-existent disease 2 33.5 (2.6) 
(ICED) 3 24.6 (3.1) 
4 23.2 (3.4) 
----------------------------------------------------------------------
Insuumental ADL 
Co-existent 
disease severity 
subindex 
Functional seve,;ty 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
2 
3 
4 
33.1 ( 3.7) 0.6646 
34.8 ( 4.0) 
31.0 ( 2.9) 
29.5 ( 3.4) 
35.7 ( 2.3) 0.0166 
27.6 ( 2.7) 
14.3 (11.3) 
35.6 ( 3.5) 0.0376 
36.6 ( 3.5) 
25.6 ( 3.4) 
26.8 ( 3.9) 
----------------------------------------------------------------------
Social activity 
Co-existent 
disease sevel;ty 
subindex 
Functional seve,;ty 
subindex 
Index of 
co-existent disease 
(ICED) 
0 
1 
2 
3 
0 
1 
2 
1 
2 
3 
4 
29.3 (4.2) 0.5777 
32.6 (6.0) 
34.5 (3.7) 
27.6 (5.7) 
34.9 (2Jn 0.0141 
29.7 (4.2) 
4.4 (7.3) 
31.6 (4.2) 0.0549 
39.1 (4.0) 
29.4 (5.2) 
22.6 (5.0) 
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Figures 6-2d, 6-2e and 6-2f show the relationship between change in each dimension of 
health status and the ICED (mean change with standard error plotted). The interpretation 
was difficult in Japan because of the large standard en'or at the highest level of the ICED. 
in which only 7 patients were classified. However. reflecting the weak association with 
preoperative basic ADL and social activity, the mean change in these two dimensions was 
increasing with the severity of the ICED except for the highest level. A weak 
dichotomous pattern was observed again in the UK, patticularly for instrumental ADL. in 
which lower ICED levels had greater change in health status. 
Figure 6-2d: Change in mean (+/-SEM) basic ADL in Japan and the UK 
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Figure 6-2e: Change in mean (+/- SEM) instrumental ADL in Japan and the UK 
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Figure 6-2f: Change in mean (+/- SEM) social activity in Japan and the UK 
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3. Relationship between outcomes and other independent variables 
From previously published studies, several factors were considered as potentially 
confounding the relationship between comorbidity and outcome (Table 6-3a). The 
relationship between such factors and outcomes were examined. Some additional factors 
were analysed for some specific outcomes. 
Table o-3a: Independent variables considered as possible confoundin!; factors 
Sociodemographic: age, sex, living alone. marital status. education level, 
home ownership 
Severity of hip disease: past history of hip surgery, limp. need for walking support 
Clinical management: anaesthesia, duration of surgery. amount of transfusion, 
cement use, surgical approach, hospital (in the UK only) 
3-1. Sel;ous complications 
Among the variables examined in relation to the occurrence of serious in-hospital 
complications in the UK, only two were found to be significantly associated: the surgical 
approach and the hospital (Table 6-3b). Significant interaction was observed between 
surgical approach and hospital (p<O.OOOl. based on Chi square test) suggesting that the 
difference in complication rates between hospitals may have arisen from the surgical 
approach adepted. There was no association between surgical approach and the duration 
of anaesthesia. In Japan, no factors were found to be significantly associated with serious 
com pI ications. 
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Table 6-3b: Factors si£nificantly related to seJious in-hospital complications in the UK 
Variabl~s 
Surgical approach 
Anteriorl Anterolateral 
LaterallPosteti 01'1 
Posterolateral 
Hospital 
A 
B 
C 
D 
E 
F 
Number 
of 
patients 
60 
IR8 
64 
37 
36 
26 
86 
19 
Number Complication 
of rate. Cf'c Probability 
com plicati 0 n s (95% Conf. J nO (Chi sguare) 
18 30.0 (19.2-'+3.4) 0.0221 
31 16.5 (11.6-22.8) 
7 10.9 ( 4.9-21.8) 0.0128 
4 10.X ( 3.5-26.4) 
5 13.9 ( 5.2-30.3) 
4 15.4 ( 5.5-35.7) 
25 29.1 (20.0-40.0) 
7 36.8 (17.2-61.4) 
The two most frequent serious complications. hypotension and neuropathy. were 
investigated further as follows. 
3-1 a. Hypotension 
Criteria of postoperative hypotension in this study was a drop in blood pressure to below 
90/60 mmHg, observed any time during the admission. whether or not it immediately 
recovered. The frequencies of postoperative hypotension varied considerably between 
countries; 0.8% in Japan. 12.3% in the UK. and 3.4% in the USA. Due to the small 
number of cases in Japan. further analyses were confined to the UK cases. When the 33 
UK patienl~ were compared with those without hypotension. there was no difference as 
regards their age. sex. length of stay (preoperative and total). use of cement, duration of 
anaesthesia (surgery). and OCCUJ1"ence of postoperative dislocation (Table fi-3c). 
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Table 6-3c: Relationship between postoperative hypotension and patient characteristics 
(UK) 
Variables 
Age 
Number of 
patient 
With hypotension 
Without hypotension 
33 
235 
Sex 
Male 
Female 
Length of stay 
With hypotension 
(N=33) 
9 
24 
Mean age 
(95% Conf.TnO 
69.9 (66.5 - 73.3) 
68.1 (6().4 - 69.7) 
Without hypotension 
(N=232) 
gg 
147 
Mean stay. days (95% Conf.TnO 
Period of stay 
Preoperative 
Postoperative 
Total 
Cement 
Both cemented 
Hybrid 
Cementless 
With hypotension 
(N=33) 
1.6 ( 1.2 - 2.0) 
1504 (13.0 - 17.9) 
17.0 (14.6 - 19.4) 
With hypotension 
(N-30) 
Without hypotension 
(N=232) 
2.0 ( l.7 - 2.3) 
14.0 (12.9 - 15.1) 
16.0 (14.9 - 17.2) 
Without hypotension 
(N-232) 
lXl 
22 
29 
Probability 
(Mann-Whitney) 
0.6868 
(Chi square) 
0.2548 
(Mann-Whitney) 
0.2543 
0.1534 
0.2781 
(Chi square) 
0.1441 
----------------------------------------------------------------------
Duration of 
anaesthesia/surgery 
With hypotension 
Without hypotension 
Number of 
patient 
29 
220 
Mean duration. min 
(95% Conf.Tntl 
106.7 ( 97.g - 115.6) 
104.5 (100.5 - lORA) 
(Mann-Whitney) 
0.3273 
----------------------------------------------------------------------
Dislocation 
Dislocated 
Not dislocated 
With hypotension 
(N-33) 
o 
33 
Without hypotension 
(N-235) 
165 
3 
232 
(Chi square) 
1.0000 
The difference in incidence among the six hospitals was statistically significant (Table 6-
3d). In hospital F, postoperative hypotension was observed more frequently than in the 
other hospitals. There was no significant difference in the incidence between teaching 
.... 
and non-teaching hospitals. 
Table n-3d: Tnterhospital difference in postoperative hypotension rate in the UK 
Number Number Hypotension 
of of rate, % Probability 
Hospital patients hypotension (95% Conf.Tnt) (Chi sQuare) 
A 64 4 6.3 ( 2.0-1 n.O) 0.0041 
B 37 I 2.7 ( 0.1-15.8) 
C 36 4 11.1 ( 3.6-27.0) 
D 26 3 11.5 ( 3.0-3l.3) 
E 86 14 16.3 ( 9.5-26.2) 
F 19 7 3n.R {17 .2-n 1.4) 
Total 268 33 12.3 ( 8.7-17'() 
----------------------------------------------------------------------
Teaching status 
Teaching 
Non-teaching 
148 
120 
21 
12 
14.2 ( 9.2-21.1) 
10.0 ( 5.5-17.2) 
0.2993 
Possible causes of the international and inter-hospital differences were: 1) the detection of 
hypotension, 2) patient characteristics. 3) reporting bias, and 4) the quality of 
postoperative care. 
(a-I) The detection of hypotension 
It is unlikely that an episode of hypotension would have been mistakenly detected. Most 
hypotension was reported on the day or the Jay after surgery. though some patients were 
hypotensive when receiving physiotherapy or at a later time on the ward. Because it 
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brings immediate staff attention once it happens and blood pressure would be measured 
frequently until it stabilised, errors in detection are considered unlikely to be the cause of 
observed differences. 
(a-2) Patient charactelistics 
Compared with Japanese patients, the UK patients were R years older on average (Table 
5-1), with more comorbidity, particularly insufficient cardiac function (Table 5-3b). 
Considering Japanese live about four years longer than Britons. the difference in mean 
patient age could be even more significant as regards physiological age leading to more 
cardiac dysfunction for the UK patients. Although the USA figure is not available 
regarding their cardiac comorbidity. the number of complications (Table 6-la) suggests 
the presence of a substantial number of patient~ at risk of heart failure. 
(a-3) RepOlting bias 
Health professionals in all countries should be equally motivated to report medical 
findings in the case notes. On the other hand they might underreport complications if 
there is a financial disincentive. This is unlikely in Japan because the insurance system is 
based on a fee-for-service method. in which the more procedures pelt'ormed, including 
blood pressure monitoring, the larger the profit. Recording of every procedure is 
mandatory for charging purposes. In contrast. in the UK there are neither financial 
incentives nor disincentives to repolt blood pressure measurements. In the USA, where 
the majOlity of patients undergoing THR are eligible for Medicare. the payment is fixed, 
adjusted for complications. This is likely to provide staff with an incentive to repOlt in-
hospital complications. Thus. financial incentives cannot be accountable for the 
differences in rates of hypotension repOlted. 
Another possibility is the teaching status of the hospitals. In general. teaching hospital 
staff kept more information in the case notes. perhaps for research purposes, while in 
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community or district general hospitals the amount of data w~s relatively less. However. 
the majOlity of Japanese hospitals were teaching hospitals whereas only half the UK 
hospitals were. So this too is unlikely to account for the international differences in the 
rates observed. 
(a-4) Quality of postoperative care 
The biggest difference in postoperative care between Japan and the UK was in the long 
length of hospital stay in Japan. For THR patients in Japan. it is usually recommended to 
stay in bed dUling the first week after surgery and then gradually start mobilisation. 
Walking exercises only statt two weeks after the surgery. when British and American 
patients are already being discharged from hospital. Also during their hospital stay, 
Japanese patients usually receive three to four days' (sometimes a week or more) 
intravenous infusion to supplement their oral intake of water. This double effect of bed 
rest and fluid replacement may have contributed. to some extent, to maintaining their 
blood pressure. Because of differences in the recording of tluid balance between Japanese 
and British hospitals, it was difficult to know how far tluid replacement prevented 
hypotension. 
The other possibility is the method of anaesthesia. In the UK. a significantly higher 
proportion of patients underwent general anaesthesia than in Japan and the USA. 
Moreover, in the UK general anaesthesia was often applied in combination with regional 
anaesthesia. This was to control the level of analgesia and sedation so that the anaesthesia 
would not be too deep. Although no data were available regarding the depth of 
anaesthesia, frequent postoperative hypotension may also suggest the poor recovery of 
Blitish patienl~ after such anaesthesia. However. none of these factors would explain 
why the UK hospitals had more cases of hypotension than the USA where postoperative 
care is similar and the length of hospital stay is even sholter than in the UK. 
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In conclusion, it would appear that differences in patient characteristics plus, perhaps. 
differences in clinical management accounted for the observed differences in the rates of 
hypotension. 
3-1 b. Neuropathy 
The incidence of neuropathy was similar among the three countlies: 2.Xlk in Japan. 2.20C 
in the UK, 3.4% in the USA. The anatomical position of the sciatic nerve suggests a 
posterior approach to the hip joint is more likely to cause neuropathy than anterolateral. 
The proportion of laterallpostelior/posterolateral approaches was 49.4% in Japan, about 
two thirds of that in the UK (75.8%). Despite this the rates of neuropathy were similar. 
Other possible factors associated with neuropathy include: a previous surgery on the same 
hip which may lead to scar formation in the surrounding tissue which could reduce 
flexibility and require extra effOlt to develop the surgical area for better exposure; use of 
cement which takes extra time during the surgery which may be associated with 
developing neuropathy: and postoperative dislocation, which usually occurs in a postelior 
direction and may damage the sciatic nerve temporalily. 
Therefore past history~ cement use, duration of surgery, total blood loss. and dislocation 
were examined for any association with neuropathy. However, none of these factors 
were associated with postoperative neuropathy in Japan or in the UK (Tables 6-3e and 6-
30. 
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Table 6-3e: Relationship between neuropathy and patient charactetistics in Japan 
Variables 
Previous hip surgery 
Operated 
Never operated 
Cement 
Both cemented 
Hybrid 
Cementless 
Duration of 
anaesthesia/surgery 
With neuropathy 
(N-7) 
3 
4 
With neuropathy 
(N=7) 
4 
o 
3 
Without neuropathy 
(N-242) 
4H 
194 
Without neuropathy 
(N-242) 
57 
40 
145 
Number of Mean duration. min 
Probability 
(Chi square) 
0.3111 
(Chi square) 
0.0910 
~~~~~~~~~~pa~t~~~n~t~~~~(9~5~~~c~C~o~n~fuln~t)~ (~ann-Whitney) 
With neuropathy 
Without neuropathy 
7 164.1 (120.3 - 20H.O) 0.2360 
242 142.5 (135.9 - 149.1) 
----------------------------------------------------------------------
Total blood loss 
With neuropathy 
Without neuropathy 
Number of 
patient 
6 
234 
~ean blood loss 
(95% Conf.lntl 
1257J~ ( g57.3 - 165~(4) 
1327.3 (1259.3 - 1395.2) 
(~ann-Whitney) 
0.8582 
----------------------------------------------------------------------
Dislocation 
Dislocated 
Not dislocated 
With neuropathy 
(N-7) 
o 
7 
Without neuropathy 
(N-242) 
170 
I 1 
231 
(Chi square) 
1.0000 
Table 6-3f: Relationship between neuropathy anJ patient characteristics in the UK 
Variables 
Previous hip surgery 
Operated 
Never operated 
Cement 
Both cemented 
Hybrid 
Cementless 
Duration of 
anaesthesia/surgery 
With neuropathy 
Without neuropathy 
Total blood loss 
With neuropathy 
Without neuropathy 
With neuropathy 
(N=o) 
1 
5 
With neuropathy 
(N=5) 
3 
1 
1 
Number of 
patient 
5 
244 
Number of 
patient 
5 
220 
Without neuropathy 
(N-202) 
75 
187 
Without neuropathy 
(N-257) 
206 
22 
29 
Mean duration. min 
(95% Conf.Tntl 
111.0 ( 57.3 - 164.7) 
104.6 (100.9 - 108.2) 
Mean blood loss 
(95% Conf.Tntl 
844.4 ( 26.3 - 1662.5) 
1034.2 (941.3 - 1127.1) 
Probability 
(Chi square) 
0.8536 
(Chi sq uare) 
0.5204 
(Mann-Whitney) 
0.9421 
(Mann-Whitney) 
0.4850 
----------------------------------------------------------------------
Dislocation 
Dislocated 
Not dislocated 
With neuropathy 
(N-6) 
o 
6 
Without neuropathy 
(N=262) 
171 
3 
259 
(Chi square) 
1.0000 
3-2. Minor complications 
Of all the variables examined in relation to episodes of minor in-hospital complications in 
the UK, only the patient's education level was found to be significantly associated 
(p<O.005, based on Chi square test). In Japan, no variables were found to be significant. 
One of the commonest complications wa....1\ dislocation. Several factors were examined for 
an association with dislocation: previous surgery on the same hip, surgical approach, use 
of cement, duration of surgery, total blood loss as an indicator of surgical difficulty and 
length of stay. In Japan where shallow acetabula were common and a bone graft was 
often necessary (34.5% of cases) it was more difficult to reconstruct the joint. However, 
none of these variables was significantly related to dislocation. 
3-3. Overall complication rate 
Previous hip surgery was the only factor found to be significantly associated with the 
overall complication rate in Japan (Table 6-3g). In the UK, the only factor found to be 
significantly associated with the overall complication rate was the hospital. 
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Table 6-3t;: Relationship between patient charactelistics and overall complication rate 
JAPAN 
Previous 
hip surgery 
UK 
Yes 
No 
Total 
Hospital 
A 
B 
C 
0 
E 
F 
Number 
of 
patients 
51 
19R 
249 
Number 
of 
patients 
64 
37 
36 
26 
86 
19 
3-4. Change in health status 
Number Complication 
of rate. % Probability 
complication (95£K Conf. Tnt> (Chi square) 
18 35.3 (22.R-50.0) 0.0444 
43 21. 7 ( I h.3-2R.2l 
61 24.5 (1t).4-30A) 
Number Complication 
of rate. % Probability 
complication (95% Conf.Tnt) (Chi square) 
18 28.1 (17.9-41.0) 0.0097 
11 29.7 (16.4-47.2) 
6 16.7 ( 7.0-33.5) 
1 1 42.3 (24.0-62.~n 
38 44.2 (33.6-55.3) 
1 1 57.9 (34.0-78.9) 
In Japan, the factors significantly associated with a change in health status were age, sex, 
whether the patient lived alone and education level (Table 6-3h). In the UK, mmital 
status and whether living alone were found to be significantly associated with 
instrumental ADL. Among the three dimensions of health status, sociodemographic 
factors were signiticantly associated with a change in instl1Jmental ADL rather than basic 
ADL or social activity. 
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Variable 
Age * 
Sex 
Marital status 
Living alone 
Table 6-3h: Relationship between change in health status 
and patient sociodemographic characteJistics 
JAPAN UK 
8-ADL l-ADL SA 8-ADL I-ADL 
0.3094 0.0179 0.1832 0.2399 0.3532 
0.0655 0.0024 0.0940 0.1568 O.R'+54 
0.3796 0.3013 0.2762 0.7078 0.0105 
0.1153 0.0053 0.0177 0.6015 0.0276 
Home ownership 0.4042 0.7443 0.9433 0.4870 0.2376 
Education level 0.4749 0.0083 0.0355 0.3816 0.8885 
B-ADL indicates basic ADL; I-ADL, instrumental ADL: SA. social activity. 
SA 
0.2'+62 
0.5015 
0.6655 
0.7891 
0.4380 
0.2067 
Significance test examined by Mann-Whitney U test (sex, matital, living. home, previous 
hip) and Kruskal-Wallis test (age, education). 
* Age was dichotomised 57-66 years or others. using 25 and 50 percentiles as cut-off. 
In both countries. the severity of preoperative limp was significantly associated with 
change in health status (Table 6-3i). Previous hip surgery was not associated with any 
dimension of health status. A significant association was also found between the need of 
... 
walking SUppOlt and basic ADL. Compared to relationship with preoperative health 
status, previous hip surgery became not significant with any dimensions but preoperative 
limp remained significant. 
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Table 6-3i ; Relationship between change in health status and sevelity of hip disease 
JAPAN UK 
Variable B-ADL J-ADL SA B-ADL I-ADL SA 
Previous hip surgery 0.6746 0.6172 0.1851 0.1272 0.9315 0.44X9 
Limp <0.0001 0.0001 0.0001 <0.0001 <0.0001 0.0004 
Walking SUppOlt 0.0006 0.3288 0.1019 0.0048 0.2403 0.1541 
B-ADL indicates basic ADL; I-ADL, instlUmental ADL: SA. social activity. 
Significance test examined by Mann-Whitney U test (previous hip surgery) and KIuskal-
Wallis test (limp, walking SUPPOlt). 
The following Tables 6-3j and 6-3k show the analyses of variables significantly 
associated with change in health status (shown in bold letters in Tables o-3h and 6-3i). 
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TaQI~ 6-3i : Significant association of valiables with change in health status in J!l12!ln 
Number of Change in health status Mean 
ValiaQl~ 12atients Mean SE mnk 
Basic ADL 
No limp 4 -5.6 5.6 30.9 
Slight limp 59 17.3 3.4 93.2 
Moderate limp llO 25.1 2.3 113.8 
Severe limp 43 40.3 3.8 153.0 
Unable to walk 21 48.1 6.6 166.2 
No walking SUppOit 87 19.7 2.6 97.3 
Single cane/clUtch ll6 29.6 2.6 124.7 
Two canes/clUtches 18 34.9 5.6 138.0 
Walker 6 35.2 8.3 138.6 
Wheelchair 8 59.7 10.9 186.4 
Instrumental ADL 
::;55 years 85 31.6 3.6 125.4 
57 - 66 years 69 21.7 3.5 99.2 
66 - 73 years 53 28.1 3.8 116.5 
~73 years 22 30.4 4.3 120.6 
Female 198 25.1 2.2 112.6 
Male 38 40.5 4.1 149.2 
Living alone 27 14.4 5.0 82.7 
Living with 205 29.1 2.1 121.0 
Education completed at 
::;15 years 49 22.8 3.7 105.1 
16 - 18 years 152 25.9 2.5 114.6 
~19 years 32 41.0 4.9 150.5 
No limp 4 -5.6 13.8 45.8 
Slight limp 58 15.6 4.3 92.8 
Moderate limp 109 27.2 2.7 117.1 
Severe limp 43 38.1 3.5 143.9 
Unable to walk 20 46.0 8.0 149.1 
Social acti vity 
Living alone 20 8.3 7.8 75.0 
Living with 190 28.8 2.9 108.7 
Education completed at 
4.8 95.4 ::;15 years 43 20.9 
16 - 18 years 137 25.0 3.6 104.3 
~19 years 32 42.0 6.4 130.8 
No limp 4 -13.9 21.0 48.6 
Slight limp 51 7.3 5.0 76.4 
Moderate limp 100 31.2 3.9 114.1 
Severe limp 38 37.n 5.5 120.3 
Unable to walk 19 45) 9.0 132.1 
] 7 6 
Tabl~ Q-Jk : Significant association of variables with change in health status in th~ lJK 
Number of Change in health statlls Mean 
Variable patients Mean SE rank 
Basic ADL 
No limp 9 9.9 5.9 75.2 
Slight limp 27 10.3 5.2 87.5 
Moderate limp 80 19.3 2.5 111.4 
Severe limp 148 33.4 1.R 163.0 
Unable to walk 21 50.R 4.R 223.1 
No walking SUppOit 72 19.9 3.3 116.6 
Single cane/clUtch 133 28.5 1.9 145.2 
Two canes/clUtches 52 34.9 3.5 170.1 
Walker 8 33.3 7.9 161.9 
Wheelchair 23 32.4 6.2 163.9 
Instrumental ADL 
Not manied 113 26.6 2.9 125.0 
Manied 166 35.7 2.3 150.2 
Living alone 93 25.9 3.3 124.1 
Living with 184 34.9 2.1 146.5 
No limp 9 14.8 3.6 77.5 
Slight limp 25 17.2 5.9 97.9 
Moderate limp 81 23.2 3.3 116.4 
Severe limp 144 38.0 2.3 157.0 
Unable to walk 19 50.8 8.3 189.7 
Social activity 
No limp 7 15.9 13.0 90.6 
Slight limp 19 1.8 8.0 72.1 
Moderate limp 74 26.3 3.6 114.8 
Severe limp 135 37.3 3.2 139.5 
Unable to walk 17 44.4 10.8 149.9 
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· 4. Summary 
# Mortality: Known one year m0l1ality was O.39C in Japan and 1.11Jc in the UK. but 
both may be underestimated as some eligible patients were never traced. 
# Serious complications: Commoner in the UK (19.4%) than in Japan (4.4%) or the 
USA (10.7%). Most likely to be hypotension (l2.31Jc) in the UK and neuropathy 
(2.8%) in Japan. The ICED was not significantly associated with the rate of serious 
complications in Japan but was in the UK. The pattern of association suggested a 
threshold effect in Japan whereas it was dichotomous in the UK. The serious 
complication rate was also associated with the surgical approach and the hospital of 
treatment in the UK. No variables were found to be significantly related to serious 
complications in Japan. 
# Minor complications: The incidence was similar in all three countries. Dislocation and 
gastrointestinal symptoms were commoner in Japan whereas suspected deep vein 
thrombosis and bed sores were commoner in the UK. The ICED was significantly 
associated with the minor complication rate in Japan but not in the UK. The pattern of 
association in Japan again suggested a threshold effect but there was no clear pattern in 
the UK. 
# Overall complications: The ICED was significantly associated with the overall 
complication rate in both countries. Similar pattems of association were observed to 
those for sedous complications. Overall complications were also associated with 
previous hip surgery in Japan and the hospital of treatment in the UK. 
# Chant:e in health status: Health status improved in all countlies following surgery. The 
only international difference was that mental health improved more in Japan than in the 
UK. The ICED was not signiticantly alO\sociated with change in health status in Japan 
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but in the UK there was a significant dichotomous pattern in which patients with less 
comorbidity reported greater improvement in basic and instrumental ADL scores. 
Patient's age, sex, living alone and education were associated with change in health 
status in Japan whereas marital status and living alone were associated in the UK. In 
both countries, preoperative severity of hip disease was strongly associated with 
change in health status. 
# Mobility/Symptoms: Significant improvements in mobility were reported both in Japan 
and the UK. British patients, who were more severely affected before surgery, 
reported significantly more persistent disability one year after. Surgery had little impact 
on patient's use of walking SUppOltS in Japan. In contrast, significantly fewer British 
patients required such aids after surgery. 
# Global measures: Japanese patients were more likely than British patients to describe 
their health as better and thought it better than they had expected. This suggests 
Japanese patients may have had lower expectations as to the effect of the operation. On 
the other hand, British patients were more likely to feel the operation had made them 
feel better and to state that they were very happy about having had the operation. 
# Readmission: Significantly lower readmission rates were found in patients with 
previous hip surgery, hybrid THR and general anaesthesia in the UK. No significant 
association was found in Japan. 
# Satisfaction: A high degree of satisfaction was found in all three countries. British 
patients were more likely to be satisfied if they underwent general anaesthesia and 
were treated in a teaching hospital. No significant associations were found in Japan. 
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Chapter 7: Predictive power of the ICED 
This chapter describes the use of regression models to explore the relationship between 
comorbidity and outcomes. Dependent variables chosen as outcomes were in-hospital 
complications and change in health status. Independent variables for the regression model 
were identified from the literature and bivariate analyses repOited in Chapter 6. Finally. 
attempts were made to improve the power of the ICED to predict serious complications. 
********************************************************************** 
In the search for the influence of comorbidity on the outcome of THR, analyses were 
undertaken to define the extent to which other factors confounded the association. 
Variables included in the regression model were chosen on the basis of the literatw·e 
review reported in Chapter 1, and from those found to be significant on bivariate analyses 
reported in Chapter 6. Tables 7-1 a and 7-1 b show the cOiTelation matrix of variables in 
Japan and in the UK. Significantly correlated coefficients (p<O.05) are shown in bold. 
The ICED was more often found significantly correlated with patient sociodemographics, 
preoperative severity of hip disease and health status in Japan than in the UK. However, 
the pattern of significant relationships was generally similar between the two countries. 
For example, there were few significant correlations between in-hospital complications 
and patient variables in either country. In contrast, change in health status was correlated 
with preoperative status as well as with preoperative severity of hip disease (limp and 
need for walking support) in both countries. Among patient's sociodemographic 
characteristics, patient's age and education level were often found significantly correlated 
with other variables. 
ASA PS (available only in Japan) was strongly correlated with the ICED, minor and 
overall complications, age, education level. preoperative basic ADL, and use of cement. 
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I~ Complication Change in: Transformed Sociodemographic I ICED senous mmor overall B-ADL I-ADL SA B-ADL SA age female married alone educa~l)l 
Comorbidity ICED 1.000 
Com plication serious -0.008 1.000 
mmor 0.138 -0.014 1.000 
overall 0.IU8 0.377 0.902 1.000 
Change in: B-ADL 0.153 0.056 -0.090 -0.061 1.000 
I-ADL ()'O64 0.036 -0.105 -0.086 0.712 1.000 
SA 0.103 0.046 -0.078 -0.048 0.670 0.818 1.000 
Transfoffiled B-ADL 0.153 0.055 -0.090 -0.061 + 0.711 0.670 1.000 
change in: SA 0.100 0.014 -0.080 -0.070 0.637 0.760 + 0.637 1.000 
S()cio- age 0.287 -0.089 0.117 0.068 0.076 -0.072 -0.023 0.075 -0.051 1.000 
demographic female -0.151 -0.015 0.004 -0.012 -0.124 -0.191 -0.100 -0.126 -0.106 -0.001 1.000 
married -0.060 0.015 0.057 0.056 0.054 0.075 0.075 0.055 0.097 -0.157 -0.189 1.000 
alone 0.056 0.044 0.064 0.088 -0.088 -0.163 -0.160 -0.088 -0.202 0.002 0.091 -0.518 l.OOO 
education ·0.164 -0.003 -0.102 -0.083 -0.007 0.134 0.121 -0.007 0.126 -0.381 -0.024 0.032 0.073 1.00n 
Hip severity prev hip op -0.032 0.085 0.107 0.127 0.030 0.045 0.104 0.029 0.045 -0.070 0.137 -0.029 0.044 -0.072 
walk support 0.164 0.050 0.036 0.045 0.287 0.104 0.136 0.286 0.111 0.162 0.123 -0.038 -0.030 -0.149 
limp 0.038 0.067 -0.072 -0.055 0.385 0.324 0.320 0.364 0.308 -0.082 -0.075 0.052 -0.043 0.027 
Preoperative B-ADL -0.171 -0.044 -0.046 -0.049 -0.758 -0.420 -0.429 -0.758 -0.409 -0.138 -0.018 0.021 -0.037 0.155 
I-ADL -0.122 -0.023 -0.029 -0.022 -0.621 -0.597 -0.549 -0.621 -0.518 -0.112 -0.018 -0.007 0.113 n.l08 
SA -0.164 0.023 -0.037 -0.028 -0.593 -0.454 -0.592 -0.593 -0.555 -0.155 -0.107 0.097 0.054 0.076 
ASAPS 0.593 0.013 0.173 0.157 0.082 -0.036 0.004 0.082 -0.001 0.208 -0.090 -0.099 0.117 -0.142 
Clinical cement type ·0.158 -0.135 -0.002 -0.048 -0.079 -0.007 0.084 -0.081 0.105 -0.377 0.047 0.112 -0.115 0.199 
manal!ement 
.... 
anaesthesia 0.026 0.057 -0.069 -0.047 -0.032 -0.010 0.022 -0.031 U.007 -0.053 0.120 -0.002 -0.044 -0.00 I 
Table 7-1a: Correlation matrix of the variables in Japan (continued overleaf) 
182 
~ Hip severity Preoperati ve Clinical manage hip op support limp B-ADL I-ADL SA IASAPS cement anaest 
Comorbidity ICED 
Complication seIious 
minor 
overall 
Chan{!e in: 
.... 
B-ADL 
I-ADL 
SA 
Transformed B-ADL 
change in: SA 
Socio- age 
demographic female 
married 
alone I 
education 
Hip severity prev hip op 1.000 
walk support 0.167 1.000 
limp -0.018 0.297 1.000 
Preoperative B-ADL -0.158 -0.433 -0.449 1.000 
I-ADL -0.195 -0.379 -0.405 0.779 1.000 
SA -0.205 -0.406 -0.387 0.723 0.840 1.000 
ASAPS -0.031 0.178 0.090 -0.152 -0.100 -0.111 1.000 
Clinical cement type -0.010 -0.140 -0.018 0.202 0.160 0.086 -0.184 1.000 
management anaesthesia 0.001 0.036 -0.005 0.026 0.001 -0.020 0.101 -0.034 1.000 
Table 7-1 a: CQITelation matrix of the variables in Japan (continued) 
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l~ Complication Change in: Transfonned Sociodemographic j ICED serious mInor overall B-ADL I-ADL SA B-ADL SA age female married alone educatr:ol 
Comorbidity ICED 1.000 
Complication senous 0.139 1.000 
mInor 0.114 0.0495 1.000 
overall 0.167 0.662 0.694 1.000 
Change in: B-ADL -0.092 0.008 -0.057 -0.037 1.000 
I-ADL -0.145 -0.075 -0.037 -0.065 0.729 1.000 
SA -0.104 -0.048 -0.090 -0.102 0.642 0.685 1.000 
Transformed B-ADL -0.089 0.007 -0.059 -0.039 + 0.729 0.641 1.000 
change in: SA -0.104 -0.061 -0.115 -0.124 0.613 0.663 + 0.612 1.000 
Socio- age 0.355 0.013 0.097 0.073 0.014 -0.114 0.051 0.016 0.040 1.000 
demographic female 0.013 -0.023 0.024 -0.010 0.069 -0.020 0.045 0.069 0.059 0.049 1.000 
married -0.074 0.013 0.021 0.006 0.041 0.170 0.019 0.038 0.030 -0.218 -0.288 1.000 
alone 0.110 0.016 -0.019 0.005 0.010 -0.155 0.019 0.014 0.001 0.334 0.281 -0.847 1.000 
education -0.112 -0.009 -0.172 -0.131 -0.080 -0.045 -0.083 -0.080 -0.048 -0.295 -0.023 0.048 -0.089 1.000 
Hip severity prev hip op -0.116 -0.058 0.002 -0.051 -0.080 -0.024 -0.044 -0.082 -0.058 0.143 -0.060 -0.045 0.056 0.160 
walk support 0.107 -0.078 0.045 -0.025 0.185 0.057 0.050 0.184 -0.009 0.116 0.100 -0.041 0.090 -0.065 
limp -0.082 -0.004 -0.025 -0.004 0.453 0.330 0.271 0.453 0.228 -0.074 0.098 0.048 -0.038 0.011 
Preoperative B-ADL -0.046 0.033 -0.113 -0.031 -0.646 -0.299 -0.327 -0.644 -0.289 -0.111 -0.100 -0.013 -0.080 0.179 
I-ADL -0.049 0.077 -0.103 -0.003 -0.437 -0.403 -0.294 -0.436 -0.249 -0.063 -0.133 -0.070 0.015 0.106 
SA -0.132 0.056 -0.085 0.027 -0.377 -0.230 -0.516 -0.376 -0.433 -0.202 -0.146 0.108 -0.171 0.129 
Clinical cement type -0.274 -0.110 -0.094 -0.134 -0.034 0.045 -0.038 -0.037 -0.025 -0.694 -0.046 0.115 -0.176 0.283 
management ant approach 0.040 0.145 -0.083 0.034 -0.003 0.025 0.047 -0.004 0.067 0.057 0.080 -0.066 0.054 -0.OX6 
anaesthesia 0.020 -0.080 -0.072 -0.053 0.094 0.077 0.080 0.094 0.122 0.145 0.005 -0.103 0.129 -0.081 
Table 7-1b: Correlation matrix of the variables in the UK (continued overleaD 
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------------
Hip severity Preoperati ve Clinical management 
hip op SUppOit limp B-ADL I-ADL SA cement ant apprc anaest 
Comorbidity ICED 
Complication serious 
mmor 
overall 
Chan1!e in: 
... 
B-ADL 
I-ADL 
SA 
Transfonned B-ADL 
chan1!e in: 
.... 
SA 
Socio- age 
demographic female 
married 
alone 
education 
Hip severity prev hip op 1.000 
walk support 0.03g 1.000 
limp -0.035 0.317 1.000 
Preoperative B-ADL 0.125 -0.364 -0.510 1.000 
I-ADL O.IOt) -0.450 -0.489 0.742 1.000 
SA 0.071 -0.405 -0.397 0.675 0.739 1.000 
Clinical cement type 0.142 -0.092 0.058 0.088 0.061 0.163 1.000 
management ant approach 0.Og5 0.005 -0.014 0.058 0.027 0.062 -0.150 1.000 
anaesthesia 0.013 -0.020 -0.153 0.031 -0.003 -0.013 -0.016 0.103 1.000 
-- --
Table 7-1b: COlTelatiQn matrix of the variables in the UK (continued) 
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1 . In-hospital complications 
1-1. Regression models for Japan and for the UK 
In order to see which patient variables were confounding the possible effect of 
comorbidity (measured by the ICED) on the in-hospital complication rate, a logistic 
regression model was developed. Each level of the ICED was treated as a dummy 
variable, using level 1 as a reference category. Potential predictor variables identified by 
bivariate analyses were further examined by forward stepwise selection with the 
likelihood-ratio criterion of p<O.05. 
In the UK, the only variable with a significant association with serious complications was 
surgical approach and the only one associated with minor complications was the patient's 
education level. In Japan, only a past history of hip surgery was significantly related to 
overall complications. The possible impact of confounding between the ICED and 
outcome was explored for the following dependent vatiables: serious complications and 
minor complications in the UK and overall complications in Japan. 
Table 7-1c shows the estimates of the logistic model. In the UK. higher levels of the 
ICED were significant predictors of serious complications but not of minor 
complications. Odds ratios of ICED levels 3 and 4 for selious complications were similar. 
reflecting the dichotomous nature of the ICED in the UK. Surgical approach was a 
significant variable in the equation for serious complications. with similar predictive 
power to the higher levels of the ICED. Education level was a significant predictor for 
minor complications. Patients who completed their education at an age of 16 years or 
older were less likely to have a complication than those completing their education at a 
younger age. 
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In Japan, only the highest level of the ICED was a significant independent predictor of 
overall complications. The odds ratio of ICED level 4 was significantly high. suggesting 
a threshold effect at this highest level. Patient~ who had previous hip operations were 
twice as more likely as those who had not. 
Table 7-1 c: Prediction of in-hospital complications from ICED 
Variable* U nstandardised Standard Odds Ratio 
(Number of Regression Error of (95% Confidence 
cases analysed) Estimates Estimate Interval) 
UK 
Serious complication (248) 
Constant -2.11 0.39 
ICED leve12 -0.04 0.51 0.97 (0.35-2.61) 
ICED level 3 0.94 0.48 2.56 (1.00-6.56)a 
ICED level 4 1.03 0.50 2.79 (1.05-7 .46)a 
Antetior approach 0.77 0.35 2.16 (1.09-4.29)a 
Minor complication (258) 
Constant -1.42 0.36 
ICED leve12 0.30 0.45 1.34 (0.55-3.27) 
ICED level 3 0.73 0.45 2.07 (0.85-5.03) 
ICED level 4 0.56 0.48 1.75 (0.68-4.52) 
Education (~16 yrs) -1.06 0.38 0.35 (0.17-0.73)b 
----------------------------------------------------------------------
JAPAN 
Overall complication (249) 
Constant 
ICED level 2 
ICED level 3 
ICED level 4 
Previous hip surgery 
-1.46 
0.16 
0.10 
2.28 
0.73 
0.26 
0.33 
0.50 
0.88 
0.35 
1.17 (0.61-2.24) 
1.10 (0.41-2.94) 
9.81 (l.74-54.86)b 
2.08 (1.05-4. 12)a 
*: Each level of ICED was treated as a dummy vruiable. using level I as the reference; 
education level by the age of completion dichotomised <16 or ~16 years. 
a: p<0.05. b: p<O.O 1. 
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The association between the ICED and serious complications in the UK was more 
significant when it was dichotomised level 1+2 or 3+4 (Table 7-1 d). This was not so for 
minor complications in the UK. or for overall complications in Japan. 
Table 7-1 d: Prediction of seliolls co.mplication from dichotomised ICED adjusting for 
surg1cal approach (UK) 
U nstandardised 
Variable * Regression 
CN=248) Estimates 
Constant -2.13 
ICED level 3+4 1.00 
Anterior approach 0.77 
Standard 
Error of 
Estimate 
0.28 
0.33 
0.35 
Odds Ratio 
(95% Confidence 
Interval) 
2.71 (1.42-5.19)a 
2.15 (1.09-4.29)b 
*: ICED levels were dichotomised level 1 +2 or level 3+4. Level 1 +2 wa..~ used as the 
reference. 
a: p<O.005, b: p<O.05. 
The adequacies of the resulting models shown in Tables 7-lc and 7-ld were examined 
using residual analysis as a diagnostic statistic. When the normal probability of the 
deviances was examined. the disuibution was not normal in all the regression models, 
.... 
suggesting the models did not fit the data well. Figure 7-1 a (Appendix 8) shows the plots 
of deviances from the regression model for se1ious complications in the UK, in which 
each of the four levels of the ICED was treated as a dummy variable using level I as the 
reference as shown in Table 7-lc. The distribution of deviances was inte1Tupted in the 
middle and looked almost like two parallel lines (Fig 7-la). When the ICED was 
dichotomised as shown in Table 7-ld. the result was similar (Fig 7-1 b). Other models 
also showed non-normal disttibutions of deviances. 
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1-2. UK/Japan combined model 
In order to examine the influence of nationality (differences between the Japanese and 
British experiences), data from the two countries were combined to form a single 
database. ICED was entered using level 1 as the reference category. Nationality was 
included as a proxy of the known and unknown differences in patient's charactelistics 
and clinical management between the two countries. Each nationality was treated as a 
dummy variable, using Japan as the reference. Stepwise selection of other possible 
explanatory vatiables suggested that nationality could be a significant predictor only of 
minor complications (Table 7-le). Other variables such as patient characteristics (age, 
sex, marital status, living alone) and severity of hip disease (previous hip surgery. 
preoperative limp/walking support) were not significant predictors. but education level 
was. Patients who completed their education earlier were more likely to experience minor 
complications whereas those who went on to higher education were less likely to have a 
complication (sedous or minor). 
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Table 7-1e: LOl:istic rel:ression for in-hospital complication (all cases) 
U nstandardised Standard Odds Ratio 
Regression Error of (959C Confidence Variab1e* Estimates Estimate Interval) 
Serious complication (N=517) 
Constant 
-1.57 0.23 
ICED level 2 0.23 O.2~ 1.2<1 (0.73-2.18) 
ICED level 3 0.75 0.32 2.11 (1.13-3.96)a 
ICED level 4 1.03 0.37 2.XO (1.36-5. 78)a 
Nation-UK 
-0.35 0.24 0.70 (0.44-1.13) 
Minor complication (N=499) 
Constant 
-1.07 0.30 
ICED level 2 0.28 0.28 1.32 (0.76-2.28) 
ICED level 3 0.64 0.33 1.90 (1.00-3.60) 
ICED level 4 0.79 0.38 2.21 (1.05-4.63) 
Nation-UK 
-0.47 0.26 0.62 (0.38-1.03)a 
Education (~16 yrs) 
-0.69 0.25 0.50 (0.31-0.81)b 
Overall complication (N=499) 
Constant -1.19 0.21 
ICED level 2 0.13 0.25 1.14 (0.69-1.81) 
ICED level 3 0.56 0.29 1.74 (1.08-3.29) 
ICED level 4 0.80 0.36 2.24 (1.25-4.55)a 
Nation-UK 0.33 0.21 1.39 (0.77-1.87) 
Education (~19 yrs) -0.66 0.33 0.52 (0.48-1.11)a 
*: Each education level was treated as a dummy vaIiable. by completion of age (~15 
years, 16 - 18 years, ~19 years). Each nation was treated as a dummy vm;able, using the 
Japanese as the reference category. 
a: p<O.05, b: p<O.O 1 
1-3. SummaJY of regression models for in-hospital complications 
Higher levels of the ICED were significant independent predictors of serious 
complications in the UK. A dichotomous pattem was identified which was also apparent 
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when the four levels of the ICED were grouped into lower and higher levels. In contra.l\t. 
in a logistic regression model for overall complications in Japan. the highest level of the 
ICED was the only level of comorbidity with a significantly high odds ratio. In the UK. 
surgical approach was a significant independent predictor for seIious complications. and 
education level was for minor complications. In Japan. a past history of hip surgery was 
a significant variable for overall complications. Residual analyses. however. suggested 
the model did not fit the data well. 
In a combined model including all cases in Japan and the UK. higher levels of the ICED 
were significant predictors for serious complications and the highest level was significant 
for overall complications. Nationality was a significant predictor for minor complications 
- Blitish patients were less likely to suffer a minor complications. Irrespective to their 
nationality. patient's education level was a significant predictor of minor and overall 
com pI icati ons. 
2. Change in health status 
2-1. Model buildinl: based on bivariate findings 
Change in health status was almost nOimally distributed for instrumental ADL but not for 
basic ADL and social activity (Figures 7-2a to 7-2f in Appendix R). As basic ADL scores 
were almost multiples of 1 I. the data were transformed by dividing by 11 and rounding 
to integer values. After this transformation. basic ADL became near-nntmally distributed 
1 9 I 
(Figures 7-2g and 7-2h in Appendix 8). Change in social activity was grouped into four 
categories: much improved; somewhat improved: little or no change: worse. As all three 
dimensions of preoperative health status were also not normally distributed (data not 
shown), basic ADL and social activity were both grouped into four categories and 
instrumental ADL into six categories. Possible confounding variables were chosen from 
~ ~ 
those already known to be significantly associated with change in health status as 
reported in Chapter 6. and further selected by log linear test (signiticance level: p<O.(5). 
Preoperative limp and need for walking SUppOit were treated as a dummy variable. using 
the least severe level (no need for walking suppOtt / no limp) as the reference. Table 7-2a 
shows the model that best explained the variance in change in health status in Japan and 
in the UK. 
In general, less than a half of the total variance in change in health status was explained 
by these variables. Change in health status was explained more in the Japanese model 
than in the British model in all three dimensions. particularly in instrumental ADL and 
social activity. Basic ADL was best explained in both countries. In each equation. 
preoperative health status had the greatest explanatory power with little contribution 
observed from comorbidity (measured by the ICED). sociodemographic factors (sex and 
education level). and preoperative severity of hip disease (need for walking SUppOit and 
limp). 
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Table 7-2a: Percenta~e of total valiance explained in the re£ression model 
for change in health status in Japan and the UK: 
explanatory valiables chosen from bivariate analyses 
Health status 
JAPAN 
% Valiance 
Variables* explained 
Basic ADL 
ICED 
Preoperative B-ADL 
Walking suppOtt 
Total 
Instrumental ADL 
ICED 
Preoperative I-ADL 
Female/Education 
Total 
1.R 
46.1 
2.0 
49.9 
O.R 
23.7 
5.R 
30.3 
UK 
Valiables* 
ICED 
Preoperative B-ADL 
Limp 
Total 
ICED 
Preoperative I-ADL 
Limp 
Total 
o/c Variance 
explained 
1.8 
35.3 
1.9 
39.0 
1.9 
6.5 
4.3 
12.7 
---------------------------------------------------------------------
Social acti vity 
ICED 
Preoperative SA 
Total 
1.3 
19.9 
21.2 
ICED 
Preoperative SA 
Total 
1.4 
8.9 
10.3 
*: Each level of ICED was treated as a dummy vatiable. using level 1 as the reference. B-
ADL indicates basic ADL~ I-ADL. instrumental ADL~ SA. social activity. Limp indicates 
the patient's perception of preoperative limp. 
Tables 7-2b and 7-2c show the explanatory power and the significance of independent 
variables used in the equations shown in Table 7-2a. In all dimensions, preoperative 
health status was a significant predictor. Also, patient's need for walking support. sex. 
and education level in Japan and preoperative limp in the UK were significant variables 
for some dimensions of health status. The ICED was not a significant predictor for any 
dimensions. and change in all three dimensions of health status were more strongly 
dependent on the preoperative level of health status. 
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Table 7 -2b: Re~ression analysis of change in health status in Japan: 
explanatory variables chosen from bivatiate analyses 
Regression Standard 
Explanatory unstandardised error of 
va';ilQles * estimates estimate Beta t 
Basic ADL 
Constant R.64 0.55 
ICED level 2 0.10 0.25 0.02 0.40 
level 3 0.41 0.3R 0.05 l.O5 
level 4 -0.16 0.71 -0.01 -0.23 
Preoperative B-ADL -2.10 0.15 -0.73 -13.77 
Walking SUppOlt 
-Single cane -0.58 0.27 -0.12 -2.13 
-Two canes -0.21 0.47 -0.02 -0.43 
-Walker -1.49 0.77 -0.10 -1.93 
-Wheelchair 0.95 0.68 0.07 1.39 
Probability 
0.6928 
0.2932 
0.8202 
<0.0001 
0.0342 
0.6646 
0.0552 
0.1649 
----------------------------------------------------------------------
Instrumental ADL 
Constant 72.46 7.14 
ICED level 2 -3.23 3.64 -0.05 -0.89 0.3755 
level 3 -4.47 5.60 -0.05 -O.RO 0.4253 
level 4 10.56 10.61 0.06 1.00 0.3203 
Preoperative J-ADL -9.97 LOR -0.53 -9.21 <0.0001 
Female -18.14 4.49 -0.23 -4.04 0.0001 
Education (~16 yrs) 9.61 4.21 0.13 2.2H 0.0236 
----------------------------------------------------------------------
Social activity 
Constant 3.74 0.16 
ICED level 2 -0.08 0.12 -0.05 -0.69 0.4918 
level 3 0.20 0.19 0.07 1.06 0.2896 
level 4 -0.10 0.38 -0.02 -0.25 0.8020 
Preoperative SA -0.46 0.06 -0.45 -7.28 <0.0001 
*: Each level of ICED was treated as a dummy variable. using level I as the reference. 
Education level was dichotomised <16 years or ~16 years. by completion of age. B-ADL 
indicates basic ADL: I-ADL. instmmental ADL: SA. social activity. 
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Table 7-2c: Regression analysis of change in health status in the UK: 
explanatory variables chosen from bival;ate analyses 
Regression Standard 
~ 
Explanatory unstandardised elTor of 
valiilbl~s* estimates estimate Beta t Probilbility 
Basic ADL 
Constant 5.79 0.90 
ICED level 2 0.36 0.28 0.08 1.26 0.2075 
level 3 -0.31 0.30 -0.06 -1.01 0.3106 
leve14 -0.43 0.32 -O.OX -1.34 0.1827 
Preoperative B-ADL -1.55 0.18 -0.49 -8.47 <0.0001 
Limp -Slight 0.01 0.68 0.00 0.01 0.9887 
-Moderate 0.58 0.63 0.12 0.92 0.3600 
-Severe 1.16 0.63 0.27 I.X4 0.0672 
-Unable to walk 1.60 0.77 0.19 2.09 0.0375 
----------------------------------------------------------------------
Instrumental ADL 
Constant 26.66 11.02 
ICED leve12 0.99 4.59 0.02 0.22 0.8297 
level 3 -8.88 4.90 -0.14 -1.81 0.0713 
level 4 -7.88 5.22 -0.11 -1.51 0.1328 
Preoperative I-ADL -2.91 1.28 -0.16 -2.27 0.0241 
Limp -Slight 5.14 11.15 0.05 0.46 0.6450 
-Moderate 12.00 9.99 0.19 1.20 0.2309 
-Severe 22.94 9.81 0.40 2.34 0.0202 
-Unable to walk 27.19 11.88 0.24 2.29 0.0230 
----------------------------------------------------------------------
Social activity 
Constant 3.48 0.16 
ICED level 2 0.12 0.14 0.07 0.84 0.4026 
level 3 -0.10 0.15 -0.05 -0.64 0.5253 
level 4 -0.32 0.17 -0.15 -1.95 0.0531 
Preoperative SA -0.27 0.06 -0.30 -4.66 <0.0001 
*: B-ADL indicates basic ADL: I-ADL, instrumental ADL; SA. social activity. Limp 
indicates the patient's perception of preoperative limp. Each level of ICED was treated as 
a dummy variable. using level I as the reference. 
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The regression models based on the findings from bivariate analyses (shown in Table 7-
2a) were examined by residual analyses to check for violations of assumptions. 
Figures 7-2i and 7-2j (Appendix 8) show the plot of studentised residuals against the 
predicted values for the change in instrumental ADL and social activity in Japan. The 
residuals were almost randomly distributed in instrumental ADL. but they were 
aggregated in social activity. In the UK, the distribution of residuals were similar to Japan 
in all three dimensions of health status and Figures 7-2k and 7-21 (Appendix 8) show the 
plots for insuumental ADL and social activity. The plot for the change in basic ADL was 
similar to that for social activity in both countries (data not shown). 
As the assumption of homogeneity of variance was thought not to be met for change in 
social activity, the observed distribution of residuals was compared to that expected under 
the assumption of normality. When the two cumulative distributions were plotted against 
each other for a series of points, the plot for insuumental ADL was almost linear (Fig 7-
2m in Appendix 8) whereas for social activity in Japan was non linear (Fig 7-2n in 
Appendix 8). The results were similar for the UK data (Figures 7-20 and 7-2p in 
Appendix 8). 
2-2. Equation based on fixed combination of variables 
Relevant variables were selected from the literature review to form a fixed combination of 
explanatory variables to see how much of the total variance in Japan and the UK were 
explained (Table 7-2d). In addition to comorbidity (measured by the ICED) and 
preoperative health status, variables used in the equation were patient's 
sociodemographics (age, sex, marital status, living alone, education level) and 
preoperative sevel;ty of hip disease (previous hip surgery, limp and need for walking 
support). Change in basic ADL and social activity and preoperative health status in all 
three dimensions were transformed as described in the preceding section. 
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Similar to the results derived from models based on bivariate analyses ba..'\ed-models 
shown in Table 7-2a. change in health status was explained better in Japan than it was in 
the UK in all three dimensions. In both countries change in basic ADL was best 
explained. Inclusion of preoperative health status explained most of the variance in all 
dimensions. The increase in explanatory power for instrumental ADL and social activity 
was almost doubled in Japan compared with the UK. Comorbidity. sociodemographics 
and sevetity of hip disease contributed little to explaining the variance in change in health 
status. 
On the whole, the explanatory power of the models based on a fixed combination of 
variables was similar to or only slightly better than the regression models based on 
bivariate analyses. despite using a greater valiety of possible explanatory vatiables. 
Table 7-2d: Variance in change in health status explained by fixed equation 
JAPAN Variance explained. % 
Basic Instrumental Social 
Variable* ADL ADL activity 
Comorbidity by ICED 1.8 0.8 1.3 
Preoperative health status 46.1 23.7 19.9 
Sociodemographic 4.1 9.3 6.9 
Severity of hip disease l.1 0.7 1.1 
Total 53.1 34.5 29.2 
------------------------------------------------- - - - ------ --
UK Variance explained. % 
Basic Instrumental Social 
Vatiable* ADL ADL activity 
Comorbidity by ICED 1.8 1.9 1.4 
Preoperative health status 35.3 6.5 8.9 
Sociodemographic 0.7 1.7 2.0 
SeveJity of hip disease 2.7 4.5 2.7 
Total 40.5 14.6 15.0 
*: Patient sociodemographic characteristics were: age (dichotomised to below 67 years 
and 67 and above). sex. marital status. living alone, education. Severity of hip disease 
was measured by previous hip surgery. preoperative limp and need for walking support. 
Each level of ICED was treated as a dummy variable. using level 1 U,I\ the reference. 
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2-3. Exchan£in£ models between Japan and the UK 
In order to see which complication was most influenced by differences between the 
Japanese and British experiences. data from the two countries were combined to form a 
single database. Nationality was included as a proxy of the known and unknown 
differences in patient's charactetistics and clinical management between the two countries. 
using the Japanese as the reference. Significant predictive variables were selected by 
stepwise selection to enter into a regression model based on the primary equation 
containing the ICED and preoperative health status. 
Similar to the national models shown in Table 7-2a. preoperative health status was 
significant in all three dimensions of health status (Table 7 -2e). Also sociodemographics 
and severity of hip disease were significantly associated with change in all three 
dimensions of health status. The ICED was not a significant predictor in any dimensions. 
Nationality was found to be weakly associated with basic ADL but not significant. The 
amount of total variance explained was 44.6% for basic ADL. 20. I Ck for instrumental 
ADL, and 20.1% for social activity. 
Table 7-2f;.: Regression model for change in ht'alth status in all cases 
Regression Standard 
unstandardised error of 
Variables* estimates estimate Beta Probability 
Basic ADL 
Constant 6.6R 0.67 
ICED level 2 0.21 O. I 9 0.04 I. 11 0.2652 
level 3 -0.21 0.23 -0.03 -0.90 0.3715 
level 4 -0.36 0.28 -0.05 -1.29 0.1972 
Preoperative B-ADL -1.77 0.11 -0.59 -15.43 <0.0001 
Nationality-UK -0.34 0.17 -0.07 -1.92 0.0553 
Slight limp 0.36 0.53 0.06 0.67 0.5037 
Moderate limp 1.19 0.52 0.25 2.28 0.0232 
Severe limp 0.65 0.52 0.14 1.25 0.2117 
Unable to walk 1.37 0.59 0.16 2.31 0.0211 
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Regression Standard 
unstandardised error of 
stimates estimate Beta t Probahilit ' 
Instrumental A DL 
Constant 47.84 9.72 
ICED level 2 
-1.05 2.89 
-0.02 
-0.36 0.7159 level 3 
-6.60 3.64 
-0.09 
-1.81 0.0705 level 4 
-5.24 4.45 
-0.06 
-1.18 0.1391 
Preoperative T-ADL 
-6.89 0.95 
-0.37 
-7.26 <0.0001 
Nationality-UK 
-0.76 2.79 
-0.01 
-0.27 0.7861 
Female 
-8.98 2.83 
-0.14 
-3.17 0.0016 
Single cane/crutch 
-4.63 2.99 
-0.08 
-1.55 0.1216 Two canes/crutches 
-4.66 4.57 
-0.05 
-1.02 0.3090 Walker 
-14.49 7.79 -0.08 
-1.86 0.0636 Wheelchair 
-15.45 6.l8 -0.13 -2.50 0.0127 
Slight limp 10.07 8.23 0.13 1.22 0.2220 
Moderate limp 16.25 7.93 0.27 2.05 0.0410 
Severe limp 23.74 8.00 0.39 2.97 0.0032 
Unable to walk 29.84 9.28 0.27 3.22 0.0014 
------------------------------------------------------------
Social activity 
Constant 3.00 0.29 
ICED level 2 0.01 0.09 0.01 0.13 0.8957 
level 3 -0.03 0.12 -0.01 -0.22 0.8282 
level 4 -0.27 0.14 -0.09 -1.X7 0.0622 
Preoperative SA -0.34 0.04 -0.37 -7.65 <0.0001 
Nationality-UK 0.05 0.09 0.03 -0.51 0.6135 
Single cane/crutch -0.01 0.10 -0.01 -0.10 0.9174 
Two canes/crutches -0.10 0.14 -0.04 -0.69 0.4883 
Walker -0.16 0.28 -0.03 -0.58 0.5597 
Wheelchair -0.49 0.19 -0.14 -2.63 0.0087 
Slight limp 0.28 0.27 0.11 1.02 0.3087 
Moderate limp 0.64 0.26 0.35 2.44 0.0153 
Severe limp 0.74 0.27 0.40 2.78 0.0057 
Unable to walk 0.82 9.30 0.24 2.68 0.0076 
* B-ADL indicates ba."ic ADL: I-ADL. instrumental ADL: SA. social activity. 
Patient's nationality was treated as a dummy variable. using the Japanese a.~ the reference 
category. Each level of ICED was treated as a dummy. lIsing level 1 as the reference. 
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2-4. Summary of re!;ressi011 models for chan!;e in health status 
Variance in change in health status was mostly explained by preoperative health status. 
and little by the TCED and other patient variables. Among three dimensions of health 
status, basic ADL was best explained in both countries. Although the proportion of total 
variance explained was greater in Japan than in the UK. the TCED was not a significant 
'-' 
predictor of any dimensions of health status in both countries. The degree of variance 
'-
explained with selected variables was similar to that when all possible patient variables 
were included in the regression model. 
The regression model for combined British and Japanese cases also confirmed the 
findings from each national mode1. in that preoperative health status was the most 
significant predictor of change in health status. Difference in nationality was not 
significant in prediction of change in any dimensions of health status. 
3. Attempts to improve prediction for serious in-hospital complications 
3-1. Chan~e in clitelia of complications 
In previous chapters the inclusion critel;a for selious in-hospital complications have been 
challenged. In particular the inclusion of dislocation as a minor complication and 
neuropathy as a selious complication are questionable. Therefore. an attempt was made to 
change the definition of serious complications by excluding neuropathy and including 
dislocation. Table 7-3a shows the relationship between the ICED and the newly defined 
serious complications. 
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Table 7-3a: Num.b_er and percent {~f patients with a serious in-hospital complication 
c1~l\slhed by the rCED In Japan and the UK: comparison of oIioinal and new 
cnteria (NS: not significant at p<O.05) :. 
CriteIia of 
senous 
complication* 
Original 
Levels 
of 
the ICED 
1 
2 
3 
4 
Chi square for trend (df= 1) 
Probability 
New 1 
2 
3 
4 
Number (%) of patient.~ with complication 
JAPAN UK 
N-249 N 26R 
7 (6.7) 
2 (1.9) 
o (0.0) 
2 (2R.6) 
0.941 
NS 
1 (1.0) 
2 (1.9) 
o (0.0) 
2 (28.6) 
10 (1-+.3) 
II (13.4) 
17 (27.0) 
14 (26.4) 
-+. U';5 
<0.05 
7 (l0.0) 
11 (13.4) 
16 (25.4) 
14 (26.4) 
------------------------------------------------------ -----------
Chi square for trend (df=l) 
Probability 
13.467 
<0.001 
6.601 
<0.05 
* New cIiteIia of selious complication excludes neuropathy and includes dislocation. 
The change in clitelia reduced the number of patients with a selious complication from 11 
to 5 in Japan. and from 52 to 48 in the UK. As a result, the complication rate became 
significantly associated with the ICED in Japan. and the level of significance in the UK 
slightly increased. No other vatiables were found to be significantly associated with this 
newly defined outcome. These included sociodemographic (age. sex. maIital status, 
living alone, education). severity of hip disease (previous hip surgery. preoperative limp 
and need for walking SUPPOlt), and clinical management variables (surgical approach, 
hyblid THR. hospital. teaching status). 
Figure 7-3a illustrates the relationship of the original and newly defined serious 
complication rate with the ICED. The previously observed threshold effect in Japan was 
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enhanced by the reduction in complication rate in ICED level 1. In the UK. the 
dichotomous pattel11 was modified into more of an S-shaped CUlve. 
Figure 7-3a: Set;ous in-hospital complication rate in Japan :lnd the UK: 
detined by OI;ginal / new clitelia 
Complication 
Rate (%) 
JAPAN 
1 2 
Complication 
rate (%) 
30 JAPAN 
20 
10 
1 2 
3 
3 
Orif!inal Clitelia 
.... 
UK 
4 1 2 3 4 
ICED Level 
Newly defined ctitel1a 
UK 
4 1 2 
ICED Level 
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In order to see how such change in critelia of outcome might effect the predictive power 
of the ICED, a logistic model was developed. Although surgical approach had been found 
to be a significant independent predictor with the ICED (Chapter 7). no variables were 
found to be significantly associated with the newly defined outcome. 
Table 7-3b shows the results both for the original and the new criteria of serious 
.... 
complications. Higher levels of ICED were significant independent variables with 
increasing odds ratios. however. surgical approach became insignificant. This change in 
significance of surgical approach was also observed in the regression model for the new 
criteria of serious complications. in which the ICED was dichotomised to levels 112 or 
3/4. 
Table 7-3b: Prediction of selious complications of different critetia 
examined in lo£istic model with the four levels or dichotomised ICED (UK) 
Cliteria of 
serIOUS U nstandardised Standard Odds Ratio 
complication * Regression Error of (95CK Contidence 
(N 248) Estimates Estimate Intel-val) 
Original 
Constant -2.11 0.39 
ICED level 2 -0.04 0.51 0.97 (0.35-2.61) 
ICED level 3 0.94 0.48 2.50 (1.00-6.56)a 
ICED level 4 1.03 0.50 2.79 (1.05-7.46)a 
Antelior approach n.77 0.35 2.16 (1.09-4.29)a 
New 
Constant -2.36 0.44 
ICED level 2 0.31 0.55 1.37 (0.47-4.01) 
ICED level 3 1.20 0.52 3.31 (1.19-9.21)3 
ICED level 4 1.35 0.54 3.X7 (1.35-11.00)3 
Antelior approach 0.50 0.37 1.05 (O.XO-3.3X) 
-----
-----------------------------------------------------------------
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CIitelia of 
senous 
complication* 
(N=24R) 
Original 
Constant 
ICED level 3+4 
AnteIior approach 
New 
Constant 
ICED level 3+4 
Antelior approach 
U nstan dard ised 
Regression 
Estimates 
-2.13 
1.00 
0.77 
-2.18 
1.08 
O.SO 
Standard 
Error of 
Estimate 
0.2R 
0.33 
0.3S 
0.28 
0.34 
0.37 
Odds Ratio 
(9S% Confidence 
1 nterval) 
2.71 (1.42-S.l9)b 
2. IS (1.09-4.29)a 
2.96 (1.S1-S.79)b 
2.6S (O.R 1-3.39) 
*: New criteria of serious complication excludes neuropathy and includes dislocation. 
ICED levels were dichotomised level 1 +2 or level 3+4. Level 1 +2 was used as the 
reference. 
a: p<O.OS, b: p<O.OOS. 
3-2. Change in the structure of the TCED 
In Chapter 6 the lack of an association between the functional seveJity index of the ICED 
and in-hospital complications. both serious and minor. was demonstrated. Thus attempts 
to alter the ICED to improve its predictive power focused on the other subindex. that of 
co-existent disease (lOS). 
Although the ICED takes the severity of each co-existent disease into account, the final 
severity score is the peak intensity of two or more diseases that a patient might have. 
Thus analyses of trend between complication rate and the severity level for each co-
existent disease would not directly relate to the association of the final ICED score and 
complication rate. Also as co-existent disease scores were derived from the patients' case 
notes at the time of abstracting data. it was impossible to reclassify the level of severity of 
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co-existent disease. Attempts were therefore made to identify which co-existent diseases 
were most predictive of serious complications, irrespective of their severity. These co-
existent diseases could then be used to fonn a new index. taking the peak intensity score 
among them. This new index was examined in relation to the serious complication rate. 
using both the original and the new cliteIia desclibed above. 
The prevalence of co-existent diseases was shown previously (Table 5-3b). Tables 7-Jc 
and 7-3d show the relationship between serious complications and each of the 13 co-
existent diseases. 
Table 7-3c: Prevalence of co-existent disease in patient'\ suffering a serious complication 
(original cliteria) in Japan 
Number {%} of patients 
with without 
Co-existent complication complication Probability 
Disease N-ll N-23X ( Chi sQuare) 
Organic heatt disease I ( 9.1) 2 ( n.X) 0.2989 
Ischem ic heatt disease o ( - ) 16 ( 6.7) 0.7948 
An'hythm ia 3 (27.3) 64 (26.9) 0.7491 
Congestive heatt disease o ( - ) 2 ( 0.8) 0.1550 
Hypertension 1 ( 9.1) 66 (27.7) 0.3100 
Cerebrovascular disease o ( - ) 5 ( 2.1) 0.5394 
Petipheral vasculat· disease o ( - ) 1 ( 0.4) 0.0262* 
Diabetes mellitus o ( - ) 18 ( 7.6) 0.7252 
Respiratory disease O( - ) 10 ( 4.2) 0.9271 
Malignancy 1 ( 9.1) 7 ( 2.9) 0.7977 
HepatobiliaI'Y disease o ( - ) 3 ( 1.3) 0.2989 
Renal disease 2 (18.2) 8 ( 3.4) 0.0965 
Gastrointestinal disea.'\e 1 ( 9.1) 5 ( 2.1) 0.6366 
* 95% confidence interval was O.O%-32.2Cj( with complication and (),()%-2.7lk without 
complication. 
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Table 7-3d: Prevalence of co-ex i,,~e~t dise.ase. in patient" suffelin£ a seriolls complication 
(orJ£lnal clltella) In the UK 
Number {%) of patients 
with without 
Co-existent complication complication Probability 
Dis~ase N-52 N 21 () (Chi sQuare) 
Organic heatt disease 5 ( 9.6) 10 ( 4.6) 0.1603 
Ischemic heatt disease 5 ( 9.6) 29 (13.4) 0.4586 
At"h ythm ia 19 (36.5) 48 (22.2) 0.0323 
Congestive herut disease 13 (25.0) 25 (11.6) 0.0127 
H ypertensi on 19 (36.5) 82 (38.0) 0.8491 
Cerebrovascular disease 1 ( 1.9) 6 ( 2.8) 0.8908 
Peripheral vascular disease 7 (13.5) 26 (12.0) 0.7790 
Diabetes mellitus 2 ( 3.8) 7 ( 3.2) 0.8328 
Respiratory disease 1 ( 1.9) 17 ( 7.9) 0.2188 
Malignancy O( - ) 6 ( 2.8) 0.4880 
Hepatobiliru-y disease 4 ( 7.7) 3 ( 1.4) 0.0380 
Renal disease 6 (11.5) 17(7.9) 0.3966 
Gastrointestinal disease 8 (15.4) 26 (12.0) 0.5150 
----------------------------------------------------------------------
AtThythmia 
Congestive heatt disease 
Hepatobiliary disease 
95% confidence interval of propOition 
with complication without complication 
36.5 (24.0 - 51.0) 22.2 (17.0 - 28.5) 
25.0 (14.5 - 39.2) 11.6 ( 7.8 - 16.8) 
7.7 ( 2.5 - 19.4) 1.4 ( 0.4 - 4.3) 
Statistical1y significant associations were observed with peripheral vascular disease in 
Japan (based on only one case). and arrhythmia. congestive heart failure. and 
hepatobiliary disease in the UK. Because only one patient suffered from peripheral 
vascular disease in Japan. flllther analyses were limited to the UK Jata. 
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Using three significantly associated diseases, a final severity score was derived from the 
peak intensity among them, as described in the original method to define the ICED level 
(Chapter 2). As only one patient was classified at the new index level 3. it was combined 
with the data at level 2 so that the new index had three levels (0 to 2). 
The relationships between serious complications in the UK (Oliginal critelia) and on the 
one hand the TCED. and the other hand the new index of co-existent disease are shown in 
Table 7-3e and Fig 7-3b. This new index was found to be more significantly associated 
with serious complications. Introduction of the new index also changed the dichotomous 
pattern previously observed with the ICED into an almost linear relationship. A similar 
association was observed when the new index was applied to serious complications 
defined using the new critetia desclibed above (data not shown). 
Table 7-3e: Number and percent of patients with serious in-hospital complicarillll." 
for the ICED and new index (UK) 
Levels Number Number (%) of Chi square 
of of patient with for 
Index index patient complication tr~nd Probabilit): 
ICED 1 70 10 (14.3) 4.2 <0.05 
2 82 11 (13.4 ) 
3 63 17 (27.0) 
4 53 14 (26.4) 
New index 0 171 22 (12.9) 12.8 <0.001 
1 43 11 (25.6) 
2 54 19 (35.2) 
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5& 7-3b: Relationship of serious coplication and comorbidity index NKl 
Complication 
rate (%) 
40 40 
30 30 
20 20 
10 10 
O--~----'-----~--__ ~--~------r-________ ~ o 
1 2 3 4 o 1 2 
ICED Level New Index Level 
3-3 Predictive power of the new models 
Fmally. the prediction of serious complications was examined using the new index of 
comorbidity • taking level 0 as the reference (Table 7-30. The highest level of the new 
index was a significant independent predictor of serious complication." using the original 
criteria. Surgical approach became insignificant using the new index to predict serious 
complications using the new criteria. Using the new criteria of seriOu." complications, 
both levels of the new index were significant predictors. As regards outcome prediction. 
however, only S complications out of the 49 that occurred were predicted using the 
original cri~ and none using the new criteria. 
As a result, the prediction of serious complications seemed best when they were defined 
using the original criteria and the new co-exislent di~~ index was employed. However, 
the improved prediction demon..wated in this study i" of uncertain validity unless it can be 
teproduced in other independently colleaed data. 
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Table 7-3f: ~redi~tion ?f ~elious co~plicati()ns of different cliteria 
exammed m logIstIc model wIth the new index (UK) 
Criteria of 
senous 
complication * 
(N=24fO 
Original 
Constant 
New index level 1 
New index level 2 
Antelior approach 
New 
Constant 
New index level 1 
New index level 2 
Antelior approach 
Unstandardised 
Regression 
Estimates 
-2.21 
0.83 
1.49 
0.90 
-2.29 
l.17 
1.54 
0.61 
Standard 
Enor of 
Estimate 
0.28 
0.45 
0.39 
0.36 
0.29 
0.44 
0.39 
0.38 
Odds Ratio 
(95<K Confidence 
Interval) 
2.29 (0.95-5.49) 
4.43 (2.08-9.43)3 
2.47 (1.21-5.04)b 
3.21 (1.34-7 .67)C 
4.67 (2.16-10.10)a 
I.X3 (0.87-3.85) 
*: New c11te11a of se110us complication excludes neuropathy and includes dislocation. 
a: p<0.0005, b: p<0.05, c: p<O.Ol. 
3-4. Discussion of the predictive power of the regression models 
3-4a. Prediction of seJious complications in Japan 
On the whole. the number of serious in-hospital complications (11) was too small to 
correlate with comorbidity. Apart from the complications obselved in patients in ICED 
level 4, complications were as likely to arise by chance or at least without significant 
relevance to the level of comorbidity. Indeed. the majority of the complications were 
neuropathy and not related to a patient's physiological conditions. As a consequence. 
almost all complications defined using the new criteria were limited to patients with the 
highest ICED level. which therefore enhanced the threshold effect of the ICED. 
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3-4b. Prediction of sel;ous complications in the UK 
Prediction of sel;ous complications was limited in all attempts in the UK because of the 
high complication rate observed in the lowest level of the ICED. In this study the 
significance of the relationship between the ICED and complications was examined in two 
ways; Chi square for trend and logistic regression analysis. Both analyses were based on 
the relative risk of complications at each level of comorbidity in comparison to the 
baseline level, ICED level 1. Although the statistical analyses suggested a significant 
association, the increase was marginal and not large enough for successful prediction. 
Similar difficulty was also observed in the relationship with change in health status. 
Although a significant trend was observed in the UK in which the higher levels of the 
... 
ICED were associated with less improvement in health status. the change in health status 
measured at the ICED level I was often less than that at the level 2. suggesting poor 
classification of comorbidity at lower levels. 
Such a lack of relationship between the ICED and outcomes in the UK may have arisen 
for two reasons: (1) inability of the ICED to reflect accurately a patient's comorbidity 
level, and (2) inadequacies in the preoperative observation of a patient's condition. 
Inability of the ICED can be seen in the large regression estimate by the constant in the 
regression model. For example. mean patients' age in the UK was older than in Japan 
and the USA, suggesting British patients had fewer physiological resources to assist 
recovery from the operation. Although patient's chronological age was not statistically 
significantly associated with the serious complication rate, there may be unknown 
variables that would explain the difference among patients classified in the same severity 
level. 
As regards the second possibility. there are considerable differences the way clinicians 
practice between the three cOllntlies. In the UK, a patient's preoperative length of stay is 
much shorter than in Japan and the number of laboratory examination pert'OImed is much 
less than in the USA. As regards continuity of care. in theory it should be assured by 
2JO 
good communication with the patient's GP through exchange of information. However. 
when compared with Japanese patients who are looked after by the same doctor 
throughout the episode of care and have plenty of opp0l1unities to uiscuss the results of 
the preoperative examination, it might be difficult to reach a better unuerstanding of a 
.. 
patient's preoperative status in the British system. Consequently some of the patient's 
information could be lost and, as a result, patientl\ may be more likely to be classifieu to a 
lower level of the ICED. 
4. Summary 
# In-hospital complications: Higher levels of the ICED were significant predictors for 
selious complications in the UK and overall complications in Japan. For all cases in 
Japan and the UK. comorbidity was a significant explanatory variable for selious and 
overall complications. 
# Change in health status: The rCED was not a significant predictor in Japan and the 
UK. For all cases in both countries. the ICED was not a significant predictor for 
change in health status. Nationality was not a significant predictor for change in any 
dimensions of health status. 
# Attempts to improve prediction: Prediction of serious in-hospital complications was 
improved by changes in the complication criteria, and by a new comorbidity index 
based on fewer number of more predictable co-existent diseases. A high complication 
rate at the lowest level of the ICED limited fUl1her improvement. 
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· Chapter 8: Conclusions 
To conclude this study, the seven original objectives are reviewed. For each objective. the 
methodological limitations are described and their possible impact disclissed. Finally the 
implications of the results both for clinical practice and future research are considered. 
*******************************************************~:************** 
1 . To compare preoperative health and clinical management of patients 
in Japan and in the UK, and between hospitals within the UK 
1-1, Findim~s from this study 
As regards patients' sociodemographics, Japanese patients were younger and more likely 
to be female. married, living with others. finished education at an older age and not 
smoke. than Blitish patients, Hip disease was more severe in Blitish patients in terms of a 
history of previous hip surgery and perception of limp. but not as striking a difference in 
terms of the need for a walking suppOl1. The mix of diagnoses of hip disease were 
similar. 
Japanese patients were more likely to be classified to lower levels of severity of 
comorbidity than British patients. At1'hythmia and hypertension were common in both 
countties; organic and ischemic healt disease. congestive hemt failure. peripheral vascular 
disease, renal disease, and gastrointestinal disease were commoner in the UK; and 
diabetes mellitus was commoner in Japan. 
Japanese patients had significantly better health status as regards instrumental ADL but 
worse for mental health status. Health status was associated with patient's age and 
severity of hip disease in Japan. and with patient's sex. living alone and home ownership 
2 I 3 
in the UK. No association was observed between health status and comorbidity (the 
ICED). 
In terms of clinical management, general anaesthesia was commoner, the duration of 
surgery was less, and the anterior/anterolateral approach and blood transfusion were less 
frequently used in the UK than in Japan. Cement was used more often in the UK and in 
older patients. 
Significant differences were found between the six British hospitals as regards patient's 
age, educational level, home ownership, primary diagnosis, past history of hip surgery, 
and comorbidity. There was no statistically significant difference in severity of hip 
disease. Patients in teaching hospitals only differed significantly from non-teaching in that 
they were more likely to have received higher education and undergone previous hip 
surgery. Use of general anaesthesia, surgical approach, transfusion and cement differed 
among the six hospitals, but not between teaching and non-teaching hospitals. The mean 
length of stay differed between the six UK hospitals, and was shorter in teaching 
hospitals. 
1-2. MethodoloKicallimitations 
Difference in routine data collection in hospitals between Japan and the UK meant that 
some patient's characteristics were not available for comparison such as body height and 
weight, ASA PS, and surgical approach. Even if data were available, its accuracy was 
sometimes uncertain such as drinking and smoking habits and preoperative clinical 
assessment of disease severity. In Japan, interhospital comparisons were impossible due 
to the small surgical volume in most hospitals. 
The patient questionnaires used in the two countries were identical except for the 
questions on mental health (the Japanese version asked fewer questions). Due to 
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differences in the financing of the health care systems. it was meaningless to compare 
lengths of stay and readmission rate between the two countries. 
1-3. Discussion 
Japanese patient" were clearly healthier than British patients not only as regards the 
severity of their primary condition (hip disease) but also they suffered fewer co-existent 
diseases. This may pattly reflect their being younger. This difference may be exaggerated 
by the longer life expectancy in Japan which might result in their age-specific health status 
being better (i.e., a 60 year old Japanese person being healthier than a Bliton of the same 
age). 
A second noteworthy difference between the two countries was the greater propensity for 
Japanese patient~ to use walking SUppOlts. For a given level of immobility (measured by 
the patient's own perception of limping) Japanese patients were more likely to use aids. 
Why might this be so given that Japanese patients were generally healthier than British 
patients? It could be because Japanese patients need to CatTY on everyday matters for 
themselves and have less access to motOtised transport. However. these are inconsistent 
with the finding that Japanese patients are more likely to be living with others. An 
alternative explanation is that Japanese patient'> are more cautious about their health and 
welfare and more risk averse. 
Another stIiking difference between the two countries was the tendency for Japanese 
patients to repOIt worse mental health than the Btitish. This may reflect the greater impact 
immobility has on their life-style leading to a higher likelihood of becoming depressed. 
Japanese patient" may be less able and willing to complain of their disabilities and may 
delay seeking medical help. The likelihood that the etiology of their hip arthritis was 
congenital dislocation means they may have been suffeling since childhood which might 
have hatmed their mental health more than British patient~ who develop althlitis in middle 
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and old age. Alternatively, the British patients response to their condition may retlect a 
general stoicism to ill-health and lower expectations. 
Turning to clinical management, there is evidence of a more cautious approach in Japan 
which may again reflect a cultural difference in which the Japanese are more risk averse 
than Btitish patients and surgeons. 
Finally the significant differences between British hospitals in their case-mix has 
implications for inter-hospital comparative audit and for commissioning. Unless such 
differences are taken into account, both activities may be based on doubtful compatisons. 
2. To describe the outcome of THR one year after surgery 
2-1. Findings from this study 
The known one yeat' mortality was 0.3% in Japan and 1.1 Ck in the UK. but both may be 
underestimated as some eligible patients were never traced. In total. about 25% of 
Japanese patients and 40% of British patients had some complication dllling their stay in 
hospital. In both countries serious in-hospital complications were less frequently 
observed than minor ones. Hypotension and neuropathy were the commonest selious 
complications. and wound infection was the most frequent among the minor 
complications. 
In both countries there was a significant improvement in patient's health status after 
surgery. Such changes were observed not only in physical health but also in mental 
health. The severity of hip disease was significantly relieved in terms of patient's 
postoperative mobility. The severity of limping perceived by patients and their need for 
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walking support were both significantly decreased. Patient" reported their health had 
improved beyond their expectation and were happy to have had the operation. They were 
highly satisfied with the care they received during their stay in hospital though patient" 
who suffered a postoperative dislocation were less satisfied. 
2-2. Methodological1imitations 
Data collection on post-discharge mortality was not always possible in Japan because of 
the lack of continuity in data collection. Even in the UK where patient's data were 
organised continuously, the amount of infOimation available from hospital computers and 
GPs was limited. Despite strenuous effOlts, it was not possible to trace some cases. The 
I 
small size of the two cohorts makes accurate assessment of postoperative mortality 
unreliable. 
Although, in theory, clinical data were measured and recorded in a similar way in both 
countries. there was valiation in the way the diagnosis of in-hospital complications were 
confitmed. Also. interhospital differences were observed in both countries in the way 
medical infOimation was routinely recorded and categorised in the case notes. 
The measurement of complication rates was obviously dependent on the definitions of 
serious and minor events. The inclusion of neuropathy as well as the exclusion of 
dislocation from selious complications could be challenged clinically. 
Recruitment for the questionnaire study was successful in both countries with a high 
response rate and high degree of data completion. As has been noted, difficulty in 
implementing the same questions on mental health status impeded compaJisons between 
Japan and the UK. 
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2-3. Discussion 
Overall, THR is a highly successful operation for most patients. Improvement'\ in 
disability were reflected in improvements in their quality of life and their level of 
satisfaction. This is partly because this study limited eligibility to primary THR patient,\. 
and excluded revision surgery and patients presenting with a femoral neck fracture who 
are more likely to experience an in-hospital complication or have a poorer postoperative 
recovery. Also the short follow-up period of one year provides only a limited account of 
the outcome of THR. A longer observation period might show some differences not 
found in this study. 
A doctor's choice of diagnostic methods might add another complexity to the 
measurement of outcomes as well as comorbidity. The lack of universally agreed 
definitions of complications (palticularly minor ones) makes the measurement of rates 
difficult and makes comparisons difficult to interpret. More precise instruction on the 
identification of complications is necessary when using the ICED to adjust for such 
outcomes. 
3. To compare the outcome of THR in Japan and the UK 
3-1, Findin~s from this study 
As regards in-hospital complications. statistically significant differences were observed in 
their incidence between the two countries. The serious complication rate was higher in the 
UK than in Japan. whereas it was similar for minor complications. A variety of serious 
complications were observed in the UK. with a particularly high incidence of 
hypotension. In Japan. neuropathy was the most common serious complication. In 
contrast. similar types of minor complications were observed in both countries. 
2 I 8 
Dislocation and gastrointestinal symptoms were commoner in Japan whereas in the UK 
they were most often suspected deep vein thrombosis and bed sores. 
As regards change in mobility/symptoms, British patients, who were more severely 
affected before surgery, reported significantly more persistent disability one year after. 
While surgery had little impact on patient's use of walking supports in Japan. 
significantly fewer Blitish patients required such aids after surgery. 
Change in health status showed a striking similarity between Japan and the UK. 
Particularly for mental health status Japanese patients reported more change than British. 
The readmission rate was higher in the UK than in Japan. Significantly lower 
readmission rates were found in patients with previous hip surgery, hybrid THR and 
general anaesthesia in the UK. 
In terms of global measures, Japanese patients were more likely to desclibe their health as 
better and better than they had expected. On the other hand, British patients were more 
likely to report the operation had made them feel better and to state that they were very 
happy about having had the operation. Blitish patients were more likely to be satisfied 
with their care if they underwent general anaesthesia and were treated in a teaching 
hospital. No significant associations were found in Japan. 
3-2. Methodolo~icallimitations 
There were some difficulties experienced in collecting comparable data because of 
differences in definitions and measurement. For example. current case notes in both 
countries were useful sources of data on such aspects as preoperative examination. 
clinical management and in-hospital complications. However. some differences \vere 
observed in routine data recording between Japan and the UK. For example. recording of 
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data on ASA PS, amount of blood lost. and information on the surgical approach differed 
between the two countries. 
As regards comparison of outcomes in generaL considerable differences in the length of 
the observation period (length of stay) was a major methodological limitation for making 
... 
meaningful international comparisons. Length of stay in Japanese hospitals was almost 
four times as long as in British hospitals. 
3-3. Discussion 
Some of the observed differences in practice might have arisen from differences in the 
financial system of health services between the two countlies. In Japan there are tinancial 
incentives to intervene whereas in the UK there were disincentives. Several differences 
would not, however. be effected by such differences in health service organisation. 
First, the higher frequency of neuropathy in Japan and of hypotension in the UK. As was 
shown in a previous Chapter, none of the patient variables collected in this study were 
significantly associated with these serious complications. One possible explanation of 
neuropathy might be a difference in surgical skill. The significant difference in 
interhospital hypotension rates in the UK suggested the effect of postoperative clinical 
management was likely to be the cause. Although it was not possible to identify which 
aspect of patient care were responsible for such interhospital differences in outcome. a 
striking difference in hypotension rate between Japan and the UK suggested quality of 
postoperative care might be a possible reason. 
Secondly, BIitish patients were more likely to be readmitted if they had had no previous 
hip surgery. did not undergo a hybrid THR, and had their surgery under regional 
anaesthesia. The reason for the association with a lack of previous hip surgery is unclear. 
It may be that other patients who had previously experienced hip surgery were more 
careful dUling the convalescent peliod or had lower expectations and made less demand to 
be readmitted. The use of hybrid THR appeared to retlect clinical judgment rather than 
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any objective patient characteristic. As such, it is possible that these clinicians who 
favoured hybrid THR were also less likely to readm it patients. Patients selected for 
regional anaesthesia were those at higher risk who are also more likely to suffer a 
complication. The finding suggests however the patient's severity of disease outwei1!hed 
.... 
such differential anaesthetic effort to control their physiological status and to prevent 
higher readmission rate. 
The third issue concems the persistent postoperative disability observed in Blitish patients 
in terms of their perception of limp. As an actual difference in leg length and decreased 
muscle strength due to long term hip arthritis are the major reasons of limp, less 
improvement in British patients than in the Japanese suggests their hip arthritis had been 
more severe and suffered over a longer peliod. 
Fourth, surgery had less impact on the need for walking SUppOlt in Japan than in the UK. 
This may reflect greater caution on the PaIt of Japanese patients. Their housing could also 
be a reason, as the use of walkers and wheelchairs in Japan is not easy. even though their 
use may have been recommended by their surgeons. 
The fifth issue centered on the greater improvement in mental health status in Japan than 
in the UK. though their postoperative score was still significantly worse than that of the 
British. Even when the analyses of British answers were limited to the same three 
questions as those asked to the Japanese. the change in mental health was less in British 
patients. This partly reflects the very poor mental health before surgery of Japanese 
patientl\ which allowed for the possibility of greater improvement following surgery. 
Finally, the Japanese had a lower expectation of surgery retlecting a lower expectation of 
invasive treatment generally. Their first preference is usually for non-surgical therapy. 
The national negligence of surgery is retlected in their lack of national statistics on the use 
of surgery. Surgical rates are generally believed to be substantially lower than in the 
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West, and the small number of patients collected from each Japanese hospital in this study 
supports such a belief. Thus. patients in this study might have been delighted by the 
improvement in their health which went beyond their expectations. 
4. To assess the feasibility and reliability of a comorbidity 
measure developed in the USA (ICED) 
4-1. Findings from this study 
Measurement of comorbidity by the ICED was exam ined in terms of intenater and 
intrarater reliability. TntelTater reliability was examined twice. with similar results. Lower 
agreement was observed with the subindex of co-existent disease (kappa 0.5) than with 
the functional severity subindex (kappa 0.64-0.97). Tntrarater reliability was high for both 
subindices and the ICED. 
4-2. Methodologicallimitatinlls 
Almost all disease and functional categories of the two subindices (co-existent disease 
severity and functional severity) required for the ICED had been recorded in the patient,,' 
case notes in both countries. However, the severity of comorbidity was not always 
described in the same way as it was defined in the ICED coding manual. The instructions 
did not cope adequately with the diversity in clinical observation and recording found. 
Disagreement between raters arose from shortcomings in the organisation of case notes, 
differences in judgment by the raters, and limitations in the ICED protocol. Case notes in 
the UK were not maintained wel1 and sometimes data were missing. Reporting bias by 
patients and health carers was a possible source of disagreement, as wel1 as the way raters 
judged it. Finally the ClllTent instruction manual of the ICED coding was found not to be 
explicit enough in its clinical descriptions. Classification of the relative severity of 
conditions was not consistent throughout the 13 co-existent disease categories. For the 
')/! 
- --
functional severity subindex. some overlap with co-existent uisease subindex was found. 
In addition, it was felt that more than 10 categories of function would have been 
beneficial. More detailed information was needed to meet the diversity in clinical 
observation and practice found in the case notes. 
4-3. Discussion 
Feasibility was limited by the availability of case notes. non-stanuaruised recording of 
data, and missing data. In particular, how to deal with missing uata should have been 
clearer. In cutTent practice, if the respective data were missing. it was judged as no 
comorbidity. Thus. the less complete the recording of data. the lower the level of 
comorbidity will be. regardless of the actual level. 
The reliability of use of the ICED was limited by the data limitations described above. 
interpretation by the raters. and the ICED instrument. All three raters who participateu in 
this study were highly qualified and clinically traineu. The results suggested that the 
training had little impact on the level of agreement between the raters. However. their 
supposedly advantageous clinical experience might have workeu the other way by 
blinging in their own image of patients describeu in the case notes. In most studies of lisk 
adjustment, data are collected by trained medical personnel but not usually by doctors. in 
which case the ICED might be more likely to be determined by instruction rather than the 
rater's interpretation. 
5. To determine the effect of comorbidity on postoperative 
complications and health status one year after surgery both in Japan 
and the UK 
5-1. Findim;s from this study 
The ICED was not significantly associated with the rate of serious complications in Japan 
but was in the UK. The pattern of association suggested a threslll)ld effect in Japan 
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whereas it was dichotomous in the UK. In relation to minor complications. the ICED was 
significantly associated in Japan but not in the UK. The pattern of association with minor 
complications in Japan again suggested a threshold effect but there was no clear pattern in 
the UK. As regards association with the overall complication rate. the ICED was 
significantly associated in both countries. Similar pattems of association were observed to 
those for serious complications. 
Change in health status was not significantly associated with the ICED in Japan. but in 
the UK there was a significant dichotomous pattern in which patients with less 
preoperative comorbidity reported slightly greater improvement in basic and instIUmental 
ADL scores. 
5-2. Methodolo&ical limitations 
Major limitations in the analyses of serious in-hospital complications in Japan was the 
small number of episodes as outcome. The relatively high complication rate in the lowest 
level of the ICED in the UK was another limitation of this study. in which only marginal 
increase in complication rate had to be assessed in relation to comorbidity. 
5-3. Discussion 
The significant association with complications was in contrast with the less marked 
association with change in health status, suggesting the closer link between comorbidity 
and complications. This might be of par1icular importance when the primary disease is not 
life-threatening such as hip arthritis. In contrast. change in health status was mostly 
effected by the preoperative health status rather than the level of comorbidity. 
The pattern of the association between comorbidity and complication rate was different 
between the countries: a threshold effect was observed in Japan. a dichotomous pattern in 
the UK. The ICED did not peri'orm uniform ly in Japan and the UK, as it had in the USA. 
In Japan, the small number of patients classitied at the highest level of the ICED made 
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analyses difficult. In the UK. the high complication rate observed in patients with low 
levels of comorbidity limited the relationship with the ICED. Redefining the ctiteIia for 
selious complications successfully reduced the complication rate at the lowest level of the 
ICED and increased the odds ratios at the higher levels. 
6. To identify factors confounding the relationship between 
comorbidity and outcome 
6-1. Findings from this study 
Higher levels of the ICED were significant predictors of selious complications in the UK 
and of overall complications in Japan. In the UK the selious complication rate was also 
associated with the surgical approach and minor complications were associated with 
educational level. In Japan. overall complications were associated with previous hip 
surgery. In fitting logistic regression models. these variables (surgical approach, 
educational level, and previous hip surgery) were found to be significant independent 
predictors of outcome. 
The ICED was not a significant predictor of change in health status either in Japan or the 
UK. Patient's sex. educational level and preoperative need for walking support were 
significantly associated with change in health status in Japan whereas preoperative 
severity of limp was associated in the UK. When all patients from both countlies were 
combined, the ICED was not a significant predictor of change in any dimensions of health 
status. Nationality was not a significant predictor either. 
6-2. MethQdolo!;icallimitations 
In building regression models for change in health status. the non-normal distribution of 
change in basic ADL and social activity as well as preoperative health status in all three 
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dimensions had to be transformed to the near-normal. or grouped into categorical 
variables. The distribution of social activity proved difficult to nonnalise. 
n-3. Discussion 
In selecting significant independent predictors for the serious complication rate in the UK. 
surgical approach was chosen as a significant variable but hospital was not. However. 
there was a significant association between surgical approach and hospital. suggesting 
surgeons had a preference for a particular approach. Thus. interhospital differences in 
serious complication rates might have been due to differences in surgical approach rather 
than the overall quality of care provided by the hospital . 
Education level was a significant predictor of minor complications in the combined 
model, as well as in the UK model. The higher a patient's level of education. the lower 
the risk of a minor complication. Reasons for this association are unclear. but may retlect 
better compliance with medical instructions during the postoperative peliod by more 
highly educated patienL~. In addition. their higher socio-economic status would mean that 
their living conditions were better and they probably enjoyed more help and assistance 
from others. 
Change in health status was mostly explained by preoperative health status and to a lesser 
extent by the severity of hip disease but not by the ICED. Nationality was not a 
significant predictor in any dimensions of health status. 
7 . To inlprove the power of comorbidity to predict serious 
complications 
7-1. Findin~s from this study 
Prediction of sel;ous in-hospital complications in the UK was improved by changes to the 
complication criteria. The threshold nature of the association between complications and 
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the ICED in Japan was enhanced whereas in the UK the dichotomous pattem became less 
marked. 
The structure of the TCED was changed to create a new index with fewer more predictable 
co-existent diseases. Analysis was limited to the UK model, in which a linear association 
between complications and the new index was observed. A logistic regression mode I 
suggested that changes both to the TCED structure and the complication clitelia enhanced 
the predictive power of the ICED. 
7-2. Methodolof;icallimitations 
The rare incidence of selious complications in Japan made analyses impossible. 
Assigning the peak severity of any single disease as a final severity score also made it 
difficult to interpret the result\;\ from individual analyses of the relationship between the 
seveIity of each co-existent disease and the complication rate. 
Although the association between serious complications and the ICED was improved. the 
predictive power was limited. The relatively high complication rate observed at the lowest 
level of the ICED in the UK was a possible reason for difficulty in prediction. 
7-3. Discussion 
In discussion of risk adjustment methods. most emphasis has been general1y put on the 
classification and weighting of independent valiables but relatively less attention has been 
paid to the definition of the outcome. In this study. change in the criteria of serious 
complications brought about a stronger association between the ICED and outcome and 
modified the pattern in both countries. suggesting the importance of the outcome cliteria 
used. Change in outcome criteria also made surgical approach insignificant as a predictor 
of serious complications in the UK. When the relationship between the new outcome 
critelia and hospitals was examined. six neuropathy cases were excluded. half of whom 
were from hospital E. where the anterior approach was frequently used. Although there 
was no significant association between surgical approach and neuropathy. the result may 
suggest an indirect relationship through differences in the quality of care. 
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Another attempt presented was to change the structure of the ICED by minimising the 
number of comorbidities to the most predictable for outcome. The results showed a linear 
association between severity of comorbidity and serious complication rate. However, 
without testing in other population than that used in this study. the validity of such a new 
development is unknown. 
8. Recommendations for clinical practice 
What implication do the findings of this study have for the clinical management of THR 
patients? There are several ways in which the measurement of comorbidity might possibly 
effect clinical practice: in assisting the clinical management of THR patients; to make 
commissioning more sensitive: and to enhance audit, in particular interhospital 
comparisons. In addition, the potential benefit of using the ICED rather than the simpler 
ASA PS needs to be considered. 
8-1. Clinical management of THR patients 
In this study, comorbidity data were shown to be able to provide an indication of the 
likelihood of postoperative complications. However. currently no standard method is 
used to identify and record comorbidity in clinical practice. If comorbidity information 
was routinely classified and recorded in case notes in the structured way used in the 
ICED. it would help organise clinical data. Such data could assist surgeons to identify 
patient~ at greater lisk and to make decisions to employ preventive measures to avoid or 
reduce dsks of complications. 
8-2. Purchasing health care 
This study has shown that the ICED can be helpful in identifying the cases most likely to 
experience postoperative complications. If such predictive information were available. 
commissioning hospital care could be improved by adjusting risks for outcomes and 
using differential costing that recognised such differences in risk. This would help to 
reduce cross-subsidisation of cases with higher levels of comorbidity by those with lower 
levels. 
R-3. Audit of THR practice 
After a long history of development. postoperative mortality of THR is now negligibly 
low despite the majOl;ty of patients being elderly. However. for comparison of outcomes 
other than mortality such as in-hospital complications. comparative analyses of 
postoperative results among hospitals require good risk adjustment not only for the 
pl;mary disease but for comorbidity. For comparative audit of outcomes among hospitals 
with different case mixes such as were seen in this study. good quality data on 
comorbidity del;ved from similar. standardised recording is needed. The ICED could be 
used as a standard method of measlII;ng comorbidity. 
R-4. Compat;son with ASA PS 
In view of the considerable work involved in collecting data for the ICED. the decision as 
to whether or not to use it rather than alternative simpler methods of I;sk adjustment must 
be considered. 
In Japan, where recording of the ASA PS is already routinely practiced. the additional 
effect of using the ICED has been shown to be limited. In this study. ASA PS was 
... 
significantly associated with the ICED (Spearman rank correlation coefficient =0.6421: 
p<O.OOOl). Moreover. the highest level of ASA PS was found to be a statistically 
significant predictor both for minor and overall complications (data not shown). 
suggesting the limited value of collecting the additional clinical data needed for the ICED. 
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The same may be true in the UK but couldn't be assessed as the ASA PS is not usuallv 
recorded. However. the presence of relatively older and sicker patients may justify the 
extra effOit required of collecting data for the TCED particularly if its predictive power 
could be improved. 
9. Recommendations for further research 
Finally, several different issues for fmther research in this field are suggested . 
....... 
9-1. Use for different outcomes 
Due to preventive measures, mortality fol1owing THR is negligible and postoperative 
death was not used as an outcome. just as it hadn't been in the Oliginal study in the USA. 
However, death is the most severe type of complication that can occur so it's exclusion 
could be questioned. Moreover. because of the low risk of dying of arthritis. the 
adjustment by comorbidity will make even more sense than in other diseases/interventions 
such as coronary artery by-pass graft surgery for ischemic heart disease in which the 
primary disease could be severe enough as a major cause of mOitality. Thus. even though 
death would be difficult to predict given its low incidence, postoperative death could be 
included in the category of serious complications to be assessed as an important outcome. 
Analysis of the predictive power of the ICED for serious complication including deaths 
should be carded out. 
9-2. Prospective lise of the ICED 
Previous chapters discussed the difficulties of lIsing the ICED when data definitions are 
diverse across the hospitals due to a lack of homogeneous criteria on comorbidities and 
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outcomes. Therefore, the second recommendation is to establish the definition of all the 
key data elements, seek a consensus about their use among health professionals. and run 
a prospective study. Guidelines to identify comorbidities and outcomes should be 
explicitly written and meet the diversity of clinical practice. In these ways. better quality 
data could be obtained. 
9-3. Use in high Iisk ca"es - emergencies and elderly 
For most elective operations. patients are selected according to their physiological 
condition and any setious comorbidity is treated before surgery. Therefore patients are 
relatively stable with Iisks reduced. 
It is possible, however, that comorbidity is a more important determinant of outcome in 
emergency patients in whom stabilisation of their co-existent diseases may not be feasible 
before surgery. Also. it may be of greater practical use in very elderly patients who are 
more likely to suffer from multiple pathology. In such cases. the ICED could be 
advantageous for routine use as it doesn't require any additional examination than that in 
CUlTent practice. Thus. studies of the ICED in emergency and in very elderly patients 
would be wOlth pelfOlming. 
9-4. Creation of new Japanese and new British models 
As described in the preceding chapter, an attempt to change the ~tFtlcture of the ICED was 
very limited because the sevelity of comorbidity was collected according to the existing 
ICED severity grades and not as raw data which could be reclassified. New index could 
be developed if data were collected prospectively in each country. Raw clinical data 
should be collected and co-existent disease severity and functional severity could be 
composed in different way from that used in the ICED. Although this would require 
considerable research effOlt. the predictive power and validity of the new indices made 
for each country woulJ be greater as it would more accurately reflect cun'ent practice. 
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9-5. Test in other conditions and procedures 
The ICED could be tested in procedures other than THR. In the USA. for example, it was 
tested in acute myocardial infarction. coronary artery bypass graft surgery. and 
cholecystectomy. The TCED was also used to assess mortality in patients with end stage 
'-
renal disease in Italy and the USA. Application in such different conditions and 
procedures would demonstrate the utility of the index. 
9-0. Creation of disease-specific models 
Although a generic comorbidity index is preferable, disease-specific indices are likely to 
have greater predictive power. Using retrospectively collected data. an extensive review 
of current practice would help to identify the most predictable factors. Clalifying outcome 
definitions, as well as an improved classification of comorbidity severity levels might 
improve explanatory power of the regression model. Such evidence based tisk adjustment 
would enable a more specific index for the intervention and outcome of interest. As it 
requires considerable research investment in developing and testing a new index, the 
benefit of developing a specific model should be carefully considered tirst. 
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London School of Hygiene and Tropical Medicine 
(University of London) 
HEALTH SERVICES RESEARCH UNIT 
Department of Public Health and Policy 
London School of Hygiene and Tropical Medicine 
Keppel Street, London WCIE 7HT 
NORTH THAMES HIP SURGERY STUDY 
Information for Patients 
Although we know much about the long term benefits of -surgery for hip 
arthritis we need to increase our knowledge of the effect of coexistent disease 
on the postoperative recovery from their operation. To do this we are asking 
approximately 400 patients. who underwent surgery about a year ago. to take 
part in this study. We hope our results will lead to a better understanding 
about hi p surgery and the results of surgical treatment. 
This questionnaire asks you about your health status and quality of life. for 
example, the way you have been feeling recently, your physical and social 
activities. 
All the information you give us will be treated as confidential. 
Your name, address and personal details will not be re"ealed to 
an~·one. Also the views you express will not be provided to the surgeon who 
did the operation in any way that would allow him to identity you. 
We hope you are willing to help us with this study. Agreeing to take part will 
not affect the way you are treated in the future. If you are willing to take part 
please complete the consent form on the front of the questionnaire and return 
it with the completed questionnaire in the envelope provided. 
If you have any questions about the study please do not hesitate to contact me 
by telephone on 071 927 2105. 
Kyoko Imamura 
Research Surgeon 
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Appendix-4 
Questionnaire for British Patients 
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NORTH THAMES HIP SURGERY STUDY 0-0] 
Thank you very much for helping us with this survey. 
This questionnaire will provide us with important information about your health. 
Any information that would permit you to be identified as a member of the study will be 
regarded as strictly confidential and will be used only for this study. 
Please make sure you answer every question. Circle the number of the 
answer that most closely fits you. If none of the answers provided seems exactly 
right, choose the one that comes nearest to being right for you. 
Please remember most of these questions are about you when you were in the hospital 
for your hip replacement surgery in 
/ 
(Month/ Year) 
We would like you to fill out this questionnaire. If someone else is helping you, please 
let us know who: 
(Circle one) 
a. Spouse (wife or husband)............................................. 1 
b. Boyfriend or girlfriend ........ ......... ......... ......... ......... ..... 2 
c. Neighbour . ....................... ........... ............ .... .......... .... ..... ...... 3 
d. Other relative (parent, sister, 
brother, son , daughter).................................................. 4 
e. Nurse or health attendant ............................... ..... ....... 5 
f. Other ........................................ .... ..................... ..... .... .... .... ... 6 
CONSENT FORM 
I have read and understood the information about the North Thames Hip Surgery Study 
and I am willing to take part. 
Please sign here ______________ _ 
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Before you start, please fill in today's date / / 
Day Mo Yr 
To start, we would like to know how you have been feeling recently. Please circle 
the number of the answer that most closely fits you. 
1 . In general, would you say your health is ... 
Excellent .................................. 1 
Good ... ...... ................ ................... 2 
Fair ... ...... ................. ................... 3 
Poor- .................. ....... .... .... ..... ...... 4 
2. Compared with the period prior to your hip operation, would you say your health 
now is better, worse, or about the same? 
Better .... ... ........... ....... .......... ..... 1 
Worse .............. ........ ................... 2 
Same ...... ....... ... ....... ..... ....... ....... 3 
3. During the past month, on how many days did illness or injury keep you in 
bed all or most of the day? 
DAYS IN BED DURING THE PAST MONTH 
No. of days 
4. During the past month, how many days did you cut down on the things you 
usually do for one-half day or more because of an illness or injury? (DO NOT 
COUNT DAYS SPENT IN BED.) 
DA YS CUT DOWN ON THINGS USUALLY 
DO FOR 112 DAY OR MORE DURING THE 
PAST MONTH 
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No. of days 
5. Since your hip operation, have you used any of the following services for problems 
with the hip that was operated on? 
Please tick for each one. 
General Practitioner ,0 Yes 20 No 
Practice nurse 
'0 Yes 20 No 
Hospital outpatients ,0 Yes 20 No 
District nurse 
'0 Yes 20 No 
Physiotherapist 
'0 Yes 20 No 
Other (please specify) ,0 Yes 20 No 
6. Since your hip operation, how much rehabilitation or help with regaining your 
mobility did you receive from health service staff? 
Please tick one. 
, 0 None 2 0 A little 3 0 Quite a lot 4 0 A great deal 
7. How much extra help from friends, family or neighbors have you had since your hip 
operation? 
Please tick one. 
, 0 None 2 0 A little 3 0 Quite a lot 4 0 A great deal 
We would like to know if you have been admitted to hospital since your hip 
replacement and what the reasons for those admissions were. Please answer the 
following questions for any admission since your hip operation. 
8. First admission since your hip operation: 
a. Date: / / 
Mo. Day Yr. 
b. Namem~I __________________________________ __ 
City ____________ _ 
c. Reasonforad~~n ____________________________________ __ 
d Did you plan to come back or was it an emergency admission? 
Planned ______________ __ Eme~~ ______________ _ 
e. Number of days in hospital ________ _ 
f. Did you have any surgery during this admission? 
~S ____________ _ NO ______________ _ 
If yes, indicate type: ___________________________ _ 
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9. Second admission since your hip operation: 
a. Date: / / 
Day Mo Yr 
b. Name of hospital ________________ _ 
~--------------------
c. Reason for admission _________________ _ 
d Did you plan to come back or was it an emergency admission? 
Planned _______ _ Eme~ncy---______ __ 
e. Number of days in hospital _______ _ 
f. Did you have any surgery during this admission? 
YES _______ _ NO ________ __ 
If yes, indicate type: _________________ _ 
1 O. Third admission since your hip operation: 
a. Date: / / 
Day Mo Yr 
b. Namemhospital _______________________________ __ 
ctty _______________ _ 
c. Reason for admission _________________ __ 
d Did you plan to come back or was it an emergency admission? 
Planned _______ _ Eme~ncy-------------
e. Number of days in hospital _______ _ 
f. Did you have any surgery during this admission? 
YES _______ _ NO _______ _ 
If yes, indicate type: _________________ __ 
11 . Please list below the location and approximate dates of any other admissions to 
hospital since your hip operation. 
PLACE DATE 
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It has now been about one year since your total hip replacement. Please think 
about how you have been feeling during the past month as you answer these 
questions. 
12. For each activity you perform, on the scale from 0 to 7, where 0= NO PAIN and 
7 =SEVERE PAIN, circle the number that best represents the average amount of 
PAIN you have experienced when performing the activity, during the past 
month. 
NO SEVERE 
PAIN PAIN 
Getting in/out of bed 0 1 2 3 4 5 6 7 
Rising from a sitting position 0 1 2 3 4 5 6 7 
Walking inside the house 0 1 2 3 4 5 6 7 
Walking outside the house 0 1 2 3 4 5 6 7 
Climbing stairs 0 1 2 3 4 5 6 7 
Doing yardwork/shopping 0 1 2 3 4 5 6 7 
Putting on stockings/pants 0 1 2 3 4 5 6 7 
13. In general would you say your pain in the past month is better or worse than 
the pain you had prior to your hip surgery? 
Much 
Better 
1 
Somewhat 
Better 
2 
About the 
Same 
3 
Somewhat 
Worse 
4 
Much 
Worse 
5 
14. In the month before your surgery, what type of walking supports did you 
use? 
None ( or rarely) ..... ........ ...... .......................... ..... ....... ............ 1 
Single cane or crutch . ................... ............ .... ..... ........ ........ 2 
lrwo can~ CJHr cr1Untches ...................................................... 3 
WClI~E!r ...................................................................................... 4 
Wt1~~I<:t1C1ir .............................................................................. ~ 
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1 5. What type of walking supports do you use now? 
None ( or rarely) ..................................................................... 1 
Single cane or crutch .................... ......... ....... ..... ....... ......... 2 
Two canes or crutches ........ .................. ............................ 3 
\I\IClI~~r ...................................................................................... ~ 
\I\Itl~~Ic:t1~ir .............................................................................. !i 
16. Have you had a displaced hip since your operation? 
~~ ...................... 1 ~ •.••.••..•••••......•...•. ~ 
If yes, how many times has this happened? _______ _ 
17. Before your surgery, how much of a limp did you have? 
None ~light Moderate Severe Could not Walk 
1 2 3 4 5 
18. How much of a limp do you have now? 
None ~Iight Moderate Severe Cannot \I\Ialk 
1 2 3 ~ 5 
1 9. In the past month have you taken any medication for pain or to help you 
sleep? 
~~ ...................... 1 ~ ...•..............••...... ~ 
If yes, how often do you take these medications? ___ times per week 
What is the medication for? ___________ ----
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We would now like to ask you some questions about your social activities. 
20. About how many close friends do you have; people you feel at ease with and can 
talk with about what is on your mind? (You may include relatives.) 
Enter number on line: ________ Close friends and relatives 
21 . During the past month, about how often did you get together with friends or 
relatives, like going out together, visiting in each other's homes, or talking on 
the telephone? 
(Circle One) 
E:\lE!r)( ~)' .••••••........••.•••••..•........•••••.•..••.•••.....................•• Ei 
Several times a week ............................................... 5 
About once a week ..................................................... 4 
2 or 3 times during the month ............................. 3 
About once a month ................................................... 2 
Not at al, ........................................................................ 1 
22. During the past month, how satisfied were you with your sexual 
relationships? 
(Circle One) 
'v'er)( satisfiecj ............................................................. 5 
~t:r.sfi~d ........................................................................ 4 
Not sure .......................................................................... 3 
Dissatisfied ................................................................. 2 
'v'er)f dissatisfiecj ....................................................... 1 
Dicj not have an)' sexual relationships .............. 0 
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This group of questions refers to many types of physical and social activities. We would 
like to know how difficult it was for you to do each of these activities, on average, during 
the past month. By difficult, we mean how hard was it or how much physical effort it 
took to do the activity because of your health. Please circle the number of the 
answer that most closely fits you for each question. 
DURING THE PAST USUALLY USUALLY USUALLY USUALLY USUALLY 
MONTH, HOW MUCH 010 WITH 010 WITH 010 WITH DID NOT 00 010 NOT 00 
PHYSICAL DIFFICULTY NO SOME MUCH BECAUSE OF FOR OTHER 
DID YOU HAVE ... DIFFICULTV DIFFICULTY DIFFICULTY HEALTH REASONS 
23. Taking care of your-
self, that is, eating 4 3 2 1 0 
dressing, or bathing? 
24. Moving in and out 
of a bed or chair? 4 3 2 1 0 
25. Walking several 4 3 2 1 0 blocks? 
26. Walking one block or 
climbing one flight 4 3 2 1 0 
of stairs? 
27. Walking indoors, 
such as around 4 3 2 1 0 
your home? 
28. Doing work around 
the house such as 
cleaning, light 4 3 2 1 0 
gardening, home 
maintenance? 
29. Doing errands, such 4 3 2 1 0 
as grocery shopping? 
30. Driving a car or using 
4 3 2 1 0 public transportation? 
31. Visiting with relatives 
4 3 2 1 0 or friends? 
32. Participating in 
community activities 
such as religious 
services, social 
4 3 2 1 0 
activities, or 
volunteer work? 
33. Taking care of other 
people such as 4 3 2 1 0 
family members? 
34. Doing vigorous 
actiVities such as 
4 3 2 1 0 running or lifting 
heavy objects? 
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These next questions ask about how you feel and how things have been with you 
during the past month. For each question, please circle the number for the 
answer that comes closest to the way you have been feeling. 
DURING THE PAST A GOOD AUTTLE 
MONTH, HOW MUCH ALL OF MOST OF BIT OF SOME OF OF THE NONE OF 
OF THE TIME: THE TIME THE TIME THE TIME THE TIME TIME THE TIME 
35. Have you been 
2 3 4 5 6 a very 1 
nervous person 7 
36. Have you felt calm 
2 3 4 5 6 and peaceful? 1 
37. Have you felt 
downhearted 1 2 3 4 5 6 
and sad? 
38. Were you a 1 2 3 4 5 6 happy person? 
39. Die you feel so 
down in the dumps 
1 2 3 4 5 6 that nothing could 
cheer you up? 
40. Did you feel 
1 2 3 4 5 6 fatigued or tired? 
41. Did you have to lie 
down during the day 1 2 3 4 5 6 
in order to rest? 
42. Did you feel confused 
or disoriented; i.e., 
didn't know who you 1 2 3 4 5 6 
were or who was 
around? 
43. Did you have 
difficulty doing 
activities involving 
concentration and 1 2 3 4 5 
6 
thinking? 
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Next are some statements about medical care. Please read each one carefully, keeping in 
mind the care you received during and after your hip operation. On the line next to each 
statement, circle the number for the opinion that is closest to your own view. Some 
statements look similar to others, but each statement is different. You should consider 
each statement by itself. There are no right or wrong answers. We are only 
interested in your opinions or best impression. 
NEITHER 
HOW SATISFIED VERY SOMEWHAT SATISFIED NOR SOMEWHAT VERY 
WERE YOU WITH: SATISFIED SATISFIED DISSATISFIED DISSATISFIED DISSATISFIED 
44. The information you 
were given about , 2 3 4 
your surgery? 
45. The way your , 2 3 4 pain was treated? 
46. Your hospital stay , 2 3 4 in general? 
47. Do you feel the length of time you spent in the hospital was: 
Much too 
Long 
Somewhat too 
Long 
Just 
Right 
Somewhat too 
Short 
Much too 
Short 
1 2 3 4 5 
48. How has the operation changed the way you feel? 
I feel much better ..... ....... ... ..... ................................... ............. 1 
I feel somewhat better ... ... ....... ............... ...... ....... ......... .... ... 2 
I feel a little better ................ ............................................... 3 
I feel about the same ......... ... ....... ............ ..... ........... ..... ... ...... 4 
I feel a little worse ......... ............ .................. ......................... 5 
I feel somewhat worse ... ........ .......... ....... ..... ......... ...... ..... ..... 6 
I feel much worse ......................... i7 ..•••...•...•....•...........••....•....... 
277 
5 
5 
5 
49. How do you now feel about having had the operation? 
I am very happy I had the operation ....................................... 1 
I am happy that I had the operation .......................................... 2 
I am not so happy that I had the operation . ......... ... ......... ...... 3 
I am not happy at all that I had the operation ...................... 4 
50. Overall, is your health better or worse than you expected it to be at this point? 
Much 
Better 
1 
Somewhat· 
Better 
2 
What I 
Expected 
3 
Somewhat 
Worse 
4 
Much 
Worse 
5 
5 1 . How do your activities compare to what you had planned to do after your 
operation? 
Doing much 
less than 
I expected 
1 
Doing somewhat 
less than 
I expected 
2 
Doing about 
what I 
expected 
3 
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Somewhat 
more 
4 
Much 
more 
5 
This group of questions refers to many types of physical and social activities. We would 
like tq know how difficult it was for you to do each of these activities, on average, during 
the month before your hip operation. By difficult, we mean how hard it was or how 
much physical effort it took to do the activity because of your health. Please circle 
the number of the answer that most closely fits you for each question. 
DURING THE MONTH BEFORE USUALLY USUALLY USUALLY USUALLY USUALLY 
YOUR HIP OPERATION, DID WITH DID WITH DID WITH DID NOT DO DID NOT DO 
HOW MUCH PHYSICAL NO SOME MUCH BECAUSE OF FOR OTHER 
DIFFICULTY DID YOU HAVE: DIFFICULTY DIFFICULTY DIFFICULTY HEALTH REASONS 
52. Taking care of your-
self, that is, eating 4 3 2 1 0 dressing, or bathing? 
53. Moving in and out 
of a bed or chair? 4 3 2 1 0 
54. Walking several 4 3 2 1 0 blocks? 
55. Walking one block or 
climbing one flight 4 3 2 1 0 
of stairs? 
56. Walking indoors, 
such as around 4 3 2 1 0 
your home? 
57. Doing work around 
the house such as 
cleaning, light 4 3 2 1 0 
gardening, home 
maintenance? 
58. Doing errands, such 4 3 2 , 0 
as grocery shopping? 
59. Driving a car or using 
4 3 2 1 0 public transportation? 
60. Visiting with relatives 
3 2 1 0 or friends? 4 
61. Participating in 
community activities 
such as religious 
services, social 
4 3 2 1 0 
activities, or 
volunteer work? 
62. Taking care of other 
1 0 people such as 4 3 2 
family members? 
63. Doing vigorous 
activities such as 
running, lifting heavy 4 3 2 1 0 
objects, or 
participating in 
strenuous sports? 
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These next questions ask about how you felt and how things were during the 
month before your hip operation. For each question, please circle the 
number for the answer that comes closest to the way you have been feeling. 
DURING THE MONTH A GOOD AUTTLE BEFORE YOUR HIP All OF MOST OF BIT OF SOME OF OF THE NONE OF OPERATION, HOW 
MUCH OF THE TIME: 
THE TIME THE TIME THE TIME THE TIME TIME THE TIME 
64. Have you been 
1 2 3 4 5 6 a very 
nervous person? 
65. Have you felt calm 
1 2 3 4 5 6 and peaceful? 
66. Have you felt 
downhearted 1 2 3 4 5 6 
and sad? 
67. Were you a 1 2 3 4 5 6 happy person? 
68. Did you feel so 
down in the dumps 
1 2 3 4 5 6 that nothing could 
cheer you up? 
69. Did you feel 
1 2 3 4 5 6 fatigued or tired? 
70. Did you have to lie 
down during the day 1 2 3 4 5 6 
in order to rest? 
71. Did you feel confused 
or disoriented; i.e., 
didn't know who you 1 2 3 4 5 6 
were or who was 
around? 
72. Did you have 
difficulty doing 
activities involving 1 2 
concentration and 
3 4 5 6 
thinking? 
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In order to compare your experiences with other patients, we would like to know 
. a little more about you as a person. 
73. At what age did you finish full-time education? (Circle one) 
15 or under 16-18 years 19 or over 
1 2 3 
74. Are you: (Circle one) 
Married or Living as married ... ........ .... ... ....... ........ .... ... ...... 1 
Widowed ....... ... ................ ..... ... ..... ... ... .................. ... ... ..... .... ......... 2 
Separated or divorced ... ....... ............................. ................ ..... 3 
Never married .................. .......................................................... 4 
7 S. Which of the following best describes your living arrangement? (Circle one) 
Live alone .................................................................................... 1 
Live with spouse/family or friends ................... ............. 2 
76. Which type of accommodation do you live in? 
Council flat / home ............................................ ........ ....... ...... 1 
Privately rented or housing association .. .......... ... ........ 2 
Owner occupier ................... ...................................................... 3 
Other .............................................................................................. 4 
77. Which of the following statements best describes your work situation during 
the past month? (Circle one) 
Working full-time......... ................ ................... .............. ........... 1 
Working part-time.............. ................. ............. ............. .... ....... 2 
Unemployed because of my health .......... ............. .............. 3 
Unemployed, looking for work ...................... .......... ............. 4 
Retired because of my hip condition ................................ 5 
Retired for other reasons ............................... ....................... 6 
Housework, full-time .............................................................. 7 
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78. Which of the following statements best describes your work situation for the 
month before your hip operation? (Circle one) 
~or1<ifl~ flJl~1tim~ ..................................................................... 1 
~orking part-1tim~ ............................... ................. .................... 2 
Un~mploy~d becaus~ of my health . .......................... .......... 3 
Unemploy~d, looking for work ............................................. 4 
R~tir~d because of my hip condition . ........ ....................... 5 
R~tir~d for oth~r reasons . .... ........ .... ...... ........ ..... .................. 6 
Housewor1<, flJlI-time .................................. ' ........ ......... .......... 7 
If you were working the month before your hip operation, please give the 
names of the job and brief details of what you actually did. 
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COMMENTS 
We are interested in any other comments you have about your hip operation. 
Thank you for completing this questionnaire. 
Please return it to Dr Kyoko Imamura (Health Services Research 
Unit, London School of Hygiene and Tropical Medicine, Keppel 
Street, London we, E 7HT), in the stamped addressed envelope 
provided. 
283 
Appendix-S 
Case Notes Extraction Sheet for Japan 
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Appendix-6 
Case Notes Extraction Sheet for the UK 
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· ., ~:::;~~C;:. ~~~.~~N ...................... .il· ~s!< .~ '\c;::r~~ ........ YES' ......... 'No' ............... . 
III Alcohol 1 [ ] 2 [ ] 
Smoking 1 [ ] 2 [ ] Nrume: I I Obesity 1 [ ] 2 [ ] 
..... ~~.>;rt.~.~~i.~~.: ...... I .... ( ..... (J?D/~:-:f0::.l .......... .JI Height: (inches) 
Admn Date: 1 1 (DDIMMNY) h;~;;'~~' ~~;~;!;~ ~~.~~;~~~ ~~; /~~'L .......... . 
Disch Date: f f (DDIMMNY) It ............................................................... . 
· ... .I;>.~t~. 9f.~j.M:. . . L f (P.P.IM.M~Y:,() ........... 1
1 
SurgIcal APPl r[oa]ch:A . 
ntenor 
..... ~i.r!t.~ A.~}~~~<?J.l.J?i~g: ................................ ~I 2 [ ] Posterior 
Sex: 1 [ ] Female II 3 [ ] Lateral 
2 [ ] Male I~ ............... ~~ .. ~ .. ~~~~ .(~~.~~i.~) ........................ . 
.... ·Li~~·AI~~~;·····i .[ .. ]. ·Y~~···························· ·jl Bone Graft: l [ ] Femur 
2 [ ] No II 2 [ ] Acetabular 
3 [ ] Unknown Il. .............. ~.~ .. ~ .. ~~~~ ................................. . 
.... ·Marltai"SiatUs:· .. i .( . ]. ·N~~~~ ·~~~i~~i ................. ··11 Prosthesis Type? 
2 [ ] Married II 1 [ ] Cement 3 [ ] Not documented 
. I 2 [ ] Cementless 4 [ ] Other (specify) 3 [ ] Separated/DIvorced I 
4 [ ] Widowed Il .............................................................. . 
...................... ~J..J .. ~~.~~.~ ....................... JI SURGICAL DATA 
Admit Type 1 [ ] Emergent ir··· .~~~~; ~~~~: ........ ~ .... ·f····· (~~~~; ........... . 
2 [ ] Transfer t ............................................................... . 
3 [ I Scheduled/Elective II AnestheSIa type: I [ I General 3 [ I Local 
4 [ ] In-house transfer I 
5 [ ] Other I~·····················~·~·)·~~~~~~~!·····~·[··)·~~~~~ ..... . 
...................... ~.[ .. ~ .. ~~~.~~.~ ................ ·······Jll ~:::::~ ---~---
DISEASE SEVERITY I .............................................................. . 
· .... ~~~. ;~~; ;;;~~;~~~; ................ ~~~ ...... ~~ ..... '11 ::::: :::: :: ~:;~. 
Osteotomy 1 [] 2 [] II T fu· 
rans slon.: Hip pinning 1 [] 2 [] t .............................................................. . 
Other (specify) I Initial Hematocrit? 
· ............................................................. 11 Final Hematocrit? 
Other Joint Previous: YES NO II .. 
ASA classIficatIon 
Osteotomy 1 [] 2 [] I~ .............................................................. . 
Hip pinning 1 [] 2 [] ~ ... ?~!. ~.r~.~~~~i.~~: ....... ~ .[ .. }.~~~ ... ~ r. ~ !:l? ......... . 
Total Hip Replacement I [I 2 [I II Venogram? I [ I YES 2 [ I NO 
· ....... ~~~ ~ ~~~.c.i~? ...................................... jl If yes: .'~s.~I~? ........................................... . 
Knees Previous: YES NO r . . . . . . . . . . I Blood Clot PreventIon: 
Replacement of one knee I [] 2 [] II I [ ] Coumadin 3 [ ] Pneumatic Compression 
Replacement of both knees 1 [] 2 [] I 2 [ ] Heparin 4 [ ] Other (specify) ~::::::~ :~:: ~:es : ~ ~ ~: ~ Il. ............................................................. . 
II DISEASE SPECIFIC POST-OP COMPLICATIONS 
........ ?~.~~ ~ ~~~.i~! ................... ~~~ ....... ~; ... 'It .... ~i~ ;~~~;;~~~ ...................... '1 ~ •• i ........ ~ ; .. i .... . 
Spinal Problem: II Thrombophlebitis? 1 [ ] - [ ] 
1 [] 2 [] I! 1 [ ] ~ [ ] Hematoma? 
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Post Surgical Complications? 1 [ ] YES 2 [ ] NO I Pulmonary Embolism? 
............................................................ ·11 1 [ ] Documented 
Pneumo~ialPulmonary Complications? I~ ..... ~. ~ . ) .. ~.~t. ??~~~~~~? ................................... . 
YES NO II Blood Pressure Drop? 
Documented 1 [] 2 [ ] II 1 [ ] Documented ~.~~::~~~:~;;,.~g I F I [1 2 [1 II .... 2 . ~ . ] .. ~:'~90!6.0 .nun~~. ~t .~~ .p~~~ .d~~~ospi~lisati~~:. 
or I Coma? I [ ] Documented 
b. sputum and fever> I 0 1 F I 2 [ ] Not documented 
Interpreted from culture resultts I [] 2 [] It .................................................................. . 
I t d fr h t X 1 [] 2 [] II Fever? I [ ] Documented as > 1 0 I F38.3C twice in 24 hours nterpre e om c es -ray 2 [ ] N t d d An ·b· . h 0 ocumente tl lottc start or c ange 1 [] 2 [] r ................................................................. . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ·1 Gastro-intestinal Complications? 
Significant Cardiac Changes: 
MI? 
CHF? 
Stroke? 
UTI? 
Wound drainage? 
Wound infection? 
Systemic infection? 
Renal Failure? 
YES NO II Documented : 1 [] :2 [ ] 
1 [] 2 [] II Postitive X-Ray fmdings : 1 [] :2 [ ] 
~ ~ ~ 2 [] Il. ...... I.~~~~!~~ ~.~ ~ .~:~~~~r.e.s.s.i~.~ ~~.~ .: ..... ~ .. ~ ...... ~ .[ .. ~ .... . 
2 [] II Neuropathy? 1 [ ] Documented 
: t l H l 1~··Sh·~~k?······· .. ;: .. ;.::~~::::nt~ ...................... . 
1 [] 2 [] I~ .................. ~.~ .. ~. ~~~ .~~~~~~.~t~.~ ....................... . 
1 [] 2 [] II Septicemia/Bacteremia? 
1 [] 2 [ ] 1 [ ] Documented II 2 [ ] Not documented 
• ...................................................................................................................... • .............................................................................. 0 .................................................. .. 
ORGANIC HEART DISEASE 3 o 1 2 
............................................................................................................................................................................... 
ISCHEMIC HEART DISEASE 0 1 2 3 
................................................................................................................................................................ 
ARRHYTHMIAS 0 1 2 3 
...................................................................................................................................... 
CONGESTIVE HEART FAILURE 0 1 2 3 
..................................................................................................................................... 
HYPERTENSION 0 1 2 3 
........................................................................................................................................................ 
CEREBRAL VASCULAR ACCIDENT o 1 2 3 
................................................................................................................................................................. 
COMORBIDITY INDEX PERIPHERAL VASCULAR DISEASE 0 1 2 3 
........................................................................................................................................................... 
DIABETES MELLITUS 0 1 2 3 
...................................................................................................................................................... 
RESPIRATORY PROBLEMS 0 1 2 3 
....................................................................................................................................................... 
MALIGNANCIES 0 1 2 3 
......................................................................................................................................... 
LIVER DISEASE 0 1 2 3 
RENAL DISEASE o 1 2 3 
GASTRO-INTESTINAL DISEASES o 1 2 3 
CIRCULATION o 1 2 
RESPIRATION o 1 2 
NEUROLOGICAL 0 1 2 
...................................................................................................... 
MENTAL STATUS 0 1 2 
...................................................................................................... 
[ FUNCTIONAL STATUsl 
URINARY 0 1 2 
.................................................................................................... 
FECAL 0 1 2 
.................................................................................................. 
FEEDING 0 1 2 
.......................................................................................................... 
VISION 0 1 2 
........................................................................................................... 
HEARING 0 1 2 
............................................................................................................ 
SPEECH 0 1 2 
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The Index of Coexistent Disease (ICED) 
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· 1 Scorinl: system 
The two dimensions are scored separately using medical data recorded in admission. To 
determine patients' overall burden of comorbidity. scores are determined for each 
component. 
(1) The disease sevelity 
The severity of each of a selected list of 13 disease categOlies is recorded before surger\'. 
~ ~ . 
Each condition, or set of conditions in a given category, is classified into one of four 
mutually exclusive ranks. The conditions are rated by using an explicit list of symptoms. 
signs and lab tests indicating the presence of increasing severity of each identified 
condition. 
(2) The functional severity 
This component is intended to act as a snapshot of the impact of all the conditions. 
diagnosed or not, on the patient's current functional status. Ten body systems are 
assessed by using explicit criteria, and the severity impairment of each system IS 
classified in one of three levels, with the higher level indicating increasing impairment. 
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2 Disease severity 
2-1 General characteIistics 
Grade 0 Absence of coexistent disease in that category 
Grade 1 A comorbi~ c?ndition which is asymptomatic or mildly symptomatic 
where there IS lIttle or no comorbidity 
Grade 2 A m!ld t? moder~te con~ition t~at is generally symptomatic and requires 
medIc~1 mterventIOn. ThIS also mcludes past conditions. presently benign. 
that stIll present a moderate Iisk of morbidity 
Grade 3 An uncontrolled condition which causes moderate to severe disease 
manifestations dming medical care. These conditions are usually acute or 
subactive and require medical intervention. 
2-2 Specific classification 
2-2-1 Organic herut disease (OHD) 
Grade 0 Absence of coexistent disease 
Grade 1 Asymptomatic with ECG or echo changes only; no murmur or gallops by 
physical examination. No rales, increased JVP or edema 
Grade 2 Stable with medications, mild/moderate SOB produced by strenuous 
activities, minimal edema, NYHA Class I-II 
Grade 3 Pulmonary congestion/CHF, acute endocarditis, cerebral involvement or 
em boli, cru'diac insufficiency, acute MI (cannot walk 1 block. clim b 1 
tlight of stairs), NYHA Class III-IV 
2-2-2 Ischemic herut disease (IHD) 
Grade 0 Absence of coexistent disease 
Grade 1 Asymptomatic with ischemic ECG, abnormalities. mild angina produced 
by prolonged exertion (NYHA Class I-II) 
Grade 2 History of MI or coronru'y rutery bypass graft surgery (CABG) w~t~ .no 
residual effects, minimal CHF, angina or dyspnea produced by actIVItIeS 
of daily living (e.g., 1 tlight of stairs, 1 block of walk. emotional su"ess), 
NYHA Class II 
Grade 3 History of acute MI in past 6 months, moderate to severe CHF. angina. 
SOB at rest, cannot pelform most routine activities. NYHA Class ill-IV 
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2-2-3 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
2-2-4 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
2-2-5 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
2-2-6 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Plimary arrhythmias & conduction problems 
Absence of coexistent disease 
No medications, asymptomatic with ECG changes only 
Controlled with minimal symptoms by medication or pacemaker 
Significant symptoms such as recurrent dizziness or syncope due to 
arrhythmias or conduction blocks 
Congestive hea.rt failure (no known IHD or OHD) 
Absence of coexistent disease 
History of a single episode of CHF easily controlled with no further 
problems 
Mild pedal edema. mild dyspnea on exertion. mild olthopnea, history of 
multiple episodes of CHF presently under control 
Refer to appropliate cardiovascular disease (moderate-severe dyspnea on 
exertion, moderate-severe pedal edema, cardiomegaly, chronic fatigue) 
Hypertension 
Absence of coexistent disease 
Diagnosed hypertension, not on medications, asymptomatic, physical 
exam normal or history of treated hypel1ension but not currently on 
medications 
Under control on anti-hypertensive medications. BP< 160/1 00 
On medications, not controlled (BP<1601l00), but no central nervous 
system signs or symptoms of hypertensive crisis 
Cerebral Vascular Accident (CVA) 
Absence of coexistent disease 
History of one transient ischemic attack (TIA) with no residual effects 
History of CV As with no residual effects. history of CV ~ with ~ild 
paraesthesia or ataxia, history >=2 TIAs, aneurysm or partIal occlUSIOn 
with no symptoms 
History of CV A resulting in hemiplegia. paraplegia, quadriplegia; acute 
subarachnoid hemorrhage, frequent TIA 
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2-2-7 PeIipheral Vascular Disease (PVD) 
Grade 0 Absence of coexistent disease 
Grade 1 History of thr~mbophlebitis with. no residual effects. peripheral vascular 
bypass graft wIth no recurrence of symptoms. edema without obstruction 
Grade 2 Intennittent claudication from pelipheral vascular disease (PVD) 
Grade 3 ~ajor edema due to venous obstruction. ischemic ulcer or gangrene. 
hIstory of pulmonary embolus. rest pain from PYD 
2-2-8 Diabetes mellitus 
Grade 0 Absence of coexistent disease 
Grade 1 Chemical diabetes only. not on medication 
Grade 2 Controlled (BS<300) on medications. insulin or diet 
Grade 3 Diabetes not controlled (>300) or with any of neuropathy. nephropathy 
(creatinine 3.0-6.0), retinopathy. gangrene, etc. 
2-2-9 Respiratory problems 
Grade 0 Absence of coexistent disease 
Grade 1 Chronic cough. no medications. physical examination and X-rays nonnal 
Grade 2 Productive moming cough. mild dyspnea pelforming strenuous activities. 
pulmonary function test with FEV 1 60-XOo/c or predicted 
Grade 3 Dyspnea at rest. FEY1 <60%, recurrent respiratory infections prior to 
hospitalisation 
2-2-10 Malignancies (excluding Basal cell carcinomas of the skin) 
Grade 0 Absence of coexistent disease 
Grade 1 History of cancer. but >=5 years since last treatment 
Grade 2 History of cancer, between 1 and 5 years since last treatment 
Grade 3 Cun'ent diagnosis of cancer, or cancer treatment within the last year 
'-
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2-2-11 Hepatobiliary disease 
Grade 0 Absence of coexistent disease 
Grade 1 History (I year or more ago) of hepatitis: mild. asymptomatic cirrhosis 
Grade 2 BiliaJ!,. obstructio~, common duct obstruction: recent « I Year) history of 
hepat1t]s: uncomplIcated acute viral hepatitis or toxiddrug induced hepatitis 
Grade 3 Chronic persistent hepatitis; chronic. active hepatitis: portal hypertension: 
hepatic vein thrombosis 
2-2-12 Renal disease 
Grade 0 Absence of coexistent disease 
Grade 1 Acute, uncomplicated UTI: recent history «3 months) of uncomplicated 
nephritis, history «6 months) of nephrolithotomy or ESWL 
Grade 2 Acute nephritis, nephrolithiasis, mild renal altery stenosis: chronic UTI 
Grade 3 Acute. complicated (BUN>=40 or Creat >=3). obstructive uropathy: renal 
failure: encephalopathy: moderate/severe renal artery stenosis: working 
renal transplant 
2-2-13 Gastro-intestinal disease 
Grade 0 Absence of coexistent disease 
Grade 1 History of ulcer <I year: mildly symptomatic gastritis or diverticulitis: 
intelmiUent initable bowel syndrome 
Grade 2 Active ulcer controlled on medication; controlled divelticulitis; hiatal hernia 
with reflux esophagitis; polyp removal < 1 month: ulcerative colitis with 
minor manifestations or complications 
Grade 3 Any active GI condition resulting in pelforation. hemon·hage, obstruction. 
pelitonitis or fistula. including: . . .. . . 
Ulcers; Diverticulitis; Appendicitis: Ententts or ulceratIve cohus: HIatal 
hemia with anemia. stricture or aspiration pneumonia 
294 
3 Functional severity 
3-1 General characteristics 
Level 0 
Levell 
Level 2 
No significant impaitmentinOImal function 
Mild or moderate impairment. Selection of level 1 mllst be based on 
documentation. 
Serious/severe impairment. Selection of level 2 must be based on 
documentation. 
3-2 Severity categOlies 
3-2-1 Circulation 
Level 0 
Levell 
Level 2 
No problems: walking freely: climb 1 flight of stairs: perfOlmance of usual 
ADL 
Walking with SOB: chest pain: dizziness (transient): walking with 
assistance: pacemaker 
HeaIt failure with edema: bedtidden 
3-2-2 Respiration 
Level 0 No problems: detined as any chronic lung condition with no symptoms 
Levell SOB: chronic cough: walking limited to one block 
Level 2 COPD documented FEV <60%: tracheotomy: oxygen tank: respirator 
3-2-3 Neurological 
Level 0 No problems: a neurological disease with no symptoms 
Levell Dizziness: numbness: seizures by history (controlled): syncope by history 
Level 2 Ataxia: partial paralysis: seizures (uncontrolled): bedridden 
295 
3-2-4 Mental status 
Level 0 
Levell 
Level 2 
No problems 
Transient condition of mild depression, irrational thinking. hallucinations, 
suicidal, forgetfulness ... 
.... 
Chronic/recurring condition of confused. dysoriented. psychotic, long-
telm depres.~ion over many years, intellectual deterioration 
3-2-5 UIinary 
Level 0 
Levell 
Level 2 
3-2-6 Fecal 
Level 0 
Levell 
Level 2 
No problems (U1inary diagnosis but no symptoms) 
Hesitancy: dribbling: frequency: occasional incontinence: -ostomy 
Incontinence: retention 
No problems 
Chronic dial1'hea or constipation: pain with bowel movements: occasional 
incontinence: -ostomy 
Incontinence 
3-2-7 Feeding 
Level 0 
Levell 
Level 2 
3-2-8 Vision 
Level 0 
Levell 
Level 2 
No problems 
Slight motor problems (needs food cut) 
Paralysis: cannot feed oneself: cannot eat: anorexia: tube feeding 
No problems 
PaItial problem (difficulty in reading. driving, etc): slight blUlTing: slight 
functional involvement 
Severe blurting (cannot read, drive, etc): blindness 
.... 
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3-2-9 Hearing 
Level 0 
Levell 
Level 2 
No problems: hearing aid 
Hearing limited to one ear: hard of hearing 
Deaf 
3-2-10 Speech 
Level 0 
Levell 
Level 2 
No problems 
Minor speech problems: sluning: prosthesis. but able to communicate 
Aphasia (cannot speak or be understood well) 
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4 Groupin~ rules 
The scoring goal is to have two overall independent subscales retlecting the severity of 
each of the two dimensions, and. after assigning patients to the two categories. a 
composite score reflecting the overall amount/severity of comorbidity. 
First Step: Assembling an overall physiologic severity score. 
In the case in which only one disease has been identified and scored. patients are placed 
in the level cOITesponding to that single score. When more than one coexistent disease has 
been assessed, patient~ are placed in the level con'esponding to the highest single score 
(peak severity of coexistent diseases), independent of the number of conditions recorded. 
Eventually a subscale reflecting the maximum of the severity of the coexistent disease 
roughly corresponds to: 
Level 0 
Levell 
Level 2 
Level 3 
No history or evidence of coexistent disease 
Asymptomatic controlled disease 
Symptomatic controlled disease 
Uncontrolled disease 
Second Step: Delive an overall estimate of the physical impailment. 
The same procedure is adopted to delive the overall physical impainnent subscale score. 
A single number is generated from each system so that patients are classitied according to 
the highest score recorded in these dimensions. This roughly cOiTesponds to: 
Level 0 
Levell 
Level 2 
No major identified problem or impailment 
Mild or moderate impailment 
Severe/selious impailment 
At the end of this process each patient has a cornorbidity profile indicating the presence 
and amount of a given peak disease, the number of identitied diseases and the impact of 
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diagnosed or not conditions on physical impailment. A classitication system that takes 
into account two dimensions with 4 and 3 levels respectively generates 12 combinations. 
The two subscales were condensed into a single composite "c;lle assessing the overall 
severity of coexistent illness, called Index of Coexistent Disease (ICED) using only -+ 
categOlies. 
The two dimensions were combined in order to have a -+ point scale where patient~ were 
ranked in increasing intensity of physiologic and physical impailment. as shown below. 
Peak Intensity Peak Intensity 
of Disease of Functional ICED Levels 
Severity Severity (1,2,3.4) 
(0,1,2,3) (0,1,2) 
0 0 1 
0 1 1 
1 0 2 
2 0 2 
1 1 3 
2 1 3 
3 any (0,1 or 2) 4 
any (0-3) 2 4 
299 
Appendix-8 
Figures to Chapter 7 
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Fig 7-1a: Normal plot of deviance from the regression model 
for serious compl ication in the UK 
(using four levels of the ICED) 
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Fig 7-1b: Normal plot of deviance from the regression model 
for serious compl ication for the UK 
(using dichotomised ICED 1/2 or 3/4) 
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Figure 7-2a: Distribution of change in basic ADL in Japan 
Count Midpoint One symbol equals approximately 1.00 occurrence 
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Figure 7-2b: Distribution of change in instrumental ADL in Japan 
Count Midpoint One symbol equals approximately .80 occurrences 
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Figure 7-2c: Distribution of change in social activity in Japan 
Count Midpoint One symbol equals approximately .80 occurrences 
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Figure 7-2d: Distribution of change in basic ADL in the UK 
Count Midpoint One symbol equals approximately 1.50 occurrences 
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Figure 7-2e: Distribution of change in instrumental ADL in the UK 
Count Midpoint One symbol equals approximately 
.80 occurrences 
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Figure 7-2f: Distribution of change in social activity in the UK 
Count Midpoint One symbol equals approximately 1 . 00 occurrence 
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Figure 7-2g: Distribution of change in basic ADL in Japan 
after transformation 
Count Ualue One symbol equals approximately 1.00 occurrence 
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Figure 7-2h: Distribution of change in basic ADL in the UK 
after transformation 
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Figure 7-2i: Distribution of residual over predicted value from 
regression model for change in instrumental ADL in Japan 
Standardized Scatterplot 
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Figure 7-2j: Distribution of residual over predicted value from 
regression model for change in social activity in Japan 
Standardized Scatterplot 
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Figure 7-2k: Distribution of residual over predicted value from 
regression model for change in instrumental ADL in the UK 
Standardized Scatterplot 
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Figure 7-21: Distribution of residual over predicted value from 
regression model for change in social activity in the UK 
Standardized Scatterplot 
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Figure 7-2m: Linearity of observed residual over expected value from 
regression model for change in instrumental ADL in Japan 
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Figure 7-2n: Linearity of observed residual over expected value from 
regression model for change in social activity in Japan 
Normal Probabil ity (P-P) Plot 
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Figure 7-20: Linearity of observed resicual over expected value from 
regression model for change in instrumental ADL in the UK 
Normal Probabi I ity <P-P) Plot 
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Figure 7-2p: Linearity of observed residual over expected value from 
regression model for change in social activity in the UK 
Normal Probabi I ity <P-P) Plot 
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